Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASGR1,Asialoglycoprotein receptor 1,40228,0.108220100647269,0.0027083937776438,0.102911648843087,0.11352855245145,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LDLR,Low-density lipoprotein receptor,40356,0.236083169653711,0.00472132754056706,0.2268293676742,0.245336971633223,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFGE8,Lactadherin,40332,0.186251060197152,0.00381414342637168,0.178775339081463,0.19372678131284,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PON3,Serum paraoxonase/lactonase 3,40422,-0.107378081883108,0.00251863531361689,-0.112314607097797,-0.102441556668418,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40411,-0.114721315601675,0.00293135409888252,-0.120466769635485,-0.108975861567865,1.1125369292564e-308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRAP1,Proline-rich acidic protein 1,37998,0.152004038064856,0.0039085993298958,0.144343183378261,0.159664892751452,1.11254186409307e-308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS8,Prostasin,40293,0.138103756579467,0.00376022387634515,0.130733717781831,0.145473795377104,1.76788441431766e-283
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCG,Pro-glucagon,39980,0.421328972150828,0.0116292801026006,0.398535583149731,0.444122361151925,5.47263017619038e-276
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGRP,Agouti-related protein,40516,0.178555043891395,0.00498044208043481,0.168793377413743,0.188316710369048,7.33939811404511e-271
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,0.104974011042723,0.00298844960851169,0.0991166498100396,0.110831372275405,2.51804500420508e-260
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF9,Protein turtle homolog A,37990,0.254372495379497,0.00743006280625638,0.239809572279234,0.268935418479759,1.96092020837812e-246
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOM,Apolipoprotein M,40372,-0.0853170809113809,0.00250952659823291,-0.0902357530439174,-0.0803984087788444,1.24687951802816e-244
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40332,-0.0994274589381811,0.00294144821763349,-0.105192697444743,-0.0936622204316194,6.26843228311953e-242
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR37,Prosaposin receptor GPR37,40042,0.212608581722335,0.00628885391465449,0.200282428049612,0.224934735395058,7.59009490416053e-242
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLTP,Phospholipid transfer protein,40461,-0.104301905732765,0.00321420704909739,-0.110601751548996,-0.0980020599165342,8.90468182947898e-224
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40313,0.162749798481055,0.00518456836615678,0.152588044483387,0.172911552478722,6.65636430323354e-210
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GDF15,Growth/differentiation factor 15,40536,0.126563447064934,0.00405658162707793,0.118612547075861,0.134514347054006,1.57017824827669e-207
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,0.196716796655528,0.00635351364642446,0.184263909908536,0.20916968340252,2.0363125089781e-204
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPL,Lipoprotein lipase,40359,-0.133255995091836,0.00432124384166936,-0.141725633021508,-0.124786357162164,7.35363100767747e-203
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADIPOQ,Adiponectin,38013,-0.193590552744742,0.00626572560055531,-0.20587137492183,-0.181309730567654,1.27733563864177e-202
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPY,Pro-neuropeptide Y,40489,0.192300608606008,0.0062770670164665,0.179997557253733,0.204603659958282,2.33939372652936e-200
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,40063,0.121767670643988,0.00399377890880902,0.113939863982722,0.129595477305253,2.24702623635647e-198
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PYY,Peptide YY,37562,0.270750329581912,0.00892594085081436,0.253255485514316,0.288245173649508,2.18155628944252e-195
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFF3,Trefoil factor 3,40309,0.150259620193286,0.00504997766315548,0.140361663973501,0.160157576413071,2.33103217856325e-189
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOF,Apolipoprotein F,37987,-0.0675264016628885,0.00228664729077042,-0.0720082303527985,-0.0630445729729784,8.48583661173886e-186
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD4,T-cell surface glycoprotein CD4,40309,0.084352898182761,0.00288053929348767,0.0787070411675251,0.0899987551979968,1.24528775765814e-183
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN1,CCN family member 1,40280,0.215187253614431,0.00735737021957726,0.20076680798406,0.229607699244802,3.44249046099935e-183
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CES1,Liver carboxylesterase 1,40352,0.208780733983768,0.00719032369356823,0.194687699544375,0.222873768423162,1.14739194871228e-180
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTN4R,Reticulon-4 receptor,40489,0.0908990845042546,0.0032018153164837,0.0846235264839466,0.0971746425245627,4.98465718924918e-173
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OXT,Oxytocin-neurophysin 1,40471,0.351573860612867,0.0125050264382785,0.327064008793841,0.376083712431893,8.38142428560968e-170
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS4,Galectin-4,40357,0.139939739055001,0.0050111017990082,0.130117979528945,0.149761498581057,1.38820153914704e-167
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,0.0907422485128493,0.00326780694371179,0.0843373469031742,0.0971471501225244,8.84900885981401e-166
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOS3,"Nitric oxide synthase, endothelial",39961,0.143352153619747,0.00518050950353513,0.133198354992818,0.153505952246676,1.48793446042274e-164
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,0.0995133305647541,0.00361434524518442,0.0924292138841926,0.106597447245316,4.23612382249874e-163
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40424,0.11990069085884,0.00437438182598763,0.111326902479904,0.128474479237776,1.1290050194921e-161
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40453,0.108366604360456,0.00397506385390954,0.100575479206794,0.116157729514119,5.35353613842252e-160
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS15,Enteropeptidase,40305,0.236311941614429,0.00872129792404265,0.219218197683305,0.253405685545552,4.28826754397391e-158
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF1,Macrophage colony-stimulating factor 1,40422,0.0692426865922976,0.00257038652179748,0.0642047290095745,0.0742806441750206,2.36875076175735e-156
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACY1,Aminoacylase-1,40359,0.151176005870255,0.00564249123114911,0.140116723057203,0.162235288683307,1.051956265577e-154
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,0.115655983406169,0.00435770393783607,0.10711488368801,0.124197083124327,7.21650635706465e-152
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FURIN,Furin,40411,0.0842148516087213,0.00319321175624221,0.0779561565664866,0.090473546650956,4.50336354479388e-150
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HGF,Hepatocyte growth factor,40516,0.0856894926807311,0.00324942623195196,0.0793206172661052,0.0920583680953569,4.56991504579873e-150
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NHLRC3,NHL repeat-containing protein 3,37370,0.0798556840601335,0.00304738649757277,0.0738828065248909,0.0858285615953761,1.62494900649724e-147
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGF,Placenta growth factor,40516,0.0650924624230579,0.00249308618904092,0.0602060134925377,0.0699789113535781,3.32025742651598e-147
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTRK3,NT-3 growth factor receptor,40471,-0.0539668789852262,0.00207189244149458,-0.0580277881705556,-0.0499059697998969,1.60190580051445e-146
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KITLG,Kit ligand,40359,-0.0893966117424774,0.00346082124696657,-0.0961798213865319,-0.0826134020984229,3.66935679078766e-144
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,0.0948949478391337,0.00370912271592091,0.0876250673159287,0.102164828362339,1.67212933151174e-141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL23,C-C motif chemokine 23,40422,0.099461904534649,0.00389648406393185,0.0918247957693426,0.107099013299955,6.67389311405195e-141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL13,C-X-C motif chemokine 13,40471,0.153327893186963,0.00601980666396101,0.141529072125599,0.165126714248327,2.55552296754134e-140
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMBP,Protein AMBP,40470,0.0484033245155715,0.00190040069755115,0.0446785391483713,0.0521281098827718,2.58838238206711e-140
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUSB,Beta-glucuronidase,40419,0.141050133987751,0.00555422206230886,0.130163858745626,0.151936409229876,1.65369551816976e-139
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MXRA8,Matrix remodeling-associated protein 8,37671,-0.0740141075432511,0.0029101434027751,-0.0797179886126903,-0.0683102264738119,2.36622860647242e-139
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40489,0.0793155088981401,0.00313330046088964,0.0731742399947964,0.0854567778014838,1.17423114228262e-138
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF8,Immunoglobulin superfamily member 8,40359,0.0716281558980454,0.00284193346561292,0.0660579663054441,0.0771983454906467,1.77909000981707e-137
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL16,C-C motif chemokine 16,40536,0.125846445117281,0.00503593631234381,0.115976009945088,0.135716880289475,2.97197713841347e-135
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,0.0727862821416574,0.00292570443555736,0.067051901447965,0.0785206628353498,4.71013389770716e-134
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACE2,Angiotensin-converting enzyme 2,40042,0.115566755395587,0.00465355506601573,0.106445787466196,0.124687723324978,1.49329372116878e-133
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS9,Galectin-9,40350,0.0759647772953515,0.00306151101538083,0.0699642157052051,0.0819653388854979,2.21839773468433e-133
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP5,Retinol-binding protein 5,40305,0.130189878011857,0.00526179513881856,0.119876759539772,0.140502996483941,1.2108187109148e-132
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSD,Cathepsin D,39243,0.0933843574331206,0.00378973419643899,0.0859564784081002,0.100812236458141,2.00127043344921e-131
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MVK,Mevalonate kinase,40044,0.179141359595382,0.00728239324000601,0.16486786884497,0.193414850345794,4.01365284272387e-131
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,0.0808494758290606,0.00330110771519428,0.0743793047072798,0.0873196469508414,4.40113844696596e-130
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOMO1,Nodal modulator 1,40332,0.0550855213531734,0.00225334817747019,0.0506689589253318,0.0595020837810149,1.36062732806557e-129
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,0.101859684506147,0.00417113763541099,0.0936842547407415,0.110035114271553,2.77014104686485e-129
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37671,0.0879855388593155,0.0035973641592699,0.0809347051071465,0.0950363726114845,2.99339753449186e-129
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,0.0899273242200879,0.00369332769460653,0.0826884019386591,0.0971662465015167,4.04571435012547e-128
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTH,Parathyroid hormone,37572,0.182919678627552,0.00752270043854428,0.168175185768005,0.197664171487098,8.8061273446802e-128
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLUL1,Clusterin-like protein 1,40338,-0.105005278132544,0.00433766500982811,-0.113507101551807,-0.0965034547132807,3.6647710383922e-127
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHI3L1,Chitinase-3-like protein 1,40054,0.17143857543369,0.00709779633936117,0.157526894608542,0.185350256258838,1.42084808165849e-126
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,0.126123382267398,0.00523123780503126,0.115870156169537,0.136376608365259,3.75135352385417e-126
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,0.141184108994186,0.00588058209618214,0.129658168085669,0.152710049902703,4.26792249223069e-125
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECTIN2,Nectin-2,40330,0.0660348455419911,0.00275658916150245,0.0606319307854463,0.0714377602985359,1.31046933263214e-124
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,0.172267868070149,0.00718474901441762,0.158185760001891,0.186349976138408,1.91104729815551e-124
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,0.0657717259555164,0.00275811679884751,0.0603658170297753,0.0711776348812575,1.61379703053229e-123
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAMDC4,Apical endosomal glycoprotein,37900,0.123840256338028,0.00520676183066328,0.113635003149928,0.134045509526128,1.60878879168723e-122
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCAM,Cell surface glycoprotein MUC18,40403,-0.0763865327407514,0.00324843154201398,-0.0827534585630988,-0.070019606918404,3.16122617371133e-120
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,0.162185000128198,0.00692943672023743,0.148603304156533,0.175766696099864,8.50965346024732e-119
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL15,C-C motif chemokine 15,40536,0.0991393929290066,0.00424841794574651,0.0908124937553434,0.10746629210267,1.77997657709063e-118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,0.0660836588038601,0.00284038313271847,0.0605165078637319,0.0716508097439883,8.99744348561522e-118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF21,Fibroblast growth factor 21,40453,0.258797815480321,0.0111574193582885,0.236929273538075,0.280666357422566,4.32299125930005e-117
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,0.0857521908332302,0.00369561494242587,0.0785087855460755,0.0929955961203849,7.97374470251252e-117
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40305,0.120560023537842,0.00522171925541794,0.110325453797223,0.130794593278462,4.95501284801144e-116
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F9,Coagulation factor IX,40372,0.0395685161063227,0.00171693865570948,0.0362033163411321,0.0429337158715133,1.25078337353675e-115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OCLN,Occludin,37959,0.0959053129557128,0.0041685061622168,0.0877350408777679,0.104075585033658,6.3193501146556e-115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,0.121887544697824,0.00530621068859233,0.111487371748183,0.132287717647465,7.32032289552371e-115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40391,0.0505267051740905,0.00221082500707168,0.04619348816023,0.054859922187951,8.88022662676726e-114
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40471,0.0757494608937336,0.00331504464642226,0.069251973386746,0.0822469484007212,9.51117934348131e-114
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL7,Angiopoietin-related protein 7,40489,0.0806328505233709,0.00353018778491232,0.0737136824649427,0.087552018581799,1.1623890177882e-113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UPB1,Beta-ureidopropionase,37990,0.199460147736776,0.00872205157838461,0.182364926643142,0.21655536883041,1.34149177642952e-113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40305,0.167217807221431,0.00734639243939954,0.152818878040208,0.181616736402654,7.00464830067301e-113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFA,Protransforming growth factor alpha,40341,0.103112318710031,0.00457183516576316,0.0941515217851353,0.112073115634927,6.74046957471379e-111
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AREG,Amphiregulin,40305,0.106410130716813,0.00473102955365361,0.0971373127916518,0.115682948641974,2.6300608500149e-110
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLA,Alpha-galactosidase A,37642,0.0780611781072222,0.00346970989486251,0.0712605467132917,0.0848618095011528,5.04985064161554e-110
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40312,0.0436068076841125,0.001942482507166,0.0397995419700672,0.0474140733981579,6.70262437479978e-110
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,0.18013224735157,0.00803287480165999,0.164387812740316,0.195876681962824,1.22507002152064e-109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,0.0801524775383989,0.00357972336689278,0.073136219739289,0.0871687353375087,2.4353126778834e-109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSO,Cathepsin O,40516,0.0641506650626247,0.00287118108633198,0.0585231501334141,0.0697781799918354,6.41619798306432e-109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASET2,Ribonuclease T2,40465,0.0563856272035147,0.00252364492805199,0.0514392831445328,0.0613319712624966,6.49603858482608e-109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFNA4,Ephrin-A4,40203,0.0628271272295335,0.00281225691034692,0.0573151036852536,0.0683391507738135,7.29414789808499e-109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,0.0706681754860863,0.00316667102196371,0.0644615002830375,0.0768748506891352,1.18298289621981e-108
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18R1,Interleukin-18 receptor 1,40516,0.0691952784763783,0.00310739196492495,0.0631047902251254,0.0752857667276312,3.26091325796772e-108
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL27,C-C motif chemokine 27,40359,0.126051790093635,0.00568112522505463,0.114916784652528,0.137186795534742,1.90972022726654e-107
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40422,0.0603847625370662,0.00272223216146341,0.0550491875005979,0.0657203375735345,2.1304839203274e-107
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UMOD,Uromodulin,40502,-0.114843634676335,0.0051814701625906,-0.124999316195013,-0.104687953157658,3.06932704756897e-107
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MENT,Protein MENT,37671,-0.0462104599746057,0.00208169254292146,-0.0502905773587318,-0.0421303425904797,3.19503170965446e-107
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPY30,Protein dpy-30 homolog,40414,0.125055595920783,0.00567274974732563,0.113937006416024,0.136174185425541,4.06893472276839e-106
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTA1,Glutathione S-transferase A1,40333,0.174081563127193,0.00790296967902444,0.158591742556305,0.189571383698081,6.04284680530158e-106
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA11,Integrin alpha-11,40341,-0.0716316335197606,0.00325323133083213,-0.0780079669281916,-0.0652553001113297,7.27508245491101e-106
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPM,Carboxypeptidase M,40415,0.0719097459390198,0.00326760568295751,0.0655052388004231,0.0783142530776166,9.20215251527074e-106
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST3,Cystatin-C,40372,0.0589468504272174,0.00268581962279892,0.0536826439665315,0.0642110568879033,3.30890580818932e-105
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,0.0572092518483974,0.0026133780635251,0.0520870308438882,0.0623314728529066,1.11375978754558e-104
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA1,Ephrin type-A receptor 1,40400,0.0711273078367999,0.00326311654343647,0.0647315994116644,0.0775230162619354,8.01649027576939e-104
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUC13,Mucin-13,39961,0.104539401486893,0.00479746408702938,0.0951363718763156,0.113942431097471,1.01988544343122e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40359,-0.0560052913833527,0.00257078598954901,-0.0610440319228688,-0.0509665508438367,1.04473093943887e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD27,CD27 antigen,40411,0.0846467517661347,0.00388960404871162,0.0770231278306599,0.0922703757016095,1.68108604210028e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARB2,Lysosome membrane protein 2,40011,0.0642554749721113,0.00295245358386293,0.05846866594774,0.0700422839964827,1.79165677349454e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,0.0754043241842684,0.00347241656828471,0.0685983877104303,0.0822102606581064,4.62837499253155e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOC1,Apolipoprotein C-I,37981,-0.0750520021439111,0.00347688776775574,-0.0818667021687123,-0.0682373021191098,1.24999344254512e-101
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIGR,Polymeric immunoglobulin receptor,40154,0.0724902349476996,0.00336513881516872,0.0658945628699689,0.0790859070254303,1.86135442945648e-101
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSZ,Cathepsin Z,40345,0.0640141749038808,0.00297446110997541,0.058184231128329,0.0698441186794326,2.73540981856938e-101
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP1,Metalloproteinase inhibitor 1,40167,0.0576934582289507,0.00269088932027062,0.0524193151612203,0.0629676012966811,1.54349384034498e-100
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAV,Integrin alpha-V,40489,-0.0334652536325389,0.00156584136853308,-0.0365343027148637,-0.0303962045502141,6.00118926586549e-100
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,0.0761930198720747,0.00356868625446639,0.0691983948133206,0.0831876449308288,9.36244535619733e-100
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FETUB,Fetuin-B,40372,0.0689501180429014,0.00323651866537988,0.0626065414587568,0.0752936946270459,2.5390084662206e-99
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA14,Carbonic anhydrase 14,40489,-0.0697991341328969,0.00330190357068219,-0.076270865131434,-0.0633274031343598,7.49500111118724e-98
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINF1,Pigment epithelium-derived factor,37790,0.0526364437940575,0.00248975305178353,0.0477565278125618,0.0575163597755533,1.31633798423496e-97
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTSL2,ADAMTS-like protein 2,37998,0.0624481030904051,0.00296270956683974,0.0566411923393992,0.068255013841411,4.54467022344848e-97
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37815,0.0627076018485643,0.00297715762117114,0.0568723729110688,0.0685428307860597,6.49566448690145e-97
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,40141,0.297249571947391,0.0141558942875708,0.269504019143752,0.32499512475103,1.44279173685885e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37920,0.16755894044243,0.00797175688213923,0.151934296953437,0.183183583931423,1.54643779497069e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCA,Calcitonin,40192,0.11030187144302,0.00525978761859838,0.0999926877105671,0.120611055175473,2.50832545466541e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRIP2,Cysteine-rich protein 2,40228,0.071982844984842,0.00345422029217567,0.0652125732121777,0.0787531167575063,3.6509063472241e-95
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD5,T-cell surface glycoprotein CD5,40470,0.066479511443526,0.00319441276763759,0.0602184624189563,0.0727405604680956,6.16301580013797e-95
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFR2,Fibroblast growth factor receptor 2,40411,0.0424656098238225,0.00204439690049078,0.0384585918988606,0.0464726277487844,1.38747295222107e-94
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOD,Apolipoprotein D,37345,-0.0889594254609299,0.00427597001775625,-0.0973403266957321,-0.0805785242261276,1.39914555219831e-94
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40372,-0.0587833823658595,0.00284454567609553,-0.0643586918910068,-0.0532080728407123,1.20145126250709e-93
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,0.107652094271098,0.00521363042571501,0.0974333786366965,0.117870809905499,1.79828080382579e-93
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40341,0.0741769975185761,0.00360812390161633,0.0671050746714081,0.0812489203657441,1.03955508947489e-92
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGRN,Agrin,40422,0.0650465413656375,0.00317809704167124,0.0588174711639619,0.0712756115673131,6.37180891552174e-92
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCLY,Selenocysteine lyase,40434,0.0931338965081078,0.00455671594408367,0.0842027332577038,0.102065059758512,1.11962752720628e-91
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G15,Phospholipase A2 group XV,40411,0.0501483849900576,0.00246274569621632,0.0453214034254736,0.0549753665546416,5.11401716089826e-91
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BPIFB1,BPI fold-containing family B member 1,40261,-0.119780749423924,0.00589928225615573,-0.131343342645989,-0.108218156201858,1.67573227826284e-90
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,0.178473641658756,0.00878971589011908,0.161245798514122,0.195701484803389,1.72001676946334e-90
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39535,0.0739535327115715,0.0036442008533771,0.0668108990389524,0.0810961663841906,2.35331706106541e-90
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE6,Ribonuclease K6,37917,0.0576218575126324,0.00284199985081402,0.052051537805037,0.0631921772202279,4.68860162614223e-90
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F7,Coagulation factor VII,40376,0.0580495871300678,0.00286981070565991,0.0524247581469744,0.0636744161131613,7.49940305577375e-90
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HJV,Hemojuvelin,37959,0.0890182411464698,0.00442492561192286,0.080345386947101,0.0976910953458386,1.02920104196628e-88
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA3F,Semaphorin-3F,40359,0.0497796882301575,0.00247733562853741,0.0449241103982242,0.0546352660620908,1.04681115572916e-88
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300LG,CMRF35-like molecule 9,40332,-0.0719770177347518,0.00361019003004191,-0.079052990193634,-0.0649010452758697,2.26459787043658e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INHBC,Inhibin beta C chain,40332,0.0809287160411385,0.00407906137109455,0.0729337557537932,0.0889236763284838,1.49892163930391e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,0.0643885745106101,0.00324640249636996,0.058025625617725,0.0707515234034953,1.68411762292532e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40264,0.0507072574192836,0.00256450919550747,0.0456808193960889,0.0557336954424782,5.58289107344539e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMOT,Angiomotin,37671,0.0792851529331227,0.00402112243668493,0.0714037529572202,0.0871665529090252,2.57159283271885e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL10,C-X-C motif chemokine 10,40422,0.127314648303708,0.00647154508306685,0.114630419940897,0.139998876666519,3.7376117995132e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40332,0.0814722994377041,0.00415792533551609,0.0733227657800926,0.0896218330953157,1.71259380221598e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUCB2,Nucleobindin-2,40447,0.0696262561634568,0.0035555625551786,0.0626573535553067,0.0765951587716068,2.1256679122294e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGR3,Anterior gradient protein 3,39963,0.111808914706203,0.00571140400564657,0.100614562855136,0.123003266557271,2.55278673400269e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTA3,Glutathione S-transferase A3,39980,0.141899565475062,0.00726416693584281,0.12766179828081,0.156137332669314,5.71506913857995e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40359,0.0660315844028594,0.00338610132954592,0.0593948257969494,0.0726683430087695,1.02498879953173e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,0.0647883721959069,0.00332953915823895,0.0582624754457585,0.0713142689460552,2.27232632130886e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC39A5,Zinc transporter ZIP5,40341,0.0988624485192956,0.00512448454791335,0.0888184588053855,0.108906438233206,5.4059172808044e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGFR,Epidermal growth factor receptor,40536,-0.0302748348668144,0.0015715111217884,-0.0333549966655197,-0.0271946730681091,8.83813319513497e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40341,0.0979816756347402,0.00508601397187736,0.0880130882498605,0.10795026301962,9.0448289581287e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFA,Vascular endothelial growth factor A,40456,0.107882620672291,0.0056267778253196,0.096854136134665,0.118911105209918,5.0256050591523e-81
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MME,Neprilysin,40305,0.148931904139357,0.00779557790853326,0.133652571438631,0.164211236840082,1.84914885109102e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,0.107477697527026,0.00562838363201243,0.0964460656082817,0.11850932944577,2.28442954602645e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40502,0.0692937871427931,0.0036309891930213,0.0621770483244713,0.0764105259611148,2.65513438208539e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,0.0893203364401424,0.00468158566027743,0.0801444285459986,0.0984962443342862,4.47507738372369e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40332,0.0629204194554627,0.00330335910588929,0.0564458356079197,0.0693950033030058,5.37618443796361e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KYNU,Kynureninase,40516,0.0812957807381014,0.00427298157301557,0.0729207368549909,0.089670824621212,7.90102345022214e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40536,-0.0631354953343503,0.0033202171178909,-0.0696431208854164,-0.0566278697832841,9.5097239136004e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,-0.0448495730211909,0.00236017820908431,-0.0494755223109961,-0.0402236237313856,1.24153516363469e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,0.0499719477469419,0.00263149910855116,0.0448142094941817,0.0551296859997022,1.55283957671038e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4D,C-type lectin domain family 4 member D,40341,0.111149680843925,0.00586760865007593,0.0996491678897757,0.122650193798073,3.75886008997967e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300E,CMRF35-like molecule 2,40436,0.0725214590104391,0.00383086536738183,0.0650129628903707,0.0800299551305075,4.65080647292866e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SULT2A1,Bile salt sulfotransferase,40341,0.0961445151808793,0.0051032673217071,0.0861421112303334,0.106146919131425,2.54039831556495e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,0.0940788908464048,0.00499820978747153,0.0842823996629606,0.103875382029849,3.44124183463165e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSG2,Desmoglein-2,40332,-0.048478461981013,0.00258402662091787,-0.0535431541580121,-0.043413769804014,1.09126449315916e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,0.082263394392036,0.00438754045991616,0.0736638150906003,0.0908629736934717,1.97741179134107e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,0.0689805006857614,0.00369130371074714,0.061745545412697,0.0762154559588258,4.20001389823433e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,0.0743664484654693,0.00398015158884315,0.0665653513513368,0.0821675455796019,4.46277159354957e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF3,Immunoglobulin superfamily member 3,40305,0.0618872292800548,0.00331241338612425,0.0553948990432513,0.0683795595168583,4.5370178140974e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL6A3,Collagen alpha-3(VI) chain,40536,0.0615319355223392,0.00329553444738216,0.0550726880054702,0.0679911830392082,5.51500943540943e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD274,Programmed cell death 1 ligand 1,40228,0.0621354227100224,0.00333316688955981,0.0556024156064851,0.0686684298135596,9.85617546060904e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40305,0.156715497239565,0.00841623267388048,0.14021968119876,0.173211313280371,1.43218238512541e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF23,Fibroblast growth factor 23,40469,0.109840708678847,0.00591766645782448,0.0982420824215112,0.121439334936183,4.13482147482278e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGLN1,Egl nine homolog 1,40341,0.093902560279478,0.00508591947527294,0.083934158107943,0.103870962451013,2.50184314446945e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40310,0.120348008161747,0.00652289742651553,0.107563129205776,0.133132887117717,3.18657975844131e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HLA_E,,40341,0.0509448396685475,0.00276437020135897,0.0455266740738839,0.056363005263211,4.64368089629711e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFASC,Neurofascin,40516,0.0479316484597872,0.00261295541738992,0.042810255841703,0.0530530410778715,2.12385673527034e-74
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,0.13869365220751,0.0075860053498807,0.123825081721744,0.153562222693276,6.51197625006335e-74
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL3,C-C motif chemokine 3,40341,0.107713336810018,0.00590056334623999,0.0961482326513878,0.119278440968649,1.07359320516189e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE4,Ribonuclease 4,37575,0.0482187172059257,0.00264115557787645,0.0430420522732879,0.0533953821385636,1.48597088389814e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GZMA,Granzyme A,40516,0.0613882572084976,0.00337762400915255,0.0547681141505586,0.0680084002664366,4.39419925980428e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F11R,Junctional adhesion molecule A,40332,0.0982927699299422,0.00542344965425715,0.0876628086075982,0.108922731252286,1.1187537849152e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LSP1,Lymphocyte-specific protein 1,40341,0.069417390882866,0.00383083837342612,0.0619089476709508,0.0769258340947812,1.1786972756981e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHISA5,Protein shisa-5,37998,0.0431648090974996,0.00239556378265255,0.0384695040835006,0.0478601141114986,9.55290140536249e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39980,0.138690373111875,0.00773045126952143,0.123538688623613,0.153842057600137,2.96598759902731e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,0.0945368695356692,0.00527133246082653,0.0842050579124492,0.104868681158889,3.36730312742424e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,0.103239153105893,0.00575968568921806,0.0919501691550254,0.11452813705676,3.8262004518187e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPPC,C-type natriuretic peptide,40341,0.0738394393221686,0.00413441937018792,0.0657359773566003,0.0819429012877369,1.19113461065457e-70
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40443,0.0527100075941538,0.00296153547465819,0.0469053980638237,0.0585146171244838,3.46639330359806e-70
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40405,0.0870527599357871,0.0049069294822365,0.0774351781506036,0.0966703417209706,9.49225099758795e-70
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100P,Protein S100-P,40042,0.0913856121212303,0.00515481173197796,0.0812821811265535,0.101489043115907,1.22439265125993e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B2M,Beta-2-microglobulin,38013,0.0543236361365912,0.00306325986956828,0.0483196467922374,0.0603276254809451,1.39778323522362e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH2,Cadherin-2,40359,0.0599894081864168,0.00338616944861957,0.0533525160671225,0.0666263003057112,1.46859841924651e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18BP,Interleukin-18-binding protein,40403,0.0518174804789534,0.00293563036264482,0.0460636449681696,0.0575713159897373,4.51420024374585e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C9,Complement component C9,37987,-0.0829600613008706,0.00470149251066295,-0.09217498662177,-0.0737451359799712,6.50500936129742e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP1,"Fatty acid-binding protein, liver",40357,0.157685154201627,0.00894585950162455,0.140151269578443,0.175219038824811,6.95074080105415e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRPB1,Signal-regulatory protein beta-1,40335,0.0761882859097054,0.0043235539055834,0.067714120254762,0.0846624515646489,7.58633948413238e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOA1,Apolipoprotein A-I,38013,-0.0469628059584321,0.00266295586601246,-0.0521821994558165,-0.0417434124610476,7.69176406055547e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CKAP4,Cytoskeleton-associated protein 4,40457,0.0441988643551284,0.00251097803510891,0.039277347406315,0.0491203813039419,1.05041721848353e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTBS,Di-N-acetylchitobiase,37819,0.0460977602672007,0.00261920544867027,0.040964117587807,0.0512314029465945,1.46128730462103e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40536,0.0829023373406213,0.0047165775914773,0.0736578452613258,0.0921468294199169,1.6202791036273e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPP1,Tripeptidyl-peptidase 1,40255,0.0755527718888231,0.00430654465271622,0.0671119443694993,0.0839935994081469,2.94539563690257e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,0.074269052440442,0.00424268249970531,0.0659533947410196,0.0825847101398644,5.58742335057219e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCS1,Neuronal calcium sensor 1,40489,0.0479475831025169,0.00274243119928324,0.0425724179519217,0.053322748253112,8.1258272958694e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,0.175904599409644,0.0100621668293341,0.156182752424149,0.195626446395139,8.5251210174503e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL7,C-C motif chemokine 7,40341,0.101861322531818,0.00583694480075463,0.0904209107223393,0.113301734341297,1.43912191153386e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN1,Contactin-1,40536,-0.0463585992288773,0.00265669488755921,-0.0515657212084934,-0.0411514772492613,1.44903769162519e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FSTL3,Follistatin-related protein 3,40293,0.0524663169745792,0.00300850646421288,0.0465696443047219,0.0583629896444364,1.77045665426336e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39980,0.0603653160265336,0.00346423040842902,0.0535754244260127,0.0671552076270545,2.31718002568494e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL9,C-X-C motif chemokine 9,40422,0.11329532675376,0.00651441459306944,0.100527074151344,0.126063579356176,3.97483523351406e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18,Interleukin-18,40292,0.0790526624600523,0.00455446100688915,0.0701259188865495,0.087979406033555,7.22860021557133e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD302,CD302 antigen,40305,0.0501187082703991,0.00289200822476772,0.0444503721498544,0.0557870443909438,1.14737645982771e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM20A,Pseudokinase FAM20A,37990,0.0472275086616098,0.00272299466066762,0.0418904391267012,0.0525645781965183,1.14964254208253e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAO1,Hydroxyacid oxidase 1,40489,0.216907645167798,0.0125172333114391,0.192373867877378,0.241441422458219,1.1554544656343e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,-0.0331018425802135,0.00191258056329096,-0.0368505004842638,-0.0293531846761632,1.68824803284171e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CREG1,Protein CREG1,40145,0.0596435902368133,0.0034543408436513,0.0528730821832567,0.0664140982903698,3.44960781142573e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL16,Pro-interleukin-16,40516,0.0668929785923481,0.00387560047077001,0.0592968016696389,0.0744891555150573,3.71474421356584e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,0.0956763782603023,0.0055491243453095,0.0848000945434957,0.106552661977109,6.59221129387799e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40379,-0.0525307574468114,0.00304988350239457,-0.0585085291115048,-0.0465529857821181,6.94680088464321e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40500,-0.194130331829911,0.0112738749458872,-0.21622712672385,-0.172033536935972,7.40538371109057e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,0.136482936555228,0.0079273083849967,0.120945412120634,0.152020460989821,8.10653177528572e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPY,Pancreatic prohormone,40337,0.166546268290672,0.00968426243388251,0.147565113920263,0.185527422661082,1.0876917852548e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEL1L,Protein sel-1 homolog 1,37628,0.0538529740169252,0.00313170243266076,0.0477148372489101,0.0599911107849403,1.47338642016155e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37628,0.050244406980164,0.00292223522120397,0.0445168259466042,0.0559719880137238,1.53021756020798e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,0.0446017527805294,0.00259985271128382,0.0395060414664131,0.0496974640946457,2.82618415021487e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIAE,Sialate O-acetylesterase,40374,0.0770290454230632,0.00449646517603596,0.0682159736780328,0.0858421171680937,3.34357361450364e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELE,E-selectin,40536,0.0822554712768068,0.00480638249219879,0.0728349615920972,0.0916759809615164,4.41159409640097e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HYOU1,Hypoxia up-regulated protein 1,40536,0.0355865520994258,0.00208192255467653,0.0315059838922598,0.0396671203065918,6.25140189615291e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40357,0.0461604111440032,0.00270080155962442,0.0408668400871393,0.051453982200867,6.533073653553e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDK,Midkine,40352,0.0831902442562706,0.00486855952813267,0.0736478675811306,0.0927326209314106,7.0070289418158e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPT2,Angiopoietin-2,40489,0.0636060634546186,0.00372285888251481,0.0563092600448896,0.0709028668643476,7.16181103680099e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGR2,Anterior gradient protein 2 homolog,39839,0.166276038452503,0.00973745400462514,0.147190628603437,0.185361448301568,8.85630171431473e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS2,Trypsin-2,40403,0.0823955888972244,0.00483073674663251,0.0729273448738246,0.0918638329206241,1.16976034162762e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LBR,Delta(14)-sterol reductase LBR,40471,0.107325488504927,0.00629467790442005,0.0949879198122642,0.119663057197591,1.29390546341513e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THBS2,Thrombospondin-2,40332,0.0586476572921754,0.00344416064032894,0.0518971024371307,0.0653982121472201,1.89514714662015e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELOA,Elongin-A,40305,0.0833151158635401,0.00490176932068904,0.0737076479949896,0.0929225837320906,3.20427865495306e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,0.0342322213350784,0.00201604272591061,0.0302807775922936,0.0381836650778632,4.19916676039415e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,0.0432010563813886,0.00254604538761187,0.0382108074216693,0.0481913053411078,5.19849476214434e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,0.0860053928198518,0.00508877713600576,0.0760313896332805,0.0959793960064231,1.63437907353422e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSM,Oncostatin-M,40268,0.117683255411933,0.00696871174298564,0.104024580395681,0.131341930428185,2.00275624903135e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,40234,0.0480064131195205,0.00284648121676988,0.0424273099346515,0.0535855163043894,2.90520848290331e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPB6,Heat shock protein beta-6,40489,0.0590386187217593,0.00350568530667735,0.0521674755206717,0.0659097619228469,4.26832899264076e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39865,0.0612864723283927,0.00363880209022543,0.0541544202315508,0.0684185244252345,4.36454966921343e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM3C,Protein FAM3C,40330,0.0480718124345492,0.00285535430896569,0.0424753179889764,0.0536683068801219,4.70689824921633e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDCP1,CUB domain-containing protein 1,40228,0.0785005455059993,0.00466597694793534,0.069355230688046,0.0876458603239525,5.75583396963435e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STC1,Stanniocalcin-1,40471,0.0668585812772791,0.00397540281030621,0.0590667917690789,0.0746503707854793,6.23545522794154e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12A_IL12B,Interleukin-12,40305,0.126764319888806,0.00753713040846146,0.111991544288221,0.14153709548939,6.25568470918966e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,40192,0.118384113214564,0.00704139028057373,0.104582988264639,0.132185238164488,6.9763318782065e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPB1,Carboxypeptidase B,40536,0.0910745437512928,0.00542010598859556,0.0804511360136455,0.10169795148894,7.95257271201005e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,0.0707938268308294,0.00421346622167378,0.0625354330363488,0.07905222062531,8.27001176439943e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSTB,Cystatin-B,40097,0.0672464059499365,0.00402122905041133,0.0593647970111303,0.0751280148887427,3.09928855455791e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OMD,Osteomodulin,40422,-0.070913840277997,0.00426698566186947,-0.0792771321752612,-0.0625505483807329,1.66228486962969e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,0.0671569767174737,0.00405122527355061,0.0592165751813146,0.0750973782536329,3.34141252236032e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCG2,Secretogranin-2,40392,0.051299335722524,0.0030986667835891,0.0452259488266893,0.0573727226183586,4.74001552781635e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40341,0.0984546857054394,0.00595484083610561,0.0867831976666724,0.110126173744206,6.78423573640258e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RETN,Resistin,40283,0.0659701390374932,0.00399212060745671,0.058145582646878,0.0737946954281083,7.82196885952955e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPL,N-acetylneuraminate lyase,37990,0.0687326886578382,0.00415647241470246,0.0605860027250213,0.076879374590655,7.92913453772478e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL11,C-X-C motif chemokine 11,40471,0.125820703850624,0.00763759553969842,0.110851016592816,0.140790391108433,1.77679184516961e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRA1,GDNF family receptor alpha-1,40453,0.0440647824309725,0.00267531386113088,0.038821167263156,0.049308397598789,1.86736153204159e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADM,Pro-adrenomedullin,40489,0.0426407071585581,0.00258922310757864,0.037565829867704,0.0477155844494122,1.93514459699678e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PXN,Paxillin,39961,0.0816833643902092,0.00497617652957057,0.0719300583922509,0.0914366703881675,4.80074190449866e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPIND1,Heparin cofactor 2,37981,0.0432162162758827,0.00264261397034727,0.038036692894002,0.0483957396577634,1.52648337351585e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,0.0911170404176279,0.00557671421265215,0.0801866805608296,0.102047400274426,1.95017190038064e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDUA,Alpha-L-iduronidase,40489,0.0708079264776974,0.00434550341337283,0.0622907397874867,0.0793251131679081,3.22692109977934e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC6A,C-type lectin domain family 6 member A,39980,0.0733580441586621,0.00451860040886231,0.0645015873572919,0.0822145009600322,8.7378853891524e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40396,0.0807842724132768,0.00498471289918933,0.0710142351308657,0.0905543096956878,1.33545611994384e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REN,Renin,40359,0.111198255574165,0.00686789083810487,0.0977371895314797,0.124659321616851,1.71191809738817e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFI,Complement factor I,38013,0.0313796460767555,0.00194146633195463,0.0275743720661244,0.0351849200873866,3.22310941666132e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM3B,Protein FAM3B,40305,0.0560718918175627,0.00347433029636563,0.0492622044366861,0.0628815791984394,3.94862949062057e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XCL1,Lymphotactin,40489,0.0873863605675149,0.00542172699869599,0.0767597756500708,0.098012945484959,5.45960721668333e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUOM,Fucose mutarotase,37671,0.0970194636025691,0.00603893072683122,0.0851831593779799,0.108855767827158,1.55513321647773e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37628,-0.0983738546560967,0.00613766882591424,-0.110403685554889,-0.0863440237573048,2.83650360093133e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300C,CMRF35-like molecule 6,40471,0.0525007941548511,0.00327972105569479,0.0460725408856893,0.0589290474240129,3.136961136792e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40470,0.093998827644675,0.00587716036778495,0.0824795933238165,0.105518061965534,3.90091545849429e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17RB,Interleukin-17 receptor B,40126,-0.0819123316733213,0.00513524228971407,-0.0919774065611608,-0.0718472567854817,7.84785969397198e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37959,0.057673406567216,0.0036218061634073,0.0505746664869377,0.0647721466474943,1.41351682248222e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRP14,Signal recognition particle 14 kDa protein,40305,0.0906998941649222,0.00570782357074807,0.079512559966256,0.101887228363588,2.01158482092983e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,0.104050831061231,0.00654905142854589,0.0912146902612811,0.116886971861181,2.57449275218069e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12B,Interleukin-12 subunit beta,40516,0.0827256392429967,0.00522110893983666,0.0724922657209169,0.0929590127650765,4.08476339368731e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GHR,Growth hormone receptor,37671,0.0442706339023613,0.00279181386551679,0.0387986787259484,0.0497425890787742,4.11506227610316e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ULBP2,UL16-binding protein 2,40228,0.0568024401871072,0.00358798901974098,0.0497699817084149,0.0638348986657995,5.11037159772569e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL6,C-X-C motif chemokine 6,40516,0.118111345800246,0.00747186421362152,0.103466491941548,0.132756199658944,7.28461717293918e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNCG,Gamma-synuclein,40228,0.101715421924866,0.0064372387777054,0.089098433920563,0.114332409929168,8.19081374583928e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KHK,Ketohexokinase,37628,0.0983453106359929,0.0062192827013565,0.0861555165413341,0.110535104730652,8.24947186833185e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,0.0491115911784912,0.00310988189759889,0.0430162226591974,0.0552069596977851,9.3801480047449e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD72,B-cell differentiation antigen CD72,37671,0.0648465958518558,0.00410371623909258,0.0568033120232343,0.0728898796804772,9.76121314412073e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL21,C-C motif chemokine 21,40422,0.0646276864974755,0.00409546089332961,0.0566005831465495,0.0726547898484016,1.1194797225192e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37900,0.0777838724498535,0.00492890880817708,0.0681232111858264,0.0874445337138805,1.32222035936812e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA6,Carbonic anhydrase 6,40295,-0.0967765728474171,0.00614219845162135,-0.108815281812595,-0.0847378638822392,1.64770478542497e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCAM2,Neural cell adhesion molecule 2,40332,-0.0407669552674644,0.00260089220231978,-0.0458647039840112,-0.0356692065509176,5.85898096906333e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSC2,Desmocollin-2,40177,0.0507838808232997,0.00324854986445357,0.0444167230889707,0.0571510385576287,1.12285373068413e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,40009,0.0779144730518928,0.00499138602940834,0.0681313564342524,0.0876975896695331,1.61792225318854e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,0.0397808656353301,0.00255211375163715,0.0347787226821213,0.0447830085885389,2.23106347807788e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAL,Galanin peptides,40422,-0.0937693412981372,0.00601772282269109,-0.105564078030612,-0.0819746045656626,2.41654673259208e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,0.0860537931987742,0.00552282233538637,0.0752290614214169,0.0968785249761315,2.96298218422127e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPA2,Carboxypeptidase A2,40398,0.0959927020768048,0.00616680361744598,0.0839057669866107,0.108079637166999,3.10373918187449e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,0.056680544529427,0.00365356826043219,0.0495195507389799,0.0638415383198741,6.89304747217093e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN5,Contactin-5,40367,-0.0552675359934726,0.00356450887547275,-0.0622539733893992,-0.048281098597546,7.94914805157264e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,0.0858402677734,0.00553616184033458,0.0749893905663442,0.0966911449804558,7.96027497718608e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIP,Gastric inhibitory polypeptide,37628,0.0774660690880321,0.00499322753804023,0.0676793431134732,0.087252795062591,8.3089317669116e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,0.0412851347003775,0.00266539715023281,0.0360609562859212,0.0465093131148338,1.01400885061032e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40359,0.0462234694582125,0.00298588841051416,0.0403711281736048,0.0520758107428203,1.15428668119939e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP4,Dipeptidyl peptidase 4,40068,-0.0445666220374009,0.00288276649286856,-0.0502168443634233,-0.0389163997113785,1.61761712953211e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTSS1,Protein MTSS 1,37901,0.16542390696227,0.0106970275113668,0.144457733039991,0.186390080884549,1.73854728860406e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALM2,Paralemmin-2,37942,0.055171043351473,0.00356850209101597,0.0481767792530817,0.0621653074498643,1.83964617286138e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40341,0.0538416367206137,0.00349359395942876,0.0469941925601333,0.0606890808810941,3.32192533987462e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMMT,MICOS complex subunit MIC60,37900,0.0660229465366158,0.00429062991138597,0.0576133119102992,0.0744325811629322,5.59368594877351e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39961,0.0395882096358498,0.00257445806304338,0.0345422718322848,0.0446341474394149,5.71615401269797e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE1,Ribonuclease pancreatic,37987,0.036013874868764,0.00234142693968325,0.0314246780669848,0.0406030716705431,6.13695510672268e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,0.153853515201699,0.0100293886651282,0.134195913418048,0.17351111698535,9.85757204866741e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,0.0640344479460122,0.00417794053534915,0.0558456844967279,0.0722232113952965,1.44107158524755e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCAM1,Neural cell adhesion molecule 1,40403,-0.0407755482706886,0.00266680093937328,-0.0460024781118603,-0.035548618429517,2.09556208689209e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEP1A,Meprin A subunit alpha,37901,0.10117571293497,0.00661695926409683,0.0882064727773406,0.1141449530926,2.44149071105374e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC1,Sialoadhesin,40422,0.0637546853946328,0.00417543387333586,0.0555708350028945,0.071938535786371,2.8788014308854e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNF,Tumor necrosis factor,40014,0.0584829294407373,0.00383548339799259,0.0509653819806719,0.0660004769008028,4.0490676883234e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MET,Hepatocyte growth factor receptor,40375,-0.029422511664715,0.00193669202083492,-0.0332184280255514,-0.0256265953038785,9.1928973077887e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40451,0.0626163419867054,0.00412333943275411,0.0545345966985073,0.0706980872749034,1.00690598573009e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BST2,Bone marrow stromal antigen 2,40471,0.0781304350729246,0.00515330338935022,0.0680299604297982,0.088230909716051,1.45558476502171e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40341,0.0789115368277318,0.00520685100532759,0.0687061088572898,0.0891169647981739,1.60111149414717e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,0.12949541928988,0.00855034103909683,0.11273675085325,0.146254087726509,1.91684167532627e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBR2,TGF-beta receptor type-2,40411,0.0458866878137702,0.00303961757337619,0.0399290373699529,0.0518443382575876,3.86736350796484e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,0.0487201545231649,0.00323402043355287,0.0423814744734013,0.0550588345729285,6.19509438005681e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4A,C-type lectin domain family 4 member A,40341,-0.0497101399940011,0.00331099391401192,-0.0561996880654645,-0.0432205919225378,1.32856761004254e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSS,Cathepsin S,37057,0.0355464386296571,0.00236674785878941,0.0309076128264299,0.0401852644328843,1.50551082230679e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH2D1A,SH2 domain-containing protein 1A,40341,0.079070518613432,0.00527217808312123,0.0687370495705144,0.0894039876563496,1.68434029896126e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,0.0607873611184593,0.0040591699014953,0.0528313881115286,0.0687433341253901,2.34072741839072e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40536,0.0451817384144401,0.00301778152385364,0.0392668866276869,0.0510965902011932,2.44884758651222e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BPIFA2,BPI fold-containing family A member 2,37150,-0.160715116085832,0.010733302754734,-0.181752389485111,-0.139677842686554,2.93536151064823e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40291,0.0418232532991869,0.00279788627368153,0.0363393962027711,0.0473071103956027,3.51985080387961e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB6A,Ras-related protein Rab-6A,40341,-0.0685563121260532,0.00459829759623221,-0.0775689754146683,-0.059543648837438,6.25956082920875e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA2,Ephrin type-A receptor 2,39759,0.0442325531105327,0.00297461274367489,0.0384023121329299,0.0500627940881355,1.14612563858957e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLB1,Beta-galactosidase,40228,0.0583317806358596,0.00392775904873795,0.0506333729003333,0.066030188371386,1.47775294529925e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSME1,Proteasome activator complex subunit 1,40216,0.0538853281066918,0.00362873505179384,0.0467730074051759,0.0609976488082078,1.51255969907759e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL17,C-X-C motif chemokine 17,40516,0.0591593750832937,0.00398477857840062,0.0513492090696285,0.0669695410969589,1.56481619601844e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,0.0478470105843858,0.00322387567078128,0.0415282142696545,0.0541658068991171,1.69219309160295e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOLM2,Protein GOLM2,40471,0.032041358894927,0.00215907320954082,0.027809575404227,0.036273142385627,1.71301982111206e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,0.0456712115916787,0.00307680220238198,0.03964067927501,0.0517017439083474,1.8753731780324e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTNB,Dystrobrevin beta,37878,0.0598307083877638,0.00403081760878455,0.051930305874546,0.0677311109009815,1.89465734202382e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40332,-0.0751821826386111,0.00508088480422504,-0.0851407168548922,-0.0652236484223301,3.25457807823361e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGXT,Serine--pyruvate aminotransferase,40359,0.109524890315452,0.00740491267264553,0.0950112614770668,0.124038519153837,3.56093644551714e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40280,0.0364287588835049,0.00246461130687208,0.0315981207220357,0.0412593970449742,4.14480444440935e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,0.0695367761161506,0.00471221486040624,0.0603008349897544,0.0787727172425469,5.95816170557375e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL6,Interleukin-6,40305,0.103791920842493,0.00703429408837301,0.0900047044292819,0.117579137255704,6.0214851226559e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAXX,Protein PAXX,37671,0.0648396205600788,0.00439306831375855,0.056229206665112,0.0734500344550455,6.5437197433301e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFNA1,Ephrin-A1,40303,0.0385545830192652,0.00263320907974396,0.033393493222967,0.0437156728155633,3.1443660452516e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40341,0.0920672834397631,0.00629228955230598,0.0797343959172434,0.104400170962283,3.62433745768384e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EZR,Ezrin,40471,0.0332926641679672,0.00227709224276742,0.028829563372143,0.0377557649637913,4.23078951409654e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD83,CD83 antigen,40341,0.0472534384897214,0.00323752099303244,0.0409078973433778,0.053598979636065,6.12324259094693e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL2,Angiopoietin-related protein 2,40377,0.0560010106156827,0.0038415570627426,0.0484715587727072,0.0635304624586582,7.91697977737689e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORD,Sorbitol dehydrogenase,40417,0.0937185267367695,0.00643135589700188,0.0811130691786458,0.106323984294893,8.56419310851056e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXNB2,Plexin-B2,40472,0.0326864069155604,0.002247055699504,0.0282821777445326,0.0370906360865882,1.23990895792303e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN5,CCN family member 5,40332,0.0550266657648986,0.00378347614657056,0.0476110525176203,0.0624422790121769,1.29112074865545e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,0.0787032840205252,0.00542294786435553,0.0680743062063884,0.0893322618346621,2.33325651635929e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,40044,-0.053833711612191,0.00371294480444378,-0.0611110834289008,-0.0465563397954812,2.5003960953657e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40303,0.0676448033568762,0.00466772735033726,0.0584960577502152,0.0767935489635373,2.72975183056136e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPA1,Carboxypeptidase A1,40536,0.0799410161286079,0.00551688980014293,0.0691279121203278,0.0907541201368881,2.77296691822393e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFF2,Trefoil factor 2,40396,0.0796470928168374,0.00550187827229045,0.0688634114031481,0.0904307742305267,3.40531686836275e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,0.0811577980154759,0.00560751043462705,0.0701670775636069,0.092148518467345,3.56737459478996e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PVR,Poliovirus receptor,40471,0.051166983513901,0.00353876320568902,0.0442310076307506,0.0581029593970515,4.35360145095125e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COLEC12,Collectin-12,40357,0.0356755922498894,0.00246735582547482,0.0308395748319588,0.0405116096678201,4.3724855999386e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40341,0.0384370650138088,0.00266169593426348,0.0332201409826524,0.0436539890449653,5.68098933181213e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFPI,Tissue factor pathway inhibitor,40309,-0.0432695459888777,0.00300350223930412,-0.0491564103779138,-0.0373826815998416,9.31233660143813e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4M,C-type lectin domain family 4 member M,37969,-0.0674988318328713,0.00468693533233716,-0.0766852250842521,-0.0583124385814904,1.12161761150062e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPO,Erythropoietin,40341,0.108422352571213,0.00754252244520937,0.093639008578603,0.123205696563824,1.45896783996211e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAST,Gastrin,37942,0.180432922004776,0.0125890311867482,0.155758420878749,0.205107423130802,2.99366356913297e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH1A1,Retinal dehydrogenase 1,40332,0.0727427911056415,0.00508927161089812,0.0627678187482812,0.0827177634630018,4.64740725756594e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300A,CMRF35-like molecule 8,37671,0.0410505718319886,0.00287184391532807,0.0354217577579456,0.0466793859060316,5.23938371885139e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHBG,Sex hormone-binding globulin,37987,-0.0746999712069271,0.00522739455117203,-0.0849456645272243,-0.06445427788663,5.44847055420327e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARSA,Arylsulfatase A,40332,0.0609599883960249,0.00429564320978337,0.0525405277048495,0.0693794490872003,1.97092673265043e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUS,RNA-binding protein FUS,39960,0.0539960887094904,0.00381027498292753,0.0465279497429524,0.0614642276760284,2.64918678902461e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MLN,Promotilin,40341,0.1208304091078,0.00854059196663127,0.104090848853203,0.137569969362397,3.62403680037257e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40536,0.0920800916737912,0.00651085390050444,0.0793188180288025,0.10484136531878,3.87050392073102e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMPER,BMP-binding endothelial regulator protein,37671,0.030849696155231,0.00218105861955542,0.0265748212609024,0.0351245710495597,4.31291200018294e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,0.0557102117502936,0.00394252390914135,0.0479828648883765,0.0634375586122106,4.63288645294802e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PON1,Serum paraoxonase/arylesterase 1,37987,-0.0355019848637555,0.00251315835213137,-0.040427775233933,-0.030576194493578,5.44698996264182e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40350,0.0669930874649142,0.00476365837567475,0.0576563170485917,0.0763298578812367,1.1810825871864e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSR1,Macrophage scavenger receptor types I and II,40471,0.0605410269110376,0.0043066237570699,0.0521000443471806,0.0689820094748946,1.27327619163298e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSL,Cathepsin L1,40359,0.032825514107216,0.00233771709216423,0.0282435886065741,0.0374074396078579,1.59746395210711e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP12,Macrophage metalloelastase,40346,0.0699115100713021,0.0049863236136531,0.060138315788542,0.0796847043540621,2.14264835955828e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLL1,Delta-like protein 1,40411,0.0395586405719081,0.00282325305670862,0.0340250645807593,0.045092216563057,2.42016451407433e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,0.0550858089804489,0.00393372556231143,0.0473757068783185,0.0627959110825793,2.75324572218852e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP1,Interstitial collagenase,39757,0.125722852327444,0.00898392012318394,0.108114368886004,0.143331335768885,3.16719752348871e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB8,Serpin B8,40516,0.073223301535509,0.00525636347859645,0.06292082911746,0.0835257739535581,7.44834364265006e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,-0.0326931770893284,0.00234735370223387,-0.0372939903457068,-0.0280923638329501,7.76540053744034e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRP1,Neuropilin-1,40424,-0.0378182207950129,0.00271874817058751,-0.0431469672093644,-0.0324894743806614,9.88770610358202e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39980,0.145975700339898,0.0104955053341803,0.125404509884904,0.166546890794891,1.0300849255047e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,0.030736431405424,0.00221040355010517,0.0264040404472179,0.0350688223636301,1.06027472255643e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,0.0509448360050015,0.00366696275192387,0.0437575890112307,0.0581320829987722,1.27224008307483e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CES2,Cocaine esterase,40305,0.0716298380891006,0.00515835588338979,0.0615194605576566,0.0817402156205446,1.38276001219989e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40422,0.0346287542208823,0.00249422430679182,0.0297400745795704,0.0395174338621943,1.42711705823357e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,0.0591446072834882,0.0042617860584412,0.0507915066089435,0.067497707958033,1.55004154812066e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YTHDF3,YTH domain-containing family protein 3,40044,0.113001650616317,0.00815665238310457,0.097014611945432,0.128988689287202,2.17707834018331e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACAN,Aggrecan core protein,40224,-0.0378616999370598,0.00274071720011432,-0.0432335056492839,-0.0324898942248358,3.71594427997774e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSN,Gelsolin,37928,-0.0255024462904879,0.00184801684551019,-0.0291245593076878,-0.0218803332732879,5.00498366273604e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,0.0895459220706032,0.00650651275512568,0.0767931570705569,0.10229868707065,7.64380252753444e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,0.0470330645761761,0.00342065885839778,0.0403285732137165,0.0537375559386358,8.9401790006042e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABL1,Tyrosine-protein kinase ABL1,40305,0.089984436654936,0.00654635343676538,0.0771535839188759,0.102815289390996,9.49979600598508e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37598,0.112049525411178,0.00815367082539632,0.0960683305934012,0.128030720228955,1.11819025963241e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HYAL1,Hyaluronidase-1,40214,0.0304179130281802,0.00222088761772149,0.0260649732974461,0.0347708527589144,1.86995016299579e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,0.0972581961133187,0.00712614875866092,0.0832909445463434,0.111225447680294,3.59784803758331e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,0.0456274016288422,0.00334352976304199,0.0390740832932799,0.0521807199644045,3.66679503436323e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD80,T-lymphocyte activation antigen CD80,37990,0.0448992394520276,0.00329429894254898,0.0384424135246316,0.0513560653794236,5.07101946841688e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,0.0922925599826549,0.00677972545198947,0.0790042980967555,0.105580821868554,6.43492104888004e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,40208,0.0529699445117449,0.00389369308142899,0.045338306072144,0.0606015829513457,6.53541168453055e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,-0.0506689953535799,0.00373382321681932,-0.0579872888585458,-0.0433507018486141,1.02640056209626e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP5,Fatty acid-binding protein 5,40432,0.0902825574673939,0.00665686334313523,0.0772351053148488,0.103330009619939,1.13900869263892e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAPIN,SNARE-associated protein Snapin,37959,0.0750924480272118,0.00554860969032212,0.0642171730341805,0.0859677230202432,1.84609300379756e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37990,0.0853515612853114,0.00630964584221105,0.0729846554345778,0.0977184671360451,2.00899211346577e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40306,0.046918174278417,0.00347242751675481,0.0401122163455776,0.0537241322112565,2.26229425372262e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSL5,Insulin-like peptide INSL5,37901,0.1230090691799,0.00910433364013938,0.105164575245227,0.140853563114573,2.50359798321744e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD209,CD209 antigen,40382,-0.0505735142385484,0.00374947228468028,-0.0579224799165217,-0.0432245485605751,3.09193873628064e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,0.0748207162835962,0.00554756222324296,0.06394749432604,0.0856939382411523,3.13746302078322e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37900,0.0883494603402808,0.00656234235745169,0.0754872693196755,0.101211651360886,4.75542286884162e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,0.0963880424955521,0.00716230588519634,0.0823499229605673,0.110426162030537,5.09151078763429e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLAT,Tissue-type plasminogen activator,40490,0.0635303119778428,0.0047272088255538,0.0542649826797573,0.0727956412759282,5.92778345190687e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNMT,Histamine N-methyltransferase,40147,0.0600362159831339,0.0044722840437627,0.051270539257359,0.0688018927089088,7.34481734572695e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40497,-0.0822542410497431,0.00612961439953832,-0.0942682852728382,-0.070240196826648,7.75428960015744e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOP2B,DNA topoisomerase 2-beta,37598,0.102570663674104,0.00764747893723251,0.0875816049571283,0.11755972239108,9.48398386745179e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCN1,Ficolin-1,37967,0.0734314640536473,0.00547828848961939,0.0626940186139932,0.0841689094933013,1.04106945267738e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHAD,Chondroadherin,37671,-0.0700355060907944,0.00522647123473562,-0.0802793897108762,-0.0597916224707126,1.1116827225239e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,0.0656864523597792,0.00490565562693053,0.0560713673309953,0.075301537388563,1.14437157397914e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDHR2,Cadherin-related family member 2,40305,0.0991063038174365,0.00740737301138778,0.0845878527151165,0.113624754919757,1.32471297856348e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37942,0.0377694363997926,0.00282288687653494,0.0322365781217841,0.0433022946778011,1.44077592112247e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKK1,Dickkopf-related protein 1,40471,0.0766447671628152,0.00574477632867634,0.0653850055586095,0.0879045287670208,2.17664227038976e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PENK,Proenkephalin-A,37671,0.0399432599128829,0.00299581066234132,0.0340714710146939,0.0458150488110719,2.70710074056776e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADH1B,All-trans-retinol dehydrogenase,37671,0.0956039478668853,0.00717357060243713,0.0815437494861085,0.109664146247662,2.92262770244788e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEPH,Hephaestin,37990,0.0323318760142106,0.00242642134130381,0.0275760901852552,0.0370876618431661,2.97208121837816e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,0.108630850431083,0.00816830656574074,0.0926209695622315,0.124640731299935,4.24897763644984e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40373,0.0344903773145391,0.00259551014945083,0.0294031774216155,0.0395775772074628,4.41434692240312e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG4,Regenerating islet-derived protein 4,40379,0.0624411629918241,0.00470036405213168,0.053228449449646,0.0716538765340022,4.66247331994114e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAYN,Layilin,40192,0.0440282503561035,0.00331461637170017,0.0375316022675712,0.0505248984446358,4.76850728683529e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40422,0.0537541645121355,0.00404904727748364,0.0458180318482675,0.0616902971760034,5.21435019593039e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD160,CD160 antigen,40516,0.0584807152435654,0.00440819955673403,0.0498406441123667,0.0671207863747641,5.88706158252564e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40490,0.0409759780675941,0.003091958225203,0.0349157399461962,0.047036216188992,7.07838672594585e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENO3,Beta-enolase,37628,0.0727362943164258,0.00549481717908368,0.0619664526454218,0.0835061359874298,9.58824042675347e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFF1,Trefoil factor 1,40261,0.0992635665938272,0.00750746976817583,0.0845489258482026,0.113978207339452,1.0644613102246e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGFR,Opioid growth factor receptor,40305,0.0420580200462407,0.00318576945657086,0.0358139119113619,0.0483021281811196,1.38502991648068e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRD1,Natural killer cells antigen CD94,40516,0.0580239116629444,0.00439826618693915,0.0494033099365437,0.0666445133893451,1.55694891861936e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD2AP,CD2-associated protein,40359,0.0811737756490236,0.00616728844265252,0.0690858903014247,0.0932616609966225,2.33197155045537e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POF1B,Protein POF1B,37598,0.0592855296976438,0.00450182631465608,0.0504619501209179,0.0681091092743697,2.34165142149725e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRP,Gastrin-releasing peptide,37628,0.0692110796265454,0.00526867167438327,0.0588844831447542,0.0795376761083367,3.59227033463278e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NELL1,Protein kinase C-binding protein NELL1,40411,-0.0536773634915609,0.00409908109671157,-0.0617115624411156,-0.0456431645420062,5.58762426634767e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSME2,Proteasome activator complex subunit 2,40152,0.046741215723789,0.00357061808703462,0.0397428042732011,0.0537396271743769,5.96718775711019e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN4,CCN family member 4,40489,0.0516043890705973,0.00394696667969711,0.043868334378391,0.0593404437628036,7.28395970489238e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELN,Elastin,37990,0.0444599144265497,0.0034007071487823,0.0377945284149364,0.051125300438163,7.99441091157493e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTYMK,Thymidylate kinase,37990,0.0875578860327228,0.0066978364991522,0.0744301264943845,0.100685645571061,8.11613933433239e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTDH,Protein LYRIC,37598,0.115433542637381,0.0088555801707722,0.0980766055026673,0.132790479772094,1.33989164609331e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,0.0391718848819953,0.00300905859250523,0.0332741300406851,0.0450696397233056,1.51607012506237e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COCH,Cochlin,37990,0.0587561084343806,0.00451233254612874,0.0499119366439682,0.0676002802247929,1.57862798612935e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEG1,Protein HEG homolog 1,37671,0.033388677900426,0.00256557877666994,0.0283601434981529,0.0384172123026991,1.75338873194153e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BECN1,Beclin-1,37628,0.0767880541626177,0.00590271135374881,0.06521873990927,0.0883573684159654,1.87723814377704e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS3BP,Galectin-3-binding protein,38013,0.03736768527452,0.00287333510917357,0.0317359484605398,0.0429994220885002,1.94568233973247e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL14,C-C motif chemokine 14,40309,0.0489271284293917,0.00376943854990942,0.0415390288715692,0.0563152279872141,2.49244227029263e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAP29,Synaptosomal-associated protein 29,40411,0.113875104445597,0.00878627672083262,0.096654002072765,0.131096206818429,3.19217058946344e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EREG,Proepiregulin,40192,0.100231581824337,0.00773569637358225,0.085069616932116,0.115393546716558,3.36199513572285e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,0.0347478562858953,0.00268745264696162,0.0294804490978505,0.04001526347394,4.74958144730263e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40332,-0.0537801676061486,0.00416039210276897,-0.0619345361275757,-0.0456257990847214,4.94868220167055e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,0.0487942953325012,0.00377596745364035,0.0413933991233661,0.0561951915416362,5.20634524702901e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMNB2,Lamin-B2,37942,0.0342000321427254,0.00264951655425588,0.0290069796963839,0.0393930845890669,6.79709312669867e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFH,Complement factor H,37301,0.0290233989675929,0.00224916000171612,0.0246150453642294,0.0334317525709565,7.33234711647489e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37959,0.0770938830372768,0.00597534683323169,0.0653822032441427,0.0888055628304109,7.33921307435173e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP5,Microfibrillar-associated protein 5,40536,0.0510672777114571,0.00396044217651201,0.0433048110454935,0.0588297443774206,7.46051553939407e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH1,Cadherin-1,39806,0.0497661248500583,0.0038736608083923,0.0421737496656094,0.0573585000345073,1.39069905577132e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD5,Programmed cell death protein 5,40471,0.0721411645153383,0.00562048041242706,0.0611250229069812,0.0831573061236953,1.58981009691533e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERMAP,Erythroid membrane-associated protein,37598,0.0558205632846193,0.00434906887763348,0.0472963882844577,0.0643447382847809,1.75127761597193e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP20,Centrosomal protein 20,39980,0.0912035909355393,0.00711573200240782,0.0772567562108199,0.105150425660259,2.03354595410409e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,0.0344210077547151,0.00269017092854169,0.0291482727347734,0.0396937427746568,2.66699041357097e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37959,0.0645011994571586,0.00503995899280798,0.0546228798312549,0.0743795190830622,2.77100757241634e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1RL,Complement C1r subcomponent-like protein,37993,0.0240698777001736,0.00188156132218734,0.0203820175086864,0.0277577378916607,2.96654377083751e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRC1,Macrophage mannose receptor 1,37987,0.0351233552209114,0.00274654587823462,0.0297401252995715,0.0405065851422513,3.13434908939448e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAN,Brevican core protein,40228,-0.0413624539860734,0.00323612481618437,-0.0477052586257948,-0.0350196493463521,3.18331730041216e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNXB,Tenascin-X,40332,-0.0314410023801529,0.00246076877188955,-0.0362641091730564,-0.0266178955872494,3.36480341121694e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40411,0.0409739870118784,0.00320710241935631,0.03468806626994,0.0472599077538167,3.3959810669029e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,0.046668185481452,0.00365773427038099,0.0394990263115052,0.0538373446513987,4.23733203198399e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP3S2,AP-3 complex subunit sigma-2,37942,0.0575663962539902,0.00451148838178099,0.0487238790256994,0.0664089134822809,4.49329578951918e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,0.0752904773832545,0.00590646914500234,0.0637137978590499,0.0868671569074591,4.91276152324376e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD63,CD63 antigen,40203,0.0639926778795157,0.00502700119249883,0.0541397555422181,0.0738456002168135,6.1416361106008e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG1B,Lithostathine-1-beta,40536,0.0687157156083676,0.0054012721973712,0.0581292221015201,0.0793022091152152,6.70950166927448e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AFM,Afamin,38013,0.0228873521218491,0.00180810574330697,0.0193434648649675,0.0264312393787308,1.62149705310376e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUMB,Protein numb homolog,37598,0.102185439336508,0.0080749810736553,0.0863584764321437,0.118012402240873,1.72251312098868e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,0.0612945406629709,0.00484915554831086,0.0517901957882816,0.0707988855376602,1.91567404547111e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APLP1,Amyloid-like protein 1,40359,-0.0634761997644208,0.00502409355732052,-0.073323423136769,-0.0536289763920725,2.04205588966884e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,0.0702652330887335,0.00556083758061718,0.0593659914307238,0.0811644747467432,2.15938233275007e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,0.0604397761828773,0.00478293852144976,0.0510652166808358,0.0698143356849188,2.16368328288981e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40305,0.103906577637558,0.0082277503869153,0.0877801868792035,0.120032968395912,2.19310991849445e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCAN,Neurocan core protein,40471,-0.0454127281503208,0.00359661741221011,-0.0524620982782526,-0.038363358022389,2.24771180319283e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,0.0366082992641629,0.0029009121328015,0.030922511483872,0.0422940870444539,2.64463630211641e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAG1,Dystroglycan,40422,0.0574996247262823,0.00456879377424714,0.0485447889287579,0.0664544605238067,3.77631326358955e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD48,CD48 antigen,40396,0.0356423048577928,0.00283609755153284,0.0300835536567884,0.0412010560587972,4.73007430255499e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,0.0928078964476264,0.00738955589534817,0.078324366892744,0.107291426002509,5.61515103821415e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAT,Linker for activation of T-cells family member 1,40516,0.0912678432674178,0.00728450705785899,0.0769902094340142,0.105545477100821,7.61753679819327e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,0.0851190108518003,0.00679512715911287,0.0718005616199391,0.0984374600836615,8.56155983241694e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGBL1,Integrin beta-like protein 1,37998,0.0423795269098969,0.00338380570394383,0.035747267730167,0.0490117860896268,8.685293904345e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,0.0601208296308649,0.00480800759733052,0.0506971347400971,0.0695445245216327,1.13877853889802e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,0.0349341275862484,0.00279630514857872,0.0294533694950341,0.0404148856774626,1.29580586222492e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD59,CD59 glycoprotein,39665,0.0271453787589269,0.00217856511308495,0.0228753911372804,0.0314153663805734,1.83289431742721e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC3B,Tetranectin,37681,-0.0255170706909851,0.00205061497956905,-0.0295362760509404,-0.0214978653310298,2.38858595864191e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,0.047521233693451,0.00382842611158886,0.0400175185147368,0.0550249488721651,3.46905074072897e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,0.0538594923462212,0.00434377697578072,0.045345689473691,0.0623732952187514,3.8465232912499e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMSB10,Thymosin beta-10,40332,0.0908268392036424,0.00732572632871712,0.0764684155993569,0.105185262807928,3.87960843618671e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKK4,Dickkopf-related protein 4,40203,0.0544752931143304,0.00439900787596089,0.045853237677447,0.0630973485512137,4.67180049252413e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39980,0.0593701717194736,0.00479606039036366,0.0499698933543608,0.0687704500845863,4.97090435929327e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTGR1,Prostaglandin reductase 1,37990,0.0951982153105389,0.00769555746334187,0.0801149226823888,0.110281507938689,5.82763361745171e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP1,Guanylate-binding protein 1,37931,0.077088609613634,0.00623734944708297,0.0648634046973514,0.0893138145299166,6.71363652102516e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMN,Protein amnionless,40044,0.056725837788751,0.00459256584270697,0.0477244087370454,0.0657272668404567,6.94664414758526e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,0.031517107482728,0.00255243131336324,0.0265143421085361,0.03651987285692,7.21434976735244e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,0.123526459739703,0.0100010583935143,0.103924385288415,0.143128534190991,7.40151824537106e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CES3,Carboxylesterase 3,40305,0.0816841738182348,0.0066206310896173,0.0687077368825849,0.0946606107538847,8.18635119828095e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THOP1,Thimet oligopeptidase,40288,0.0356592221596413,0.00289072083123654,0.0299934093304177,0.041325034988865,8.40057760838855e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POSTN,Periostin,37998,-0.0452317643671669,0.00366987818109699,-0.052424725602117,-0.0380388031322168,1.01788607415602e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXLNA,Alpha-taxilin,40228,0.105679977110085,0.0085947981011911,0.0888341728317505,0.12252578138842,1.37379586151139e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37628,0.0861556113385017,0.00700681918505269,0.0724222457357985,0.099888976941205,1.47262364985898e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,0.0564185463398503,0.00458888698795303,0.0474243278434624,0.0654127648362383,1.48158545748851e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40434,0.0856620090728042,0.0069766218132586,0.0719878303188173,0.099336187826791,1.69167758756851e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP4,Metalloproteinase inhibitor 4,40332,-0.0481191072364619,0.00392365695623909,-0.0558094748706905,-0.0404287396022333,2.02705689789888e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBKS,Ribokinase,39991,0.0588303089414552,0.00480320148346561,0.0494160340338626,0.0682445838490478,2.47487286662971e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF8,SLAM family member 8,39980,0.0634266604441913,0.00518394055699519,0.0532661369524807,0.0735871839359019,2.89844321249498e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,0.0217561546526638,0.00178287782246208,0.0182617141206381,0.0252505951846895,4.31001553729069e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP8,Neutrophil collagenase,40442,0.0858154275324555,0.00706578197689186,0.0719664948577475,0.0996643602071636,8.56838948207196e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,0.127629239766311,0.010505433980152,0.107038589165213,0.148219890367409,8.75180249996312e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,0.035529181663222,0.00293160715019722,0.0297832316488355,0.0412751316776085,1.17150667734997e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSB,Cathepsin B,40353,-0.0631677776104322,0.00521936522725979,-0.0733977334558614,-0.052937821765003,1.43763735737525e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL5,C-C motif chemokine 5,40403,0.117152460860804,0.00968276297293526,0.0981742454338508,0.136130676287757,1.49818387557091e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,0.114457903144584,0.00945840898558341,0.0959194215328402,0.132996384756327,1.5677270427492e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINH1,Serpin H1,37714,0.150869882578807,0.0124948445452091,0.126379987270197,0.175359777887417,2.15389341662691e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL22,C-C motif chemokine 22,40204,0.0600356024446732,0.00497466781419539,0.0502852535288503,0.0697859513604962,2.18119326762836e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARF6,ADP-ribosylation factor 6,37901,0.122922925192598,0.0101869404553057,0.102956521900199,0.142889328484997,2.3540334495846e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGL1,Fibrinogen-like protein 1,37987,0.0735383695661103,0.00610315221820285,0.0615761912184327,0.0855005479137879,2.89646393637598e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN2,CCN family member 2,40358,0.0670552970683848,0.00556834137117607,0.0561413479808797,0.0779692461558899,2.97312066313519e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL3,Angiopoietin-related protein 3,40355,-0.0422545926841241,0.00351065700700865,-0.0491354804178611,-0.0353737049503872,3.20112453048158e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,0.03323198876654,0.00276352872255428,0.0278154724703336,0.0386485050627464,3.63471431155565e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FMNL1,Formin-like protein 1,39961,0.0695550859409842,0.00578703181199593,0.0582125035894722,0.0808976682924962,3.95670418928485e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASAH2,Neutral ceramidase,40228,0.0608980634559658,0.00506965642210994,0.0509615368686304,0.0708345900433013,4.27159644426158e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37910,0.047789959415057,0.00397974362361487,0.0399896619127719,0.0555902569173422,4.74121189581512e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PI3,Elafin,40074,0.0617924427638423,0.00516622408634816,0.0516666435545999,0.0719182419730847,7.92562031602758e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37900,0.092300508224307,0.00771461976890672,0.0771798534772498,0.107421162971364,8.01448777906621e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARSB,Arylsulfatase B,40305,0.0633458954303727,0.00530131156736816,0.0529553247583311,0.0737364661024143,9.0751259381351e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAT2,Linker for activation of T-cells family member 2,40305,0.140821659275478,0.0117963197638972,0.117700872538239,0.163942446012716,1.03880478262797e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40408,-0.0279223319692667,0.00233966446015968,-0.0325080743111797,-0.0233365896273538,1.07989331070578e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NADK,NAD kinase,40359,0.0616695462664578,0.00517264614023935,0.0515311598315887,0.0718079327013269,1.24825888427025e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,0.0588764960141331,0.00494051162784369,0.0491930932235595,0.0685598988047068,1.4065088131198e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTN1,Dynactin subunit 1,40489,0.075515816009608,0.00634143885184933,0.0630865958599833,0.0879450361592327,1.46944332375081e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40471,0.076951165149188,0.00646427439059133,0.064281187343629,0.089621142954747,1.54594468233146e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHB4,Ephrin type-B receptor 4,40536,0.0283385869087736,0.00238168327468683,0.0236704876903874,0.0330066861271598,1.64851742277972e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,0.0805327839472474,0.0067693307345544,0.0672648957075208,0.0938006721869741,1.70388907395591e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYH9,Myosin-9,37998,0.129172036630895,0.0108741272470247,0.107858747226726,0.150485326035063,2.20752411454518e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP3,"Fatty acid-binding protein, heart",37990,0.0547425810559999,0.00460844426275659,0.045710030300997,0.0637751318110029,2.21026801256416e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDT,D-dopachrome decarboxylase,37998,0.0470763950281662,0.00396462567518657,0.0393057287048005,0.0548470613515318,2.33473091804041e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,0.0528474637447204,0.00445413776202697,0.0441173537311475,0.0615775737582932,2.46315665728742e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EEF1D,Elongation factor 1-delta,37990,0.105075159623159,0.00887030859492091,0.087689354777114,0.122460964469204,3.26648508511076e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,0.101393691744964,0.00857442869045358,0.0845878115116748,0.118199571978253,3.95831157696957e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCXR,L-xylulose reductase,40411,0.0595348821727895,0.00504245565614567,0.0496516690867439,0.069418095258835,4.89799064569577e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP9,Matrix metalloproteinase-9,40312,0.0697533366769303,0.00591081036932018,0.0581681483530627,0.0813385250007978,5.251180833302e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,0.0482707456280219,0.00409310396122805,0.0402482618640149,0.0562932293920289,6.11011999570194e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA5,Plasma serine protease inhibitor,37835,0.0376102585440081,0.00319990294640715,0.0313384487690501,0.0438820683189661,9.69622696587774e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM1,Intercellular adhesion molecule 1,40291,0.0322847499461404,0.0027596705820941,0.026875795605236,0.0376937042870449,1.74250376647276e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL19,Interleukin-19,39924,0.0767573058968201,0.0065691647458898,0.0638817429948761,0.0896328687987641,2.07320945271544e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,0.157860706207018,0.0135316275571573,0.131338716194989,0.184382696219046,2.68867683451976e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,P4HB,Protein disulfide-isomerase,40266,0.043472231120736,0.00372848465282464,0.0361644012011998,0.0507800610402723,2.75633148524217e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40471,0.0922219222581914,0.00791634656666111,0.0767058829875356,0.107737961528847,3.08265387021118e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FYB1,FYN-binding protein 1,40311,0.102732517240844,0.00882136055048865,0.0854426505618859,0.120022383919801,3.22666089313999e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,A1BG,Alpha-1B-glycoprotein,38013,0.0197867095843682,0.00170114646726605,0.0164524625085267,0.0231209566602096,4.01013671210162e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,0.0270992492987569,0.00233817593755785,0.0225164244611436,0.0316820741363703,6.18972191098922e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB1,Integrin beta-1,40333,-0.0245382328176978,0.00211920205259164,-0.0286918688407774,-0.0203845967946182,7.00644680279715e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PZP,Pregnancy zone protein,38013,0.0733488782364698,0.00633510043443269,0.0609320813849818,0.0857656750879579,7.42533289547613e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APP,Amyloid-beta precursor protein,40309,0.0747411706040475,0.0064708834423794,0.0620582390569839,0.0874241021511111,9.75554357697942e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,0.030658502648932,0.00265722252045992,0.0254503465088306,0.0358666587890335,1.12828099844589e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,0.0644798483786956,0.00559796541470751,0.0535078361658689,0.0754518605915224,1.41624419228131e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST7,Cystatin-F,40376,0.102183988376749,0.00889536621353162,0.0847490705982274,0.119618906155271,2.01317897717724e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RASSF2,Ras association domain-containing protein 2,39980,0.0611462914095021,0.00532371027179062,0.0507118192767925,0.0715807635422117,2.06664681293782e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40357,0.0558592761384316,0.00486797112050995,0.0463180527422321,0.0654004995346311,2.3235548723314e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT5,ADP-sugar pyrophosphatase,40332,0.0578170719311653,0.00503914236842526,0.0479403528890518,0.0676937909732789,2.35849072620076e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC1B,C-type lectin domain family 1 member B,40471,0.106435472127026,0.00928815480405614,0.0882306887110755,0.124640255542976,2.77256152714017e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GDF2,Growth/differentiation factor 2,40359,-0.0394877000562923,0.00345326437465967,-0.0462560982306252,-0.0327193018819593,3.67130505115292e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLIN1,Perilipin-1,39961,0.03914789892605,0.00342469179246184,0.0324355030128248,0.0458602948392752,3.86162541038206e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL20,C-C motif chemokine 20,40516,0.097684105099739,0.0085661019760401,0.0808945452267004,0.114473664972778,5.2352641340354e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL25,C-C motif chemokine 25,40516,0.0537731381083071,0.00471946391485722,0.0445229888351869,0.0630232873814272,5.84416845663138e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGN,Mimecan,40332,0.0448381796829648,0.00393735747268917,0.037120959036494,0.0525554003294356,6.27799063014787e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,0.0455425455515235,0.00400238530976747,0.0376978703443792,0.0533872207586677,6.94948743288892e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,-0.0283977682999823,0.00250098427314848,-0.0332996974753533,-0.0234958391246113,9.13333232465214e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGR,Tyrosine-protein kinase Fgr,39961,0.0604817108550797,0.00534260625761768,0.0500102025901491,0.0709532191200104,1.35509808479003e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWC2,Brorin,40167,0.0424300336873364,0.00375456572011734,0.0350710848759064,0.0497889824987664,1.68767825965459e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFC,Vascular endothelial growth factor C,40411,0.0608845305244733,0.00538935345752715,0.05032139774772,0.0714476633012265,1.75330460825999e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNCA,Alpha-synuclein,37671,0.12499937066991,0.0110736903333043,0.103294937616634,0.146703803723187,2.05153405361733e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA5,Integrin alpha-5,40332,0.0271183137566256,0.00240494458303712,0.0224046223738728,0.0318320051393783,2.22796221723692e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA7,Thyroxine-binding globulin,38013,0.0205026705488051,0.00181802774350783,0.0169393361715297,0.0240660049260804,2.29215726650418e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS3,Galectin-3,40374,0.0321965511609803,0.00285828856139706,0.026594305580642,0.0377987967413185,2.5427806725236e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARF1,Scavenger receptor class F member 1,40536,0.0460107832535118,0.00409386543657968,0.0379868069978156,0.054034759509208,3.37210319797156e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,-0.0373051047472315,0.0033213804184324,-0.043815010367359,-0.030795199127104,3.66317195475735e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLR1,Folate receptor alpha,40299,0.030775609096768,0.00274036779423249,0.0254044882200724,0.0361467299734637,3.72345349352665e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFB,Platelet-derived growth factor subunit B,40422,0.0929689264921722,0.00827983894392218,0.0767404421620847,0.10919741082226,3.80562235520741e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,0.10827406799958,0.00964969790192688,0.0893606601118034,0.127187475887357,4.15182499042656e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39961,0.0529852379925769,0.00472204981922443,0.043730020346897,0.0622404556382568,4.1723651567831e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGFL7,Epidermal growth factor-like protein 7,39980,0.0438173608531465,0.00390922031243546,0.036155289040773,0.05147943266552,4.77664438316008e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL15,Interleukin-15,40341,0.0354501565061507,0.003166808422846,0.0292432119973726,0.0416571010149289,5.58247837422642e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC27,Cell division cycle protein 27 homolog,39980,0.0659572951602043,0.00589226653047683,0.0544084527604697,0.0775061375599389,5.64063682884399e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40341,0.050829170705786,0.00454423903297721,0.0419224622011506,0.0597358792104213,6.16542754140467e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMG3,Proteasome assembly chaperone 3,40341,0.0552498155681559,0.00494717706219761,0.0455533485262486,0.0649462826100632,7.4940914711674e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HPSE,Heparanase,37848,0.100534915476397,0.00900922557739154,0.0828768333447093,0.118192997608084,8.6574813317637e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,0.032669686856636,0.00292884725998385,0.0269291462270677,0.0384102274862043,9.10793727760573e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD1,Programmed cell death protein 1,40455,0.0471490252312159,0.00423006481864541,0.0388580981866709,0.0554399522757609,9.53873079024225e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TALDO1,Transaldolase,37966,0.0482503770813366,0.00432736018905895,0.039768751110781,0.0567320030518922,9.55004348226735e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38484,-0.0338543921993098,0.00303720041521305,-0.0398073050131274,-0.0279014793854922,9.82430841779876e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF6,SLAM family member 6,39980,0.0410241045617561,0.00368183590443373,0.033807706189066,0.0482405029344462,1.00337959559869e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPK9,Mitogen-activated protein kinase 9,40341,0.0461071052399219,0.00414184828047139,0.037989082610198,0.0542251278696458,1.11879264240686e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39980,0.0691076133583636,0.00621030004715311,0.0569354252659435,0.0812798014507837,1.1777867059157e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NBN,Nibrin,40044,0.0546899440883829,0.00491674108346744,0.0450531315647867,0.064326756611979,1.23964406064978e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP85,Centrosomal protein of 85 kDa,39980,0.0676495897364604,0.00609633023501766,0.0557007824758258,0.079598396997095,1.6645758109e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELP,P-selectin,40403,0.0618326105329388,0.00557630954705228,0.0509030438207164,0.0727621772451613,1.81383217714065e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASGR2,Asialoglycoprotein receptor 2,37987,0.0278809750307723,0.00251511847027856,0.0229513428290263,0.0328106072325183,1.95856531514257e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAA80,N-alpha-acetyltransferase 80,37572,0.127589171541475,0.011540312501889,0.104970159037772,0.150208184045177,2.73491609063427e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDC1,Syndecan-1,40359,0.0427392869011343,0.00387028458460215,0.0351535291153141,0.0503250446869545,3.003950883262e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40516,0.0596192812680331,0.00539970204499097,0.0490358652598508,0.0702026972762154,3.05436135555256e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,0.0824529935962131,0.00746701844252094,0.067817637448872,0.0970883497435541,3.1521925754201e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSAP,Prosaposin,37901,0.0304394916742517,0.00276079388584077,0.0250283356580038,0.0358506476904996,3.79463561165339e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YES1,Tyrosine-protein kinase Yes,40305,0.120756451535271,0.0109571589533612,0.0992804199866828,0.142232483083859,3.83889841888549e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD248,Endosialin,37998,-0.0428489296123767,0.00388704860880689,-0.0504675448856382,-0.0352303143391152,3.87650581645743e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37541,0.0660800752135245,0.00600482880700308,0.0543106107517984,0.0778495396752505,4.82480939575714e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALB2,Calretinin,39961,0.0334740219097024,0.00304518341263733,0.0275054624209332,0.0394425813984716,5.2715262916117e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,L1CAM,Neural cell adhesion molecule L1,40411,-0.0300545534578015,0.00273548249281594,-0.0354160991437207,-0.0246930077718823,5.56406421831724e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRLB,Fc receptor-like B,39980,0.0649777261957293,0.00591676991804417,0.0533808571563627,0.0765745952350959,5.91399126332153e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,0.089238700219769,0.00812672233925695,0.0733103244348254,0.105167076004713,6.20246852538655e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY96,Lymphocyte antigen 96,40228,0.0367749165992176,0.00335484885946241,0.0301994128346713,0.043350420363764,7.35800854846803e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,0.0924609322571106,0.00843828580498193,0.075921892079346,0.108999972434875,7.7037755871616e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP3,Metalloproteinase inhibitor 3,40422,0.139710248056539,0.0127506444681461,0.114718984898973,0.164701511214106,7.71779157330942e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGLC2,Immunoglobulin lambda constant 2,37978,0.0258489299944567,0.00236175355586563,0.02121989302496,0.0304779669639533,9.20025272334255e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,0.0563948728942538,0.0051527778256907,0.0462954283559,0.0664943174326076,9.29642559737579e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAPG,Macrophage-capping protein,40185,0.0612855635993766,0.00560781431785752,0.0502942475363759,0.0722768796623773,1.05818334007396e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,0.0574961952477543,0.00526567663580319,0.04717546904158,0.0678169214539285,1.17258772448059e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THY1,Thy-1 membrane glycoprotein,40471,0.029544954266943,0.00270612306625596,0.0242409530570813,0.0348489554768047,1.18574905582194e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,0.102356177225941,0.00938518414325855,0.0839612163051543,0.120751138146728,1.35008186462703e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHMP6,Charged multivesicular body protein 6,37990,0.0588574143617702,0.00540121441451713,0.0482710341093166,0.0694437946142238,1.54869853602254e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASAH1,Acid ceramidase,37882,0.0488061908870664,0.00447953323251597,0.0400263057513351,0.0575860760227976,1.58089711747232e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM4,Intercellular adhesion molecule 4,40341,-0.0554741863885912,0.00509806727285209,-0.0654663982433813,-0.0454819745338011,1.76698574136772e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCF2,Neutrophil cytosol factor 2,40324,0.0873468047975514,0.00803016596713986,0.0716076795019573,0.103085930093146,1.84769823152837e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRPK2,SRSF protein kinase 2,40341,0.0867592175382425,0.00797791657903974,0.0711225010433246,0.10239593403316,1.89643017026525e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDRKH,Tudor and KH domain-containing protein,39961,0.08920720125649,0.0082183143646697,0.0730993051017374,0.105315097411243,2.37605704196698e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLF4,Krueppel-like factor 4,37541,0.0413468802281577,0.00380868420939873,0.0338818591777362,0.0488119012785793,2.44325775334397e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAB2,Stabilin-2,37998,0.029384605117583,0.00270932980130947,0.0240743187070164,0.0346948915281495,2.70580285676136e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSF,Cathepsin F,40411,0.0419152964567868,0.00386622208014837,0.034337501179696,0.0494930917338776,2.72706910064314e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH3,Cadherin-3,40471,0.0369992027198184,0.00342438709668835,0.0302874040103092,0.0437110014293275,4.05928712158586e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GM2A,Ganglioside GM2 activator,37714,0.0404046364490692,0.00373844585755147,0.0330772825682683,0.0477319903298701,4.09759187579809e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FSHB,Follitropin subunit beta,37628,-0.0732326894849172,0.00678504836527109,-0.0865313842808485,-0.0599339946889858,4.80654075364555e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,0.0597569091157473,0.00555026683061113,0.0488783861277495,0.0706354321037451,6.16280422212211e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL3A1,Collagen alpha-1(III) chain,37998,0.0241251012318373,0.00224403176783624,0.0197267989668783,0.0285234034967963,7.54023470894892e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLO1,Lactoylglutathione lyase,40042,0.0615596720046812,0.00572960211672354,0.0503296518559031,0.0727896921534593,7.83935989111978e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD99L2,CD99 antigen-like protein 2,40332,0.0246600391644683,0.00229774308935212,0.0201564627093381,0.0291636156195984,8.87029560391904e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BID,BH3-interacting domain death agonist,40341,0.0693007587773106,0.00646288848393065,0.0566334973488066,0.0819680202058147,9.81261802525742e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHRDL2,Chordin-like protein 2,40359,0.0588501431463154,0.00550832766247022,0.0480538209278738,0.069646465364757,1.49055206315199e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,0.0645209127784826,0.00604476208542519,0.0526731790910492,0.076368646465916,1.72088623443384e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS1,Galectin-1,40359,0.0346700913691233,0.00325261987495057,0.0282949564142202,0.0410452263240264,1.94127926366192e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SARG,Specifically androgen-regulated gene protein,37931,0.112315204204589,0.0105336119172147,0.0916693248468478,0.132961083562329,1.94181091532095e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C19orf12,Protein C19orf12,39961,0.0640324760166987,0.00600725929981754,0.0522582477890563,0.0758067042443411,1.95034636832446e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,40044,0.0716340326716112,0.00672503483463887,0.058452964395719,0.0848151009475034,2.10682268715342e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBS,Cystathionine beta-synthase,37628,0.0524682509586984,0.00493008250980783,0.0428052892394751,0.0621312126779218,2.41845945545966e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN8,Septin-8,37921,0.0329014068562785,0.00309244561735306,0.0268402134462665,0.0389626002662905,2.48856431653481e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNM3,Dynamin-3,37959,0.0565395304002503,0.00532172942413432,0.046108940728947,0.0669701200715536,2.91721278331954e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FEN1,Flap endonuclease 1,39980,0.0637154534022361,0.00600583135425321,0.0519440239478998,0.0754868828565724,3.32967672761973e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BGN,Biglycan,39956,-0.124395501822718,0.011774843662344,-0.147474195400913,-0.101316808244524,5.33424277264919e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA2,Annexin A2,37441,0.0734474081258328,0.00695241267187247,0.0598206792889627,0.0870741369627028,5.55962412226318e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCOF1,Treacle protein,37990,0.0309553869326074,0.0029335727630397,0.0252055843170496,0.0367051895481652,6.26238165019549e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD46,Membrane cofactor protein,40250,0.0292669447373136,0.0027746367762549,0.023828656655854,0.0347052328187732,6.32633431823545e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,0.0279750125984594,0.00265430352450922,0.0227725776904214,0.0331774475064975,7.16520289764287e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C3,Complement C3,37360,0.0483508943107435,0.00459022555429506,0.0393540522243252,0.0573477363971618,7.71091604588762e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPE,Carboxypeptidase E,40360,-0.0389012875419271,0.00369591145055625,-0.0461452739850173,-0.0316573010988368,8.0144251835564e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL5,Fc receptor-like protein 5,40332,0.0569695361948577,0.0054145595455063,0.0463569994856654,0.0675820729040501,8.35780348374959e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STK11,Serine/threonine-protein kinase STK11,40042,0.0741870569662652,0.00705243116683254,0.0603642918792735,0.088009822053257,8.58365105861726e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFA,Platelet-derived growth factor subunit A,40536,0.0730909609305122,0.00695075909237501,0.0594674731094572,0.0867144487515672,8.88231272458763e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASPN,Asporin,37990,-0.0278171525409129,0.00264842200674197,-0.0330080596741272,-0.0226262454076987,1.04735439471654e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL4,C-C motif chemokine 4,40376,0.0686280998952788,0.00653978282078965,0.055810125566531,0.0814460742240265,1.11705439219134e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JAM3,Junctional adhesion molecule C,37671,0.0517437924216598,0.0049295732403215,0.0420818288706297,0.06140575597269,1.129724016293e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREML2,Trem-like transcript 2 protein,40332,0.033987819004674,0.00324113345230162,0.0276351974381628,0.0403404405711851,1.20986366554241e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS8,Galectin-8,40471,0.0611197287323454,0.0058317383863936,0.0496895214950139,0.0725499359696768,1.28461831311101e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,0.0627637940829535,0.00599236297439962,0.0510187626531303,0.0745088255127768,1.42494701156113e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD7,T-cell antigen CD7,37567,0.0436605336104716,0.00416934354660149,0.0354886202591327,0.0518324469618106,1.46818330855055e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,40044,0.0360340090195278,0.00344456648827085,0.0292826587025169,0.0427853593365387,1.58307744216152e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,QDPR,Dihydropteridine reductase,40290,0.0442397628457843,0.00423204138389764,0.0359449617333449,0.0525345639582237,1.70894220161092e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WDR46,WD repeat-containing protein 46,37900,0.0360626556743458,0.00345177714916849,0.0292971724619756,0.0428281388867161,1.88146056055485e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CKB,Creatine kinase B-type,37998,-0.0613488838749067,0.00587314449080931,-0.0728602470768929,-0.0498375206729204,1.91611188002798e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD207,C-type lectin domain family 4 member K,40029,0.0387547729342061,0.00371393423264563,0.0314754618382206,0.0460340840301915,2.08199099713105e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL5A1,Collagen alpha-1(V) chain,37671,0.0404166865558404,0.00387477632560323,0.0328221249576581,0.0480112481540228,2.25222364960137e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,-0.0451570768123511,0.00433520452731057,-0.0536540776858798,-0.0366600759388224,2.5169872765176e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN3,Contactin-3,40332,0.0351884855128169,0.00337859305973166,0.0285664431157429,0.041810527909891,2.55203626823569e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FST,Follistatin,40396,0.0522252771237159,0.00502922891684915,0.0423679884466916,0.0620825658007402,3.51474351846471e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39961,0.0791550371227824,0.00762391097051881,0.0642121716205655,0.0940979026249992,3.60270387847905e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,0.0744858628804579,0.00717628116581273,0.060420351795465,0.0885513739654509,3.84825874069492e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYDGF,Myeloid-derived growth factor,37990,0.101024553043457,0.00973526199175753,0.0819434395396122,0.120105666547302,3.91253797274914e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BACH1,Transcription regulator protein BACH1,40341,0.0726898736505484,0.00700758687765391,0.0589550033703468,0.0864247439307501,3.95675193009644e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAG4,BAG family molecular chaperone regulator 4,37598,0.048902521042558,0.0047203536330092,0.03965062792186,0.0581544141632561,4.7098732883698e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,0.0421155633898907,0.00406777863807513,0.0341427172592635,0.050088409520518,4.84770259966982e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39961,0.0611842410096131,0.00591275648938878,0.0495952382904111,0.0727732437288151,5.16271683259028e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPXM1,Probable carboxypeptidase X1,40411,0.0685906888559291,0.00664152478356245,0.0555733002801467,0.0816080774317115,6.33714504459091e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPBP,Platelet basic protein,37934,0.0842142355014482,0.00815246488010157,0.0682354043364491,0.100193066666447,6.39207839366663e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NIT2,Omega-amidase NIT2,37936,0.0756794940930047,0.00732678939693154,0.0613189868750189,0.0900400013109905,6.44248981918778e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTN,Pleiotrophin,40042,0.0500749100499104,0.00485999849666431,0.0405493129964483,0.0596005071033724,8.16258978021602e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,0.0362032855004052,0.00351792794139687,0.0293081467352673,0.0430984242655431,9.59554040221284e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TTR,Transthyretin,37871,0.0255204517250856,0.00248385583534109,0.0206520942878171,0.0303888091623541,1.13289581187506e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APCS,Serum amyloid P-component,37882,0.0358267594823947,0.00348928387793339,0.0289877630816453,0.0426657558831441,1.21571608166239e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA7A,Semaphorin-7A,40490,0.0267124504460862,0.00260307874620113,0.021610416103532,0.0318144847886404,1.24724030165358e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,-0.0258017658688929,0.00251460968550924,-0.030730400852491,-0.0208731308852948,1.30288623818164e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BSG,Basigin,40502,0.0200081298821829,0.0019519474241922,0.0161823129307662,0.0238339468335996,1.4040128998619e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNG,Interferon gamma,40044,0.112270474846544,0.0109877503168086,0.0907344842255988,0.133806465467489,1.97093422119176e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39980,0.0355674146460366,0.00348929159688367,0.0287284031161446,0.0424064261759286,2.53385508038724e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPARCL1,SPARC-like protein 1,40346,-0.0271699553802997,0.00267371776049083,-0.0324104421908618,-0.0219294685697377,3.47863077774896e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,0.0437592248678752,0.00431084900208252,0.0353099608237935,0.0522084889119569,3.90307404080456e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NGRN,Neugrin,37942,0.0217066190748683,0.00213825419251441,0.01751564085754,0.0258975972921965,3.98146695316134e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP43,Centrosomal protein 43,39934,0.067697209099348,0.0066706497689229,0.0546227355522592,0.0807716826464369,4.00306870116033e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37942,0.0296994543974521,0.00292659447061155,0.0239633292350535,0.0354355795598508,4.12294994314299e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,-0.0284329769626117,0.00280431037911687,-0.0339294253056808,-0.0229365286195426,4.38050182133138e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSC,Dipeptidyl peptidase 1,40349,0.0417884485111719,0.00412350370450897,0.0337063812503343,0.0498705157720095,4.60940024882876e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPR,Nucleoprotein TPR,37562,0.0460753186761096,0.00454996447742752,0.0371573883003516,0.0549932490518675,5.16396753087229e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F10,Coagulation factor X,37987,0.0255460355879789,0.00252403055996039,0.0205989356904565,0.0304931354855012,5.41990453134043e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OTUD7B,OTU domain-containing protein 7B,37959,0.0620718770416393,0.00613296947659185,0.0500512568675193,0.0740924972157593,5.42829394187732e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,0.0924826591245974,0.00914392033999768,0.0745605752582019,0.110404742990993,5.66011213559728e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCK2,Cytoplasmic protein NCK2,40422,0.102141787915935,0.010100985008023,0.0823438573002103,0.121939718531661,5.76745657057166e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLA2,Src-like-adapter 2,37959,0.101188509568952,0.0100067105805421,0.081575356831089,0.120801662306814,5.94379854722475e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40422,0.0374547701403474,0.00370598721627641,0.0301910351964457,0.0447185050842492,6.09862722714127e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PQBP1,Polyglutamine-binding protein 1,39980,0.0540229449527889,0.00534810248724403,0.0435406640777907,0.0645052258277872,6.46070780943439e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,0.0446096947945583,0.00442474077109676,0.0359372028832086,0.0532821867059079,7.83743478595938e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40291,0.0421137623280415,0.00417794580571813,0.0339249885488339,0.050302536107249,7.9897532982364e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37990,0.0583333731967451,0.00578600138392717,0.0469928104842478,0.0696739359092423,8.06883383281053e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37671,0.0357870127527665,0.00355644851846055,0.0288163736565838,0.0427576518489492,9.84377015951313e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37714,0.0541250983185651,0.00539135349483304,0.0435580454686923,0.0646921511684379,1.24431239233624e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40380,0.0460401200487425,0.00458971838790775,0.0370442720084433,0.0550359680890417,1.30701483620383e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,0.0413909908335813,0.00412653455033473,0.0333029831149253,0.0494789985522374,1.31587872418589e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL19,C-C motif chemokine 19,40471,0.126848451703922,0.0126577053577991,0.102039349202636,0.151657554205208,1.43970461348501e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RSPO3,R-spondin-3,40489,0.0276804723414539,0.00276333515148125,0.0222643354445507,0.0330966092383572,1.50439227202479e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,0.0606137521178934,0.00605164823043542,0.04875252158624,0.0724749826495468,1.56543926497231e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC7A,C-type lectin domain family 7 member A,40516,0.0566764756871398,0.00566604449515252,0.0455710284766408,0.0677819228976387,1.73497848205113e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,0.0735491219668745,0.00735572382356934,0.0591319032726786,0.0879663406610704,1.80861106873747e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,0.0619008171262976,0.00619275063166962,0.0497630258882251,0.07403860836437,1.86672441976406e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,0.0700588060930137,0.00701139483522949,0.0563164722159639,0.0838011399700635,1.99131027141111e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,0.103998864555343,0.0104087271626804,0.0835977593164897,0.124399969794197,2.00272545350894e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40359,-0.0248930035059881,0.00249474762576667,-0.0297827088524908,-0.0200032981594854,2.22515859440644e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP3B1,AP-3 complex subunit beta-1,37901,0.0740134977795764,0.00741597790373686,0.0594781810882521,0.0885488144709006,2.24230560790636e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMP10,Bone morphogenetic protein 10,37671,-0.0278941238155937,0.00279858936834466,-0.0333793589775493,-0.0224088886536382,2.5634843667409e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINE2,Glia-derived nexin,37990,0.0620578574011447,0.00622974609260589,0.0498475550596372,0.0742681597426522,2.700840097302e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YOD1,Ubiquitin thioesterase OTU1,37562,0.0612755350922732,0.00615531708334451,0.049211113608918,0.0733399565756284,2.90337083432149e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL17,C-C motif chemokine 17,40333,0.0870846020792966,0.00875812670368545,0.0699186737400731,0.10425053041852,3.15413007571824e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPON2,Spondin-2,40267,0.0332219271468598,0.00334163447140604,0.026672323582904,0.0397715307108156,3.20286168150362e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADA,Adenosine deaminase,40516,0.0326822745247205,0.00328748784293878,0.0262387983525605,0.0391257506968805,3.20810308020771e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,0.0301959663291497,0.00303740330139362,0.0242426558584182,0.0361492767998812,3.31925379204339e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL11,Eotaxin,40516,0.0361159343650724,0.00363695252785656,0.0289875074104735,0.0432443613196712,3.5850568053077e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4G,C-type lectin domain family 4 member G,40341,0.0315865138233466,0.00318080885190224,0.0253521284736182,0.037820899173075,3.58873425712623e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6AP2,Renin receptor,39980,0.0400821174773663,0.00404186113568766,0.0321600696514185,0.0480041653033141,4.12376786102803e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,0.0925335791443891,0.00933237681040766,0.0742421205959901,0.110825037692788,4.17982147512839e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,0.0656875104896145,0.00663125772836442,0.0526902453420202,0.0786847756372088,4.73525408900596e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTSS2,Protein MTSS 2,37900,0.0943103444173539,0.00953426183097965,0.0756231912286338,0.112997497606074,5.41711088579613e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,0.0738271188295048,0.00746526195204108,0.0591952054035043,0.0884590322555053,5.53824297847439e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53I3,Quinone oxidoreductase PIG3,37419,0.0516225280692937,0.00522509925989012,0.041381333519909,0.0618637226186783,6.14252418422137e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPPK1,Epiplakin,37628,0.0704931014342565,0.00714499911270136,0.0564889031733619,0.0844972996951512,7.01027515227169e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R9B,Neurabin-2,40516,0.0894033442325968,0.00906638484733546,0.0716332299318193,0.107173458533374,7.13671941226195e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,0.0825288801220623,0.00837184571326926,0.0661200625240545,0.09893769772007,7.56802174353632e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDS,Iduronate 2-sulfatase,40516,-0.00823539887490973,0.00083638579243859,-0.00987471502808937,-0.00659608272173009,8.24229208889517e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,0.0431340672384978,0.00439342485140714,0.0345229545297398,0.0517451799472558,1.09464846937985e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNGR2,Interferon gamma receptor 2,40228,0.0488239277884292,0.004990531631438,0.0390424857908107,0.0586053697860477,1.53912886020317e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NSFL1C,NSFL1 cofactor p47,40471,0.0629831800381389,0.00643936735808157,0.050362020016299,0.0756043400599788,1.57163007483983e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,-0.0313576891105215,0.00320591421088243,-0.0376412809638511,-0.025074097257192,1.60998413844305e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL1A1,Collagen alpha-1(I) chain,40536,-0.0245983735794319,0.00251587333807854,-0.0295294853220659,-0.019667261836798,1.62863661722708e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,0.0680548584571339,0.00696091232186011,0.054411470306288,0.0816982466079797,1.64042741262176e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40400,0.0673526938903722,0.00689539516891107,0.0538377193593065,0.0808676684214379,1.78983024760593e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAX1BP1,Tax1-binding protein 1,37942,0.0606569809118563,0.00622297210997019,0.0484599555763147,0.0728540062473979,2.24612305688686e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BOC,Brother of CDO,40042,-0.0222683530020434,0.00228699849556284,-0.0267508700533466,-0.0177858359507402,2.42906322509709e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPT1,Angiopoietin-1,40263,0.0799430310583914,0.00822085609105424,0.063830153119925,0.0960559089968577,2.73954519514798e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNMBP,Dynamin-binding protein,40228,0.0578156203939956,0.00595331944208052,0.0461471142875178,0.0694841265004734,3.10884076019497e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL1,Angiopoietin-related protein 1,40136,0.0278229442251753,0.00286511416175022,0.0222073204681448,0.0334385679822057,3.12835463025403e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBIN,Erbin,40305,0.0961121689879733,0.00989935742253237,0.0767094284398099,0.115514909536137,3.18532169280145e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGMN,Legumain,40422,0.0333474662473689,0.00343540485931925,0.0266140727231032,0.0400808597716347,3.2425457998402e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,0.0902631096826657,0.00929784622047608,0.0720393310905326,0.108486888274799,3.2958145844623e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTRB1,Chymotrypsinogen B,40332,0.0498951121799441,0.00514865177968543,0.0398037546917607,0.0599864696681275,3.79582442652849e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,0.105173072576989,0.0108519011662981,0.0839033462910444,0.126442798862933,3.87374457529764e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,0.0644361442160199,0.00666289862483911,0.0513768629113353,0.0774954255207046,4.62359824501166e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNLR1,Interferon lambda receptor 1,40341,0.0349232316898877,0.00361478613425139,0.027838250866755,0.0420082125130204,5.06536468629805e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK11,Kallikrein-11,40260,0.0277507623337385,0.00287339633285236,0.0221189055213479,0.0333826191461292,5.23850973802809e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YAP1,Transcriptional coactivator YAP1,37942,0.0249894391864459,0.00258739725168942,0.0199181405731347,0.0300607377997572,5.34926596831482e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGA,Glycoprotein hormones alpha chain,40332,-0.0837270358962625,0.00867178408774727,-0.100723732708247,-0.0667303390842778,5.37493756409568e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,0.078110866025064,0.00808871025026752,0.0622569939345397,0.0939647381155884,5.43846842309328e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37598,-0.0302761795706637,0.00313571695103663,-0.0364221847946955,-0.0241301743466319,5.52376884269919e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZBP1,Z-DNA-binding protein 1,37598,0.0377651929424248,0.00391378515360167,0.0300941740413655,0.045436211843484,5.85367382068999e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,0.0314755120404165,0.00326483979617219,0.025076426039919,0.037874598040914,6.17209196421219e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECTIN4,Nectin-4,40411,0.0284206087713094,0.00295691136702952,0.0226250624919315,0.0342161550506872,8.1851572397207e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL8,Interleukin-8,40209,0.0629080303714864,0.00655703545544653,0.0500562408788112,0.0757598198641616,9.71804523780493e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN4,Contactin-4,40332,-0.0225674142863786,0.00235305830941886,-0.0271794085728396,-0.0179554199999176,1.0021609680268e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A12,Protein S100-A12,40139,0.071075698911189,0.00741202822353357,0.0565481235930632,0.0856032742293148,1.01781485105853e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,0.0749361623964676,0.00781363476657565,0.0596214382539793,0.0902508865389559,1.03291614862924e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39980,0.0325793986588604,0.00340180819172108,0.0259118546030871,0.0392469427146337,1.1457816510692e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPOCK1,Testican-1,40228,-0.0232918446561232,0.00243363630373866,-0.028061771811451,-0.0185219175007955,1.21455469200621e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,0.0880908858325311,0.00920860827007059,0.0700420136231927,0.106139758041869,1.26817854685852e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL32,Interleukin-32,40341,-0.0394840343862378,0.00412746019548983,-0.0475738563693978,-0.0313942124030777,1.26847891126782e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,0.0345643486491565,0.00361861800206039,0.0274718573651181,0.0416568399331948,1.45627812197907e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PF4,Platelet factor 4,37934,0.0901460066873565,0.00945243288768474,0.0716192382274944,0.108672775147219,1.72177416331964e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,0.0543739566084428,0.0057062841256357,0.0431896397221968,0.0655582734946888,1.86486542581885e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSE,Cathepsin E,37671,0.0478663181968631,0.00502462701846916,0.0380180492406635,0.0577145871530626,1.90895002334947e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,0.0311326984856378,0.00326980007847349,0.0247238903318298,0.0375415066394459,1.94882715947395e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RFC4,Replication factor C subunit 4,37900,0.0189818042705608,0.00199311523436568,0.0150752984112041,0.0228883101299175,1.95281046608073e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,0.0691873214939748,0.00726590484227224,0.0549461480031212,0.0834284949848284,1.98730239949703e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,-0.0223025453150896,0.00234489055560511,-0.0268985308040756,-0.0177065598261036,2.14692885121082e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EBI3_IL27,Interleukin-27,40453,0.0286757845946404,0.00301596549941868,0.0227644922157798,0.034587076973501,2.21359747629839e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOXO1,Forkhead box protein O1,40341,0.0776720613670539,0.00816942906677719,0.0616599803961706,0.0936841423379372,2.22296254059212e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL10,Interleukin-10,40044,0.0790506930773524,0.00832535484471346,0.062732997581714,0.0953683885729908,2.51041206256812e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYN,Tyrosine-protein kinase Lyn,40305,0.076947344995047,0.00811231119831639,0.0610472150463469,0.0928474749437472,2.75353102915813e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,0.0577234588484877,0.00609596163873629,0.0457753740365646,0.0696715436604109,3.21059072846132e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37959,0.0694969444155597,0.00735887753835305,0.0550735444403878,0.0839203443907317,4.16983338832385e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL8,C-C motif chemokine 8,40470,0.0550528641347779,0.00583200260179423,0.0436221390352612,0.0664835892342946,4.23794916725761e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37901,0.0763770929068653,0.0080897702150002,0.060521143285465,0.0922330425282657,4.28339605498677e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAB2,Disabled homolog 2,40489,0.10049034778164,0.0106480304627468,0.0796202080746567,0.121360487488624,4.33199394035994e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,0.0533308235694347,0.00565634826224472,0.0422443809754351,0.0644172661634344,4.72242824883631e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,0.03266318266455,0.00346723808515161,0.0258673960176529,0.0394589693114472,5.22924712738565e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DFFA,DNA fragmentation factor subunit alpha,40516,0.0618001467633296,0.00656257853462792,0.0489374928354589,0.0746628006912004,5.25531176487374e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD6,T-cell differentiation antigen CD6,40502,0.0483464162250518,0.00513466460689318,0.0382824735955411,0.0584103588545624,5.32406404837267e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,40042,0.0344642878358823,0.00366128404234994,0.0272881711128764,0.0416404045588882,5.47267829548202e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFRP4,Secreted frizzled-related protein 4,37671,0.0382950842957234,0.00407762928099276,0.0303029309049776,0.0462872376864692,6.87048177377677e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,0.0712432719383869,0.00759343813860769,0.0563601331867158,0.086126410690058,7.33558046829165e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,-0.0340980652810096,0.00363708535436702,-0.0412267525755689,-0.0269693779864502,7.81789096275855e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STIP1,Stress-induced-phosphoprotein 1,40307,0.0593087897331512,0.00633066484045142,0.0469006866458664,0.071716892820436,8.32689737400237e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AXIN1,Axin-1,40341,0.0849906100730584,0.00907515750806161,0.0672033013572577,0.102777918788859,8.58745615958209e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEXIM1,Protein HEXIM1,40341,0.0738788916941266,0.00788955077140674,0.0584153721821694,0.0893424112060838,8.67276259976988e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,0.0700877123506998,0.00748448431497282,0.0554181230933531,0.0847573016080465,8.84667271069785e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A4,Protein S100-A4,40411,0.0521955234092903,0.00557861279522472,0.0412614423306498,0.0631296044879307,9.32686942276592e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,0.0591069642900716,0.00631775383753722,0.0467241667684986,0.0714897618116445,9.60157266246696e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39980,0.0518929227685902,0.00554909141716596,0.041016703590945,0.0627691419462355,9.78655170020092e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP7,Matrilysin,40015,0.0436798574094148,0.00467335523315626,0.0345200811524285,0.052839633666401,1.02579212755283e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40305,0.0280206825559663,0.00299865480811859,0.0221433191320539,0.0338980459798787,1.04440714537246e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP7,Dipeptidyl peptidase 2,40251,0.0524951034798286,0.00561887190162169,0.0414821145526501,0.0635080924070072,1.0624299368339e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,0.0364402068774779,0.00390094216581634,0.0287943602324779,0.0440860535224779,1.09776525614152e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37562,0.0334839849990924,0.00358905566883846,0.026449435888169,0.0405185341100157,1.23266328773295e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPARC,SPARC,40411,0.0637928420941035,0.00684207684503443,0.050382371477836,0.077203312710371,1.2686959854146e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATG16L1,Autophagy-related protein 16-1,37901,0.0766478349221546,0.00822350533969878,0.060529764456345,0.0927659053879642,1.33479445429517e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL16,C-X-C motif chemokine 16,40517,0.0213876725013206,0.00229920976369169,0.0168812213644849,0.0258941236381563,1.54942054529118e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37990,0.0269911206831122,0.00290133020676632,0.0213045134778502,0.0326777278883742,1.57174032121938e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37901,0.0423546380399065,0.00455355367874979,0.0334296728295569,0.0512796032502561,1.59643975160261e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAP,Prolyl endopeptidase FAP,40536,-0.0243146950869755,0.00261935018493391,-0.0294486214494459,-0.019180768724505,1.85833224276979e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLIN3,Perilipin-3,40359,0.0381302546599549,0.00410786295077991,0.0300788432764263,0.0461816660434836,1.86876088071718e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS7_LGALS7B,Galectin-7,40270,0.0360612517805648,0.00388759535146102,0.0284415648917012,0.0436809386694284,1.98293100081909e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40305,0.0290589106323807,0.0031332400352224,0.0229177601633447,0.0352000611014166,2.01189115804414e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROBO2,Roundabout homolog 2,40471,-0.0208573146676954,0.00225154629849594,-0.0252703454127474,-0.0164442839226434,2.22325675799359e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAT2,Signal transducer and activator of transcription 2,37598,0.0690943867975692,0.00745955078302164,0.0544736672628468,0.0837151063322916,2.30224478235009e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EHBP1,EH domain-binding protein 1,37990,0.0670433566967698,0.00724143132599923,0.0528501512978113,0.0812365620957283,2.38504219611727e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMP,Cartilage oligomeric matrix protein,40198,-0.0303037546597874,0.00327967963754043,-0.0367319267493667,-0.0238755825702082,2.77752834517205e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F2R,Proteinase-activated receptor 1,40396,0.051385433947854,0.00556291686691222,0.0404821168887061,0.062288751007002,2.84431429493577e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPI,Glucose-6-phosphate isomerase,37987,0.0421231674265433,0.0045593021985033,0.0331869351174768,0.0510593997356098,2.85516335629094e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CIT,Citron Rho-interacting kinase,37572,0.0405224106656084,0.00438922482600825,0.0319195300066322,0.0491252913245846,3.05157653028258e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,0.0515970590273766,0.005592072702004,0.0406365965314487,0.0625575215233044,3.14103618974381e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,0.0621063699457287,0.0067355671814998,0.0489046582699891,0.0753080816214683,3.31678960523378e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,0.0617018895809319,0.00669313688791649,0.0485833412806156,0.0748204378812483,3.44737943979299e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PON2,Serum paraoxonase/arylesterase 2,40042,0.0306310644743606,0.00332729705918283,0.0241095622383623,0.037152566710359,3.80728896801702e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37608,0.0506073646902337,0.00549859972545252,0.0398301092283468,0.0613846201521207,3.97454114346717e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDLIM7,PDZ and LIM domain protein 7,40422,0.111174864512268,0.0120902637861985,0.087477947491319,0.134871781533217,4.18763207638664e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,0.0425505495323596,0.00462867577937176,0.0334783450047909,0.0516227540599282,4.38157415280226e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG1A,Lithostathine-1-alpha,40274,0.0434443156617031,0.00472782914196435,0.0341777705434529,0.0527108607799532,4.445356931603e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TJAP1,Tight junction-associated protein 1,40411,0.0732578569171531,0.00797358729948593,0.0576296258101607,0.0888860880241456,4.50286134812468e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLSCR3,Phospholipid scramblase 3,37919,0.0534166341208245,0.00581361610081667,0.0420219465632238,0.0648113216784251,4.57171005170385e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAP23,Synaptosomal-associated protein 23,40359,0.0771172740360958,0.00840834662009776,0.0606369146607042,0.0935976334114875,5.22444615778947e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37901,0.0353007457841146,0.00385015771636783,0.0277544366600337,0.0428470549081955,5.47619702618113e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHCHD6,MICOS complex subunit MIC25,37900,0.0258200006107442,0.00281662711743893,0.0202994114605639,0.0313405897609245,5.56049966207907e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,0.0574298477375395,0.00626501630236205,0.0451504157849099,0.0697092796901691,5.56794432874256e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,0.0402897190548511,0.00439695046147766,0.0316716961503549,0.0489077419593473,5.77915193860063e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39961,0.0589383336461421,0.0064349877659148,0.0463257576249491,0.0715509096673351,5.87823565188116e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,0.0583101821107395,0.00637281079784205,0.0458194729469691,0.0708008912745099,6.37512080237638e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMMD1,COMM domain-containing protein 1,37628,0.0547011592316892,0.00597937039798751,0.0429815932516336,0.0664207252117447,6.62195334309384e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,0.0616792749040208,0.00676432625101389,0.0484211954520336,0.074937354356008,8.53230696795689e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLR2,Folate receptor beta,40471,0.0259549224818131,0.0028485114501082,0.020371840039601,0.0315380049240251,9.04697713080878e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPL14,60S ribosomal protein L14,37628,0.0366004047564109,0.00401943888338224,0.0287223045449817,0.0444785049678401,9.77720821054451e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USO1,General vesicular transport factor p115,40305,0.0796741818887957,0.008762276061763,0.0625001208077402,0.0968482429698512,1.07682567317899e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGT,Angiotensinogen,37987,0.0214467653862908,0.00236093421311231,0.0168193343285907,0.0260741964439909,1.18963626315905e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBI,Acyl-CoA-binding protein,40270,0.0693205820388888,0.00763568235789451,0.0543546446174156,0.0842865194603621,1.22823172737772e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA9,Serpin A9,40228,0.0633296411324811,0.00697958466640788,0.0496496551863217,0.0770096270786405,1.2854343364453e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADA2,Adenosine deaminase 2,40258,0.0368279146063905,0.00406277168548626,0.0288648821028374,0.0447909471099436,1.39303008764669e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40305,0.120673422406689,0.0133133976082656,0.0945791630944881,0.146767681718889,1.40108986906352e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUCA2A,Guanylin,40276,0.0293491138414938,0.00324254971781517,0.0229937163945761,0.0357045112884116,1.57504697990468e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40536,0.0534177949962038,0.00590520147447847,0.041843600106226,0.0649919898861816,1.65093829508552e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300LF,CMRF35-like molecule 1,40489,0.0531370495770898,0.00587483686544926,0.0416223693208093,0.0646517298333704,1.66706468190394e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBPL,FK506-binding protein-like,37901,0.051826125980547,0.00573029237989961,0.0405947529159437,0.0630574990451502,1.71103312181847e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,0.0831785099014089,0.00919938318936401,0.0651477188502554,0.101209300952562,1.71658774360486e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX8,Syntaxin-8,40341,0.04266102622083,0.004720872995738,0.0334081151491836,0.0519139372924765,1.79759603641034e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM3D,Protein FAM3D,37901,0.0723800672089275,0.00800834298287194,0.0566837149624985,0.0880764194553565,1.8095327219967e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,0.0550967134281976,0.00609759194411095,0.0431454332177401,0.0670479936386551,1.81003923484696e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,-0.0182993790614322,0.00202539537056322,-0.0222691539877361,-0.0143296041351282,1.82960460056186e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,0.0237979378370832,0.00263420977454385,0.0186348866789772,0.0289609889951891,1.83674543398235e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASC3,Protein CASC3,37572,0.0360391996771513,0.00398870163931132,0.0282213444641011,0.0438570548902015,1.86140043524766e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VCAM1,Vascular cell adhesion protein 1,40372,0.0236798154155015,0.00262167771811061,0.0185413270880047,0.0288183037429983,1.8700653558198e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,40228,0.051695300281344,0.00572550688997601,0.0404733067769911,0.062917293785697,1.93005714002304e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN8,Tetraspanin-8,37901,0.0913352274669448,0.010113827687964,0.0715121251985355,0.111158329735354,1.93460694346502e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,0.0393197670932552,0.0043601818651032,0.0307738106376529,0.0478657235488575,2.17941929856967e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RALY,RNA-binding protein Raly,37900,0.0422897587314213,0.00468996381032888,0.0330974296631767,0.0514820877996659,2.18986139305364e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD36,Platelet glycoprotein 4,37598,0.0387888339758246,0.00430959146818244,0.030342034698187,0.0472356332534622,2.55016028373526e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40341,0.0920052285650238,0.010238209887042,0.0719383371864215,0.112072119943626,2.83536516879161e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,0.041998964215377,0.00467432678856519,0.0328372837097893,0.0511606447209648,2.8697825993047e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDHR5,Cadherin-related family member 5,40359,0.0338305704981977,0.00376680097797717,0.0264476405813624,0.0412135004150329,2.97183770534029e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NID2,Nidogen-2,40332,0.0640232128799298,0.00714023873757386,0.050028344954285,0.0780180808055745,3.3949655765945e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40396,-0.0736106122137112,0.00821317994487109,-0.0897084449056586,-0.0575127795217639,3.51955818801505e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,METAP2,Methionine aminopeptidase 2,40453,0.0509752520077505,0.00568777988381648,0.0398272034354702,0.0621233005800308,3.52646259713907e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDA,Cytidine deaminase,37970,0.0399188605722835,0.00445568794719362,0.031185712195784,0.048652008948783,3.69742530550397e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRN,Progranulin,40262,0.0210015661812137,0.00235062013076333,0.0163943507249176,0.0256087816375099,4.53451417378423e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASHC3,WASH complex subunit 3,37942,0.0650020767319421,0.007279728639204,0.0507338085991023,0.0792703448647819,4.83988751804079e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,40225,0.0503981688729975,0.005648768696229,0.0393265822283886,0.0614697555176063,5.07538696991269e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AAMDC,Mth938 domain-containing protein,37628,0.0463450608635988,0.00521325477857826,0.0361270814975854,0.0565630402296122,6.90616445544836e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,0.0670004951059562,0.00753971705487134,0.0522226496784084,0.081778340533504,6.98642942967024e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFC1,Cryptic protein,39980,0.0398065907760994,0.00447990756855317,0.0310259719417352,0.0485872096104637,7.04528543857455e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOLGA3,Golgin subfamily A member 3,37959,0.0676233167160147,0.00761180424169414,0.0527041804022942,0.0825424530297352,7.25537715714592e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPO,Myeloperoxidase,40332,0.040202343216946,0.00452687505053724,0.0313296681178931,0.049075018315999,7.33570760157458e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCR,Breakpoint cluster region protein,40341,0.0780882767988594,0.00879344668903217,0.0608531212883563,0.0953234323093624,7.37047380278764e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5E,5'-nucleotidase,40411,0.0495534903529357,0.00559447527001521,0.0385883188237059,0.0605186618821655,9.02420976518359e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX15,Sorting nexin-15,37671,0.0467994952295317,0.00528219681645477,0.0364463894692803,0.057152600989783,9.0245057292459e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37671,0.0580574743858135,0.00655496034573731,0.0452097521081684,0.0709051966634586,9.25472545430466e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL5,C-X-C motif chemokine 5,40309,0.0982787612039082,0.0111046832918713,0.0765135819518405,0.120043940455976,9.64329386523673e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,0.041607584862385,0.00470513261157441,0.0323855249436992,0.0508296447810709,1.02798353036439e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALPP,"Alkaline phosphatase, placental type",40305,0.0882214908079598,0.00997683575341295,0.0686668927312704,0.107776088884649,1.03171810148038e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA4,Kallistatin,37781,0.0206492789750088,0.00233523125062554,0.0160722257237827,0.0252263322262348,1.05232851387703e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAMP5,Vesicle-associated membrane protein 5,40042,0.0479815507091236,0.0054284626926585,0.0373417638315129,0.0586213375867343,1.06851456643114e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY9,T-lymphocyte surface antigen Ly-9,40182,0.0245508161324564,0.00277876203850981,0.0191044425369772,0.0299971897279356,1.10352202907128e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HGFAC,Hepatocyte growth factor activator,37849,-0.0249512934052329,0.00282586001378093,-0.0304899790322435,-0.0194126077782222,1.17926350370475e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRTAC1,Cartilage acidic protein 1,40536,-0.025031968958686,0.00283748042646849,-0.0305934305945643,-0.0194705073228078,1.23902258807892e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTGES2,Prostaglandin E synthase 2,37484,0.0468959338119279,0.00531824006686194,0.0364721832808785,0.0573196843429773,1.31246802670713e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TADA3,Transcriptional adapter 3,37900,0.0332273600185001,0.00377856150068958,0.0258213794771485,0.0406333405598517,1.62188768027928e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37901,0.0549298560097004,0.00624887566414675,0.0426820597079727,0.067177652311428,1.66987782594473e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEZ6L2,Seizure 6-like protein 2,40305,-0.0202024724310199,0.00229991492755341,-0.0247103056890246,-0.0156946391730152,1.73643608837618e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLGN,Calmegin,37572,0.0380191241034114,0.00433045358314137,0.0295314350804543,0.0465068131263685,1.8437538320415e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD58,Lymphocyte function-associated antigen 3,40335,-0.0150501765752889,0.00171517332421725,-0.0184119162907547,-0.011688436859823,1.88471912917939e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPHOSPH8,M-phase phosphoprotein 8,40042,0.0634106149774464,0.00723489871741241,0.049230213491318,0.0775910164635747,2.06580025064064e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA10,Annexin A10,39961,0.0701180185857841,0.00800220056324295,0.0544337054818279,0.0858023316897403,2.10749383917484e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFX1,Transcriptional repressor NF-X1,37562,0.0576417502925742,0.00657862971973356,0.0447476360418964,0.070535864543252,2.15222385393608e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37687,0.0548268434113862,0.00625800225458133,0.0425611589924068,0.0670925278303656,2.16687368128746e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,0.0267290084600298,0.00305349195552513,0.0207441642272005,0.032713852692859,2.27168990212164e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37628,0.0874419094663579,0.00998746427085452,0.067866479495483,0.107017339437233,2.2839823100064e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOK2,Docking protein 2,40359,0.102013954224525,0.0116742733434298,0.079132378471403,0.124895529977648,2.59768189584027e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH17,Protocadherin-17,40359,0.0294727468307314,0.0033758098138771,0.0228561595955323,0.0360893340659305,2.78196406794975e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,0.0374315312615618,0.00429587312823813,0.0290116199302151,0.0458514425929086,3.29628895178674e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNIP1,TNFAIP3-interacting protein 1,37942,0.0747481803772066,0.00860493686249184,0.0578825041267226,0.0916138566276906,4.15770354405734e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40305,0.0326409191412648,0.00376051965157771,0.0252703006241725,0.0400115376583571,4.34124910410182e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTBDN,Retbindin,40305,0.0245743857084228,0.00283176874264989,0.019024118972829,0.0301246524440166,4.40982296045226e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAP3,Cytosol aminopeptidase,40044,0.0412112337008077,0.00474940430612441,0.0319024012608039,0.0505200661408116,4.45409313276589e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,0.0363369645940513,0.0041913966397119,0.0281218271802159,0.0445521020078866,4.84770894512078e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,-0.0351269663403597,0.00405951334187955,-0.0430836124904436,-0.0271703201902758,5.49133725276172e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESYT2,Extended synaptotagmin-2,37942,0.0685378443352001,0.00792114839420443,0.0530123934825595,0.0840632951878408,5.60240464365934e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,0.0453892853398364,0.00524738654000031,0.0351044077214358,0.055674162958237,5.64508729922293e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGBP1,Immunoglobulin-binding protein 1,37959,0.0514647107068361,0.00595032950884968,0.0398020648694908,0.0631273565441815,5.77321588104594e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP2B1,AP-2 complex subunit beta,37572,0.041179813634852,0.00476285537351876,0.0318446171027552,0.0505150101669488,5.94544554398038e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17C,Interleukin-17C,40044,0.058715994915754,0.00679447468972899,0.0453988245238852,0.0720331653076229,6.06756629253158e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC16A1,Monocarboxylate transporter 1,39961,0.0502442886672037,0.00582146735291298,0.0388342126554943,0.0616543646789132,6.67279537503036e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMOX2,Heme oxygenase 2,39961,0.0380822055457048,0.00441469269532503,0.0294294078628678,0.0467350032285419,6.94655990017256e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GZMH,Granzyme H,40042,0.0623734882636417,0.00723195753012796,0.0481988515045909,0.0765481250226925,7.03678337701082e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,0.0298831673301157,0.00346893423861199,0.0230840562224363,0.0366822784377952,7.82076974857333e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,0.0213331250998394,0.0024771021665547,0.0164780048533922,0.0261882453462866,7.8409201192796e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,-0.0220243137836226,0.00255787219274296,-0.0270377432813988,-0.0170108842858464,7.95584480281284e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40333,0.0808587825496161,0.00939407955078296,0.0624463866300815,0.0992711784691507,8.1634331780959e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,0.0542399091278721,0.00630334833619911,0.0418853463889218,0.0665944718668223,8.49339906385494e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAEP,Glycodelin,40228,0.109488033949183,0.0127305195352993,0.0845362156599966,0.13443985223837,8.67835934743117e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS5,Transmembrane protease serine 5,40159,-0.0314698401237328,0.00365959198985574,-0.03864264042385,-0.0242970398236155,8.76963368446281e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DGKA,Diacylglycerol kinase alpha,37598,0.0453794896914394,0.00527730265647663,0.0350359764847452,0.0557230028981336,8.94446091857986e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCTN3,Tectonic-3,37990,0.0243660613303621,0.00283396550475208,0.018811488941048,0.0299206337196762,9.00441170646959e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN1,Tetraspanin-1,40042,0.0254319224881468,0.00295914731046834,0.0196319937596289,0.0312318512166648,9.1589892325838e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,0.0293047850030593,0.00341128106921054,0.0226186741074067,0.035990895898712,9.60002859449887e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLNK,B-cell linker protein,37598,0.0319977775874848,0.00372665470110139,0.0246935343733261,0.0393020208016435,9.99263311756011e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCN2,Ficolin-2,40291,0.0340995854563119,0.00397690656577526,0.0263048485873924,0.0418943223252314,1.08697361275826e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,0.0246060642517074,0.00287517580173483,0.0189707196803072,0.0302414088231077,1.25081896647145e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40411,0.0224748299099645,0.00263067686658927,0.0173187032514495,0.0276309565684794,1.42002520647924e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37900,0.0947291941464787,0.0110864718677952,0.0729997092856001,0.116458679007357,1.42781388697316e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,40044,0.0496757640370675,0.00581519545804743,0.0382779809392946,0.0610735471348405,1.43466199697436e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37572,0.0673284243011218,0.0078895472917824,0.0518649116092283,0.0827919369930153,1.5694688682453e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2L15,Bcl-2-like protein 15,37598,0.0468261942376344,0.00549548590331162,0.0360550418671436,0.0575973466081252,1.75507648143714e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRTN3,Myeloblastin,39897,0.0387594694766095,0.00455225588410009,0.0298370479437734,0.0476818910094457,1.82788865426054e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKD2,Polycystin-2,37562,0.0491456931819626,0.00577655246275416,0.0378236503549645,0.0604677360089608,1.96372136969454e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP10,Caspase-10,39961,0.059033147157064,0.00694601482204751,0.0454189581058509,0.0726473362082772,2.08702781060286e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,0.0438848351061427,0.00516615606293742,0.0337591692227853,0.0540105009895,2.1915982762953e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD2,Sushi domain-containing protein 2,40332,-0.0235366705388779,0.00277356291647839,-0.0289728538551755,-0.0181004872225802,2.32374739263547e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,0.0421295723133152,0.00496659480834691,0.0323950464889553,0.0518640981376751,2.43051960571508e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,0.0390920516722982,0.00461414595500573,0.030048325600487,0.0481357777441094,2.65462223692776e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SWAP70,Switch-associated protein 70,37901,0.0289179474859959,0.00342197684928484,0.0222108728613976,0.0356250221105942,3.19209080020001e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40359,0.0648131288101627,0.00767209150016386,0.0497758294698416,0.0798504281504839,3.21921109272978e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,0.0911591750507549,0.0107935322391798,0.0700038518619625,0.112314498239547,3.28261628587383e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHSG,Alpha-2-HS-glycoprotein,37987,0.0221933516392059,0.00263614657392313,0.0170265043543166,0.0273601989240953,4.18074034675342e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VNN1,Pantetheinase,37987,0.0592883545818924,0.00705171298469747,0.0454669971318853,0.0731097120318994,4.59783381591163e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,-0.0311585125832095,0.00370690677556403,-0.038424049863315,-0.023892975303104,4.61612345692834e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAMBP,STAM-binding protein,40192,0.0525442063196592,0.00625180765058907,0.0402906633245047,0.0647977493148138,4.65489358711178e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,0.0544832817072868,0.00649230721940846,0.0417583595572463,0.0672082038573274,5.18819509142619e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40328,0.0295277526588264,0.00351895423852794,0.0226306023513116,0.0364249029663412,5.21927017163282e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYTL4,Synaptotagmin-like protein 4,37990,0.0596598856814629,0.00711033506915562,0.0457236289459179,0.073596142417008,5.31283644082707e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNR,Tenascin-R,40228,-0.0344703859472689,0.0041091165190979,-0.0425242543247008,-0.0264165175698371,5.32463827047175e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRLF1,Cytokine receptor-like factor 1,40422,0.0213622535219496,0.0025468968506901,0.016370335694597,0.0263541713493021,5.37364400677254e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,-0.0217512180577943,0.00259500678557739,-0.026837431357526,-0.0166650047580626,5.71670353336378e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAX,Apoptosis regulator BAX,39934,0.0724640559467385,0.00864925512322095,0.0555115159052254,0.0894165959882516,5.83755943390182e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAMP8,Vesicle-associated membrane protein 8,37598,0.0721959407364865,0.00861658320878772,0.0553074376472626,0.0890844438257105,5.88997884562992e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,0.0312400200661285,0.00373279302857722,0.0239237457301171,0.0385562944021398,6.28672951224214e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1R2,Interleukin-1 receptor type 2,40330,0.0157976087358555,0.00189226192362539,0.0120887753655497,0.0195064421061612,7.47565366084588e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,0.0628264057976704,0.00753552756565952,0.0480567717689778,0.0775960398263631,8.34525282392823e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NID1,Nidogen-1,40355,0.0319522614840205,0.00383637314359523,0.0244329701225738,0.0394715528454672,8.82784614345487e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX4,Syntaxin-4,40305,0.0481388482472891,0.00577985373718909,0.0368103349223984,0.0594673615721797,8.83272447911694e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCBP2,Poly(rC)-binding protein 2,37959,0.0580825171964477,0.00697448371844901,0.0444125291082876,0.0717525052846078,9.01837506237158e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37835,0.0475205041969159,0.00571171821033082,0.0363255365046675,0.0587154718891643,9.65579752270366e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40332,0.0240841068185553,0.00289772457609897,0.0184045666494013,0.0297636469877092,1.02168645047174e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTD,Biotinidase,38013,0.0167124715689085,0.00201049941292791,0.0127718927195698,0.0206530504182472,1.02473109447653e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOS1,"Nitric oxide synthase, brain",39961,0.0401889970604856,0.00483585209600867,0.0307107269523086,0.0496672671686626,1.03004269592613e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,0.0319265660525987,0.00384199028630804,0.024396265091435,0.0394568670137625,1.04832695177754e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CETN2,Centrin-2,39961,0.0539932703347793,0.00650318407463592,0.0412470295484929,0.0667395111210657,1.10192854128039e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,0.0733978377158914,0.00883981639079672,0.0560717975899298,0.0907238778418529,1.11020905041277e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37671,0.0307831507388627,0.00371043678747731,0.0235106946354072,0.0380556068423182,1.17670615157661e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,0.0575424910212776,0.00694356189662855,0.0439331097038856,0.0711518723386696,1.27080887230277e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGA4,Pepsin A-4,37987,0.0549295672973627,0.00663329110281324,0.0419283167358488,0.0679308178588767,1.33645321842527e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,0.0286300076597204,0.00345835972196993,0.0218516226046593,0.0354083927147815,1.36708956816732e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,0.093549709347621,0.0113255611810078,0.0713516094328456,0.115747809262396,1.59125137165705e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUB1,NEDD8 ultimate buster 1,40341,0.0666156045778891,0.00807041725319543,0.050797586761626,0.0824336223941521,1.64695390408192e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,0.0713052445429644,0.00865668062237495,0.0543381505231095,0.0882723385628193,1.90211722725898e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IKBKG,NF-kappa-B essential modulator,40341,0.0731576563626322,0.00888526978051944,0.0557425275928141,0.0905727851324503,1.95684645689507e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,0.0455048750911132,0.00553929209564562,0.0346478625836478,0.0563618875985786,2.28364086256572e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VASN,Vasorin,40116,-0.0218786374528564,0.00266414157931753,-0.0271003549483187,-0.016656919957394,2.33846417102597e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ING1,Inhibitor of growth protein 1,39925,0.0354680955222244,0.00432100111691114,0.0269989333330786,0.0439372577113702,2.41875227596417e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ISM1,Isthmin-1,40341,0.0309150777390615,0.00377057107093962,0.0235247584400199,0.0383053970381032,2.60656786752186e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39961,0.0536174189439144,0.00653937575335918,0.0408002424673304,0.0664345954204984,2.60860957214122e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CETN3,Centrin-3,37901,0.0611726227446914,0.00746573606654075,0.0465397800542715,0.0758054654351113,2.7587024991509e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,0.0232977252105701,0.00285055815809136,0.017710631220711,0.0288848192004292,3.23361609344859e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,0.0214027409652211,0.00261901779766485,0.0162694660817979,0.0265360158486442,3.25951401370825e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,0.0752103795804724,0.00921603977806093,0.057146941615473,0.0932738175454718,3.57743947791919e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,0.0817029949164078,0.0100167827452665,0.0620701007356856,0.10133588909713,3.70104661957282e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,0.0597005680270304,0.00732099320898834,0.0453514213374133,0.0740497147166475,3.76053138036671e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSLN,Mesothelin,40271,0.0427894041170935,0.00524771962516289,0.0325038736517742,0.0530749345824128,3.78569187068272e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP2,Microtubule-associated protein 2,37942,0.0363009996384184,0.00445421060353152,0.0275707468554966,0.0450312524213402,3.96386585163777e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37598,0.0248912380905802,0.00305462822858638,0.0189041667625509,0.0308783094186095,4.00933179625465e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,0.048182636653115,0.00591434118711595,0.0365905279263677,0.0597747453798622,4.01429627811624e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,0.0719770016933932,0.00884147835540289,0.0546477041168036,0.0893062992699829,4.26889046692033e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,0.0318331772393516,0.0039120781842107,0.0241655039982986,0.0395008504804046,4.39736062063316e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,0.0417481100458186,0.00513126817014558,0.0316908244323332,0.0518053956593039,4.44872865250715e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL6,Fc receptor-like protein 6,40341,0.0531423257333034,0.00653529106701357,0.0403331552419568,0.06595149622465,4.54709193194944e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLG,Plasminogen,37705,0.0177812788268242,0.00218738284300974,0.0134940084545251,0.0220685491991233,4.70966520833388e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,0.0518594723503252,0.00638073839082793,0.0393532251043025,0.064365719596348,4.76110581384317e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBLIF,Cobalamin binding intrinsic factor,40330,0.0573463584616312,0.00707419740862451,0.0434809315407272,0.0712117853825353,5.5908744981781e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LONP1,"Lon protease homolog, mitochondrial",37628,0.0683386191853684,0.00842898830052656,0.0518178021163364,0.0848594362544005,5.61773163992108e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,-0.0325770421088031,0.00402140924522277,-0.0404590042294398,-0.0246950799881665,5.846600465417e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,0.0291797241305854,0.00360172763326132,0.0221203379693932,0.0362391102917776,5.89628166557262e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMPACT,Protein IMPACT,37942,0.0447593914227841,0.00552707141219915,0.0339263314548737,0.0555924513906944,6.05306086026513e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37557,0.066621465600185,0.00823743867708002,0.0504760857931082,0.0827668454072619,6.61488811829172e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAM,Integrin alpha-M,40332,-0.0248054774889269,0.00306890498646135,-0.0308205312623912,-0.0187904237154626,6.77975571074595e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL13,C-C motif chemokine 13,40483,0.0544653197544982,0.00674089396038583,0.041253167592142,0.0676774719168544,6.94382431796898e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37987,0.0475256240440315,0.00588203071438653,0.0359968438438339,0.0590544042442291,7.03371757116242e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,0.0513712751444539,0.0063638413744602,0.0388981460505119,0.0638444042383959,7.3965139083399e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37901,0.0434613774275045,0.00538419249939246,0.0329083601286953,0.0540143947263138,7.4975464358993e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP3R1,Calcineurin subunit B type 1,40228,0.0322522317219555,0.00399762931511932,0.0244168782643217,0.0400875851795894,7.6664422891639e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEC31A,Protein transport protein Sec31A,37628,0.0599801801263862,0.00743651589841532,0.0454046089654921,0.0745557512872802,7.91239544369056e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GMPR2,GMP reductase 2,37671,0.0532864602491096,0.00661215343584272,0.0403266395148579,0.0662462809833614,8.3581066250653e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHACTR2,Phosphatase and actin regulator 2,37959,0.0892176664060659,0.0110792282971003,0.0675023789437493,0.110932953868382,8.77312048040766e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM13A,Protein FAM13A,37901,0.0527226260765306,0.00655050875347632,0.039883628919717,0.0655616232333442,9.0711774639995e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGA,Protein O-GlcNAcase,37901,0.0549349488321438,0.00682820535915186,0.0415516663282061,0.0683182313360814,9.32025473099361e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHB6,Ephrin type-B receptor 6,40192,0.0243040129166987,0.00302168914006331,0.0183815022021746,0.0302265236312228,9.37210383942202e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,0.0560103827732596,0.00696546686456052,0.042358067718721,0.0696626978277982,9.53459921908377e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,0.115284568290961,0.0143377039819233,0.0871826684863915,0.143386468095531,9.67837402583238e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS1BP3,HCLS1-binding protein 3,37628,0.0697846977369858,0.00869221422270164,0.0527479578604906,0.086821437613481,1.07070665194088e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37628,0.0392977869592631,0.00489890388719899,0.0296959353403531,0.0488996385781731,1.13013333806315e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DXO,Decapping and exoribonuclease protein,37942,0.035705512292447,0.00445186498418179,0.0269798569234507,0.0444311676614433,1.14090357281983e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF7,SLAM family member 7,40341,0.0447763092775524,0.00558515725427979,0.033829401059164,0.0557232174959408,1.15830391983879e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RILP,Rab-interacting lysosomal protein,40434,0.0466691195441501,0.00582303242796323,0.0352559759853422,0.0580822631029581,1.18103006533184e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40359,0.027276456850667,0.00340374139150179,0.0206051237233235,0.0339477899780105,1.19008566607603e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,0.0347527520571409,0.00433671045523542,0.0262527995648795,0.0432527045494023,1.20705793233911e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYAP1,Synapse-associated protein 1,37671,0.0441297361680733,0.00550851104147887,0.0333330545267747,0.0549264178093719,1.23070557135961e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,0.0167557580058664,0.00209190932152882,0.0126556157356699,0.0208559002760629,1.24302796048203e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM5,Tripartite motif-containing protein 5,40341,0.0659002119653511,0.00822966530488855,0.0497700679677696,0.0820303559629327,1.24971514821808e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATOX1,Copper transport protein ATOX1,40411,0.0554950229737753,0.00693730017597891,0.0418979146288566,0.069092131318694,1.33429913938052e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,0.0809057841437871,0.0101188645293542,0.0610728096662528,0.100738758621321,1.37891520172418e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,0.0480870394297464,0.00601329836772096,0.0363009746290134,0.0598731042304795,1.38369514276516e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40305,-0.0486799995019679,0.00609706941341435,-0.06063025555226,-0.0367297434516757,1.51116524318569e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THBD,Thrombomodulin,40359,0.0214309248678527,0.00268834511267242,0.0161617684470148,0.0267000812886906,1.66941539137385e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WIF1,Wnt inhibitory factor 1,40489,-0.0264115688937049,0.003313989631848,-0.032906988572127,-0.0199161492152828,1.69662166417899e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37928,0.0315994786704937,0.00397050110673993,0.0238172965012834,0.0393816608397039,1.87891604738264e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAP18,Chromatin complexes subunit BAP18,37942,0.0500518120641275,0.00629737331669555,0.0377089603634043,0.0623946637648508,2.04447184999612e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN2L,Ataxin-2-like protein,37959,0.0372670701672222,0.00469215631101709,0.0280704437976287,0.0464636965368157,2.13876646364906e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40357,0.0305441550016062,0.00385190191597306,0.022994427246299,0.0380938827569134,2.34314296370786e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOBR,Apolipoprotein B receptor,37628,-0.032674487251618,0.00412575374951596,-0.0407609646006693,-0.0245880099025667,2.57202747150101e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA4D,Semaphorin-4D,40471,0.022836360060228,0.00288524792516081,0.0171812741269128,0.0284914459935432,2.63614600370142e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORT1,Sortilin,40330,0.0278069233940794,0.00351620612391957,0.0209151593911971,0.0346986873969618,2.78182256345524e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37959,0.0525169511975186,0.00663985405203526,0.0395028372555295,0.0655310651395077,2.78742567018437e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,0.0443832567015879,0.00561249019311812,0.0333827759230763,0.0553837374800994,2.79189883603722e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AZI2,5-azacytidine-induced protein 2,37959,0.0423360391811227,0.00535472211125806,0.0318407838430569,0.0528312945191885,2.85629398030953e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A14,Protein S100-A14,37959,0.0412773051854825,0.00523527325160883,0.0310161696123292,0.0515384407586358,3.40020127728988e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KAZN,Kazrin,37901,0.0795803235184091,0.0100947719463049,0.0597945705036516,0.0993660765331667,3.43231945322617e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,0.0416185925298743,0.00528679481720065,0.0312564746881611,0.0519807103715876,3.71323775732078e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL2,Fc receptor-like protein 2,40442,0.0370754415868634,0.00471381520780112,0.0278363637795732,0.0463145193941536,3.91693571742857e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39980,0.0393889562870836,0.00500814469850332,0.0295729926780171,0.0492049198961501,3.93325833936924e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANG,Angiogenin,40309,0.0262508992419802,0.00334152192319626,0.0197015162725156,0.0328002822114449,4.21985553682831e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS22,Brain-specific serine protease 4,37598,0.0270186357277725,0.00344074517028161,0.0202747751940206,0.0337624962615245,4.39139435030057e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNRD2,Protein ZNRD2,37901,0.0519395241227144,0.00662128190932707,0.0389618115804333,0.0649172366649954,4.6796826168738e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39836,0.0916184397391713,0.0116818749158456,0.0687219649041139,0.114514914574229,4.69455735315031e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAX,Protein max,39961,0.0792980260668609,0.0101125110313919,0.0594775044453328,0.0991185476883889,4.73740817576326e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,0.0640589742546929,0.00819260663731662,0.0480014652455523,0.0801164832638335,5.72088875818528e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF19,Fibroblast growth factor 19,40422,0.057992861328159,0.00742118452506374,0.043447339659034,0.0725383829972839,5.86001431081491e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A11,Protein S100-A11,40207,0.0340258364596135,0.00435566266349742,0.0254887376391585,0.0425629352800684,5.98850900109934e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YWHAQ,14-3-3 protein theta,37671,0.0561935507086191,0.0071951138012811,0.0420911276581082,0.07029597375913,6.15034120811919e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PARK7,Parkinson disease protein 7,40332,0.0404364990831533,0.00518109829271531,0.0302815464294313,0.0505914517368753,6.33822880973478e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIMAP7,GTPase IMAP family member 7,37671,-0.0247102020323602,0.00316682789560268,-0.0309171847077414,-0.0185032193569789,6.5067290257611e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPL,Periplakin,37598,0.0250509777662823,0.00321109288784572,0.0187572357061047,0.0313447198264599,6.58358043384868e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MARCO,Macrophage receptor MARCO,40359,0.0200716978163553,0.00257367867982383,0.0150272876039006,0.02511610802881,6.63368549860064e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37671,0.0599637609909251,0.00769691750704076,0.0448778026771252,0.075049719304725,7.16397259477474e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHMP1A,Charged multivesicular body protein 1a,40228,0.0598508679716766,0.00768591536159486,0.0447864738629507,0.0749152620804025,7.28155657637522e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,0.031400792869439,0.00403731432525505,0.0234876567919391,0.0393139289469389,7.93451282159148e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,0.0280197097660874,0.00360335467574665,0.020957134601624,0.0350822849305508,7.94306394227841e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNPEP,Aspartyl aminopeptidase,37942,0.0449678211072299,0.00578222845283159,0.03363465333968,0.0563009888747798,7.96960029646514e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOXJ3,Forkhead box protein J3,37598,0.0330152468778132,0.00424672417914729,0.0246916674866845,0.0413388262689419,8.15007095169638e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,0.0426179225897835,0.0054832283745464,0.0318707949756725,0.0533650502038944,8.16973362145291e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37990,0.018962017769771,0.00244438555126938,0.014171022089283,0.0237530134502589,9.28869122424472e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,-0.0333353313416132,0.00429868939440806,-0.041760762554653,-0.0249099001285734,9.3829534898482e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,0.0396939454495907,0.00513339369916956,0.0296324937992184,0.049755397099963,1.13039595937103e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELENOP,Selenoprotein P,38013,-0.0170247442272973,0.00220285625929568,-0.0213423424955169,-0.0127071459590778,1.1646289407893e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB27B,Ras-related protein Rab-27B,37990,0.061557548489363,0.00796762936578368,0.045940994932427,0.077174102046299,1.18803910386935e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JUN,Transcription factor AP-1,40044,0.038711307570116,0.00502161666524386,0.0288689389062381,0.048553676233994,1.34499846556568e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,0.0593446817493221,0.00770237671429059,0.0442480233893125,0.0744413401093316,1.40243027895832e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGFLAM,Pikachurin,37901,0.0230887457294903,0.00299757557676288,0.0172134975990351,0.0289639938599456,1.42765752075708e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39961,0.0285640632005822,0.00371120866882435,0.0212900942096865,0.0358380321914779,1.48008723022032e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,0.0628869407885024,0.00817302077049875,0.0468678200783248,0.0789060614986799,1.51923847385713e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL2,C-C motif chemokine 2,40203,0.0393728812326153,0.00512034567260081,0.0293370037143177,0.0494087587509129,1.5641244129239e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40411,0.0455877296590173,0.00593918539247045,0.0339469262897753,0.0572285330282594,1.73932111857409e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXNA4,Plexin-A4,40341,0.0612165104694012,0.00797868939359038,0.0455782792579641,0.0768547416808384,1.78428703431419e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPK1,Thiamin pyrophosphokinase 1,37990,0.0202073362995522,0.00263426209300897,0.0150441825972546,0.0253704900018498,1.82335277726561e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAL,Integrin alpha-L,37598,0.0324898326641315,0.00424198573346876,0.0241755406265327,0.0408041247017302,2.00292579530805e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,0.0271919342903796,0.00355822159247896,0.0202178199691209,0.0341660486116384,2.28626247272773e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTN2,Dynactin subunit 2,40305,0.069538267176057,0.00910571932323694,0.0516910573025126,0.0873854770496014,2.35413349986334e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA4,Protein disulfide-isomerase A4,37998,0.0448375551708033,0.00587466091179551,0.0333232197836841,0.0563518905579225,2.45861549873298e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BOLA1,BolA-like protein 1,37541,0.0408419584519568,0.00535167291507333,0.0303526795384131,0.0513312373655006,2.47827930884496e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39961,0.0358996017477842,0.00471569016178328,0.026656849030689,0.0451423544648794,2.83631354928185e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40359,0.0533824876223418,0.00701518640904941,0.039632722260605,0.0671322529840787,2.90397035201524e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37598,0.0663415534458696,0.00873315167211663,0.049224576168521,0.0834585307232182,3.2473560496847e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALCAM,CD166 antigen,40536,0.0142771018311843,0.00188018388827463,0.010591941410166,0.0179622622522026,3.28535404522673e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRKL,Crk-like protein,40374,0.078287086461011,0.0103161595593586,0.0580674137246682,0.0985067591973539,3.40755718302008e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP1,Caspase-1,39961,0.0494697371693106,0.0065204764871845,0.036689603254429,0.0622498710841922,3.46405360487559e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,0.0696273983200785,0.00918260569337632,0.0516294911610609,0.087625305479096,3.57701059581217e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GASK1A,Golgi-associated kinase 1A,37562,0.031891057739718,0.00420558707802805,0.023648107066783,0.040134008412653,3.60286078549919e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS27,Serine protease 27,40314,0.0296890950694561,0.00391797386883444,0.0220098662865406,0.0373683238523716,3.71213619004281e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,0.0139081721199686,0.00183629376701666,0.010309036336616,0.0175073079033213,3.81677249739131e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,0.0873796146281985,0.0115454349285294,0.0647505621682808,0.110008667088116,3.98767873280187e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,0.0397968656036705,0.00526331828609859,0.0294807617629173,0.0501129694444237,4.25116167647292e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOXO3,Forkhead box protein O3,39980,0.0711332274839098,0.00941001552351105,0.0526895970578281,0.0895768579099915,4.27808812654345e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,0.0753818979469492,0.0099810564289372,0.0558190273462323,0.0949447685476661,4.54489180381839e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37990,0.0344814075318388,0.00456683977564733,0.02553040157157,0.0434324134921076,4.61693158866301e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNL1,Interferon lambda-1,39961,0.0331806414440125,0.00439709153265955,0.0245623420399998,0.0417989408480252,4.73557484397001e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40489,0.0394410342296861,0.00522703203680805,0.0291960514375423,0.0496860170218298,4.74363458147755e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAFA5,Chemokine-like protein TAFA-5,40305,0.0261893822658359,0.00347630063536676,0.019375833020517,0.0330029315111547,5.19811973224358e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,0.0801563157041587,0.0106479302715449,0.0592863723719308,0.101026259036387,5.43239386516116e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MIF,Macrophage migration inhibitory factor,40307,0.0501391814058401,0.0066699746602903,0.0370660310716711,0.0632123317400091,5.89722327049944e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRAS,Ras-related protein R-Ras,37572,0.0954652071856024,0.0127038100692549,0.0705657394498628,0.120364674921342,6.07380856446325e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37942,0.0387895861642857,0.00516466257147359,0.0286668475241974,0.0489123248043739,6.25630846807498e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C2,Complement C2,40372,0.0174625387838597,0.00232573675949115,0.0129040947352571,0.0220209828324624,6.30253063432957e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNST,Consortin,40359,0.0783212153564579,0.0104387505133746,0.0578612643502437,0.0987811663626721,6.57010917835001e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPEP1,Dipeptidase 1,40192,-0.0368729194470705,0.00492030136478233,-0.0465167101220438,-0.0272291287720971,7.03337579870437e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBXN1,UBX domain-containing protein 1,37671,0.0505019616140026,0.0067403407833279,0.0372908936786799,0.0637130295493253,7.18660252775668e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,0.0291717732744891,0.00389393849390139,0.0215396538264424,0.0368038927225359,7.22585880581347e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEFTY2,Left-right determination factor 2,40453,0.0375981356482936,0.00502304524147207,0.0277529669750084,0.0474433043215789,7.51922029505282e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN3,Ataxin-3,37942,0.0452711730875964,0.00605810183677781,0.0333972934875119,0.0571450526876809,8.3314370873788e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MITD1,MIT domain-containing protein 1,40228,0.0698126382306322,0.00934803451910553,0.0514904905731854,0.0881347858880791,8.5571533225339e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,0.0239328417361149,0.00320684561322494,0.017647424334194,0.0302182591380357,8.97318440257866e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFB,Complement factor B,37770,0.0238799861327263,0.00320281074097669,0.017602477080412,0.0301574951850406,9.473427874452e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,0.0458445694590188,0.00614965973043436,0.0337912363873674,0.0578979025306701,9.47393389436833e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37653,0.0395660557056875,0.00530798039572575,0.029162414130065,0.0499696972813099,9.61377759055107e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39978,0.0354621923268089,0.00475988576885884,0.0261328162198456,0.0447915684337722,9.80865880676424e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD244,Natural killer cell receptor 2B4,40516,0.019198330172401,0.00257720663226845,0.0141470051731549,0.0242496551716472,9.8616896179928e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTA,Lymphotoxin-alpha,40341,0.0290086615776361,0.00389619043604668,0.0213721283229846,0.0366451948322876,1.01609840508581e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD164,Sialomucin core protein 24,40332,0.0191205139278332,0.00257011233127562,0.014083093758533,0.0241579340971334,1.06180853258001e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,0.0707911729999056,0.00951556954858265,0.0521406566846836,0.0894416893151276,1.07141187637868e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NIT1,Deaminated glutathione amidase,37628,0.0358797923826213,0.00482390883575858,0.0264249310645345,0.0453346537007081,1.08615904681504e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LARP1,La-related protein 1,37900,0.0458698918436621,0.00616837950050975,0.0337798680226629,0.0579599156646612,1.09811401064631e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AOC3,Membrane primary amine oxidase,40403,-0.0219356735990176,0.00295061545406537,-0.0277188798889857,-0.0161524673090494,1.10480088273932e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F12,Coagulation factor XII,38013,0.0302521177447973,0.00406873259327275,0.0222774018619827,0.0382268336276119,1.10610673900551e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATG4A,Cysteine protease ATG4A,39980,0.0429104628299629,0.00577753018988453,0.0315865036577892,0.0542344220021366,1.16743987570139e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,0.0559856441015492,0.00754369807249443,0.0411999958794601,0.0707712923236383,1.2178809848239e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,0.033834578003347,0.00456401763126342,0.0248891034460707,0.0427800525606233,1.29315229602022e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GET3,ATPase GET3,37990,0.0404814148716161,0.00546096460134825,0.0297779242529735,0.0511849054902586,1.30926774611712e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL1,Growth-regulated alpha protein,40329,0.0697527725336682,0.00941526062921881,0.0512988617003993,0.0882066833669371,1.34175720356079e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLRX,Glutaredoxin-1,40260,0.0406169907510076,0.00548656387030871,0.0298633255652026,0.0513706559368127,1.39851122220735e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD226,CD226 antigen,37598,0.0301616150888508,0.00407472324735284,0.0221751575240393,0.0381480726536624,1.42165865242881e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RWDD1,RWD domain-containing protein 1,40471,0.0460933886112845,0.00622917858038593,0.0338841985937281,0.0583025786288409,1.43372606202609e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEPACAM2,HEPACAM family member 2,37942,-0.0293041964763296,0.00396103408741258,-0.0370678232876583,-0.021540569665001,1.46285106575845e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIMAP8,GTPase IMAP family member 8,37482,0.0372663449516742,0.00504062095191282,0.027386727885925,0.0471459620174233,1.52078391244467e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QA,Complement C1q subcomponent subunit A,40442,0.0162335572746897,0.00219954212275143,0.0119224547140969,0.0205446598352825,1.65537711865368e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AZU1,Azurocidin,39809,0.0555540413865445,0.00752926526418684,0.0407966814687383,0.0703114013043507,1.68379775049103e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37790,0.0402562952750088,0.00545567209968188,0.0295631779596324,0.0509494125903853,1.69168723684391e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40341,0.079692076066967,0.0108034628485861,0.0585172888837382,0.100866863250196,1.70485852355019e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,-0.0433637491957594,0.00587884314150061,-0.0548862817531006,-0.0318412166384182,1.70859035271103e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACYP1,Acylphosphatase-1,37622,0.047596781866287,0.00645409791568492,0.0349467499515446,0.0602468137810295,1.74609439803325e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CMIP,C-Maf-inducing protein,37900,0.0588023827845117,0.00797556016103442,0.0431702848688842,0.0744344807001391,1.76814403193084e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROBO1,Roundabout homolog 1,40379,0.0172019447478917,0.00233547814741664,0.0126244075789551,0.0217794819168283,1.85132630951445e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37950,0.0142414289028419,0.00193337655903331,0.0104520108471367,0.0180308469585472,1.85892294361024e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPTLC1,Serine palmitoyltransferase 1,37942,0.0256769134075602,0.00349333877437525,0.0188299694097847,0.0325238574053357,2.0921687780184e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOD3,Extracellular superoxide dismutase,37987,-0.042383605896103,0.00577164075490544,-0.0536960217757176,-0.0310711900164883,2.20088423514475e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,0.0152079785493812,0.00207214454444505,0.0111465752422689,0.0192693818564935,2.27340616820341e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MINK1,Misshapen-like kinase 1,37942,0.0660194963208312,0.0089995608709578,0.0483803570137539,0.0836586356279085,2.32879472156051e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,0.0653926503037876,0.00892479863939744,0.0479000449705686,0.0828852556370066,2.46755456841675e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBM17,Splicing factor 45,37959,0.0543029066877837,0.00742055677597016,0.0397586154068822,0.0688471979686852,2.66093100972864e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSV,Cathepsin L2,40444,-0.0300626561527928,0.00410905237215612,-0.0381163988022188,-0.0220089135033668,2.67188978585111e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSC22D1,TSC22 domain family protein 1,37959,0.0478818804037965,0.00654504020199653,0.0350536016078833,0.0607101591997097,2.70374842535581e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OLFM4,Olfactomedin-4,37177,0.0881320369072535,0.0120480532359141,0.0645178525648618,0.111746221249645,2.72710381164883e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,0.0197653633615419,0.00270246034346546,0.0144685410883496,0.0250621856347342,2.74189625769745e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCT5,T-complex protein 1 subunit epsilon,39980,0.0322520025522813,0.00441216642022518,0.0236041563686399,0.0408998487359227,2.80597788211594e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,0.0547770842860996,0.00749757787035586,0.0400818316602021,0.0694723369119971,2.88350892545917e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3BP1,SH3 domain-binding protein 1,37901,0.0332383564921901,0.00454988602798486,0.0243205798773398,0.0421561331070405,2.92187217366369e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREH,Trehalase,37998,0.0528594632051072,0.00723649198720842,0.0386759389101787,0.0670429875000357,2.93691843027275e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YJU2,Splicing factor YJU2,37900,0.0227005256403182,0.00311056050164779,0.0166038270570885,0.0287972242235479,3.08707139886273e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OPLAH,5-oxoprolinase,37628,0.0483248368550117,0.00662382693370636,0.0353421360649472,0.0613075376450761,3.14317439508087e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH9,Protocadherin-9,37901,0.0240048052298307,0.00329203803021763,0.0175524106906041,0.0304571997690572,3.22986419372403e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37572,0.0510774596746011,0.00700744006790673,0.0373428771415039,0.0648120422076983,3.30053250517297e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRAP,BRCA1-associated protein,37778,0.0776821008413126,0.010658536033654,0.0567913702153507,0.0985728314672745,3.31677655987751e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,0.0471718402182942,0.00647534837085145,0.0344801574114253,0.059863523025163,3.40251376936639e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMEM106A,Transmembrane protein 106A,37900,0.0494871532855029,0.00680833133226109,0.0361428238742712,0.0628314826967347,3.83222433025985e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB44,Ras-related protein Rab-44,37900,0.0281226199459247,0.00387742897448683,0.0205228591559305,0.0357223807359189,4.30238460288291e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37959,0.0348452895736181,0.00481389938190045,0.0254100467850932,0.0442805323621429,4.78265443400624e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INHBB,Inhibin beta B chain,37671,0.0364154759314594,0.00503282166345983,0.0265511454710781,0.0462798063918407,4.89031219289249e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3GLB2,Endophilin-B2,37942,0.0470862152018145,0.00650881843566146,0.0343289310679181,0.059843499335711,4.93477919450843e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LIF,Leukemia inhibitory factor,39961,0.0369284973465595,0.00510560725793509,0.0269215071210068,0.0469354875721123,4.94782061338078e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JAM2,Junctional adhesion molecule B,40471,0.0182106693768445,0.0025271306213505,0.0132574933589975,0.0231638453946915,6.01579099082211e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17A,Interleukin-17A,40028,0.0297714270802714,0.00413537462564515,0.0216660928140069,0.0378767613465359,6.33291974853097e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,0.0468210255390295,0.00650872164103695,0.0340639311225971,0.059578119955462,6.65405025100814e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRISP2,Cysteine-rich secretory protein 2,40489,-0.0426581783436181,0.00593477183829936,-0.0542903311466849,-0.0310260255405514,6.87255614822163e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSNL1,Visinin-like protein 1,37942,0.0261594633863695,0.00364220973503512,0.0190207323057007,0.0332981944670384,7.21379343356792e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIF1,Allograft inflammatory factor 1,39980,0.0367726430433954,0.00512118103493199,0.0267351282149287,0.0468101578718621,7.26063283801171e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37901,0.0537889409128652,0.00749097537999092,0.039106629168083,0.0684712526576474,7.310536386864e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TF,Serotransferrin,38013,0.0152610929326707,0.00212574151813607,0.011094639557124,0.0194275463082174,7.37771936744685e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CMC1,COX assembly mitochondrial protein homolog,37990,0.0627455853591865,0.00874657820011666,0.0456022920869579,0.0798888786314152,7.67745957651438e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39980,0.0413184120424105,0.00576204419587241,0.0300248054185006,0.0526120186663205,7.79289665040609e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBCA,Tubulin-specific chaperone A,37671,0.0609512188404718,0.00850125165413588,0.0442887655983655,0.0776136720825781,7.91697593071678e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,0.0202239759155392,0.00282087402213706,0.0146950628321506,0.0257528889989279,7.92320238786544e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MERTK,Tyrosine-protein kinase Mer,40516,0.0181258990475894,0.00253391249788433,0.0131594305517362,0.0230923675434427,8.83552426355287e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37628,0.0389498763176914,0.00545348027982126,0.0282610549692417,0.049638697666141,9.66663946160413e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLB1,"Phospholipase B1, membrane-associated",37942,-0.042163937687821,0.0059069218451041,-0.053741504504225,-0.030586370871417,9.94995666628221e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACRBP,Acrosin-binding protein,37900,0.0262267257952259,0.00368041235732908,0.0190131175748609,0.0334403340155909,1.08568267634221e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,0.02748088677573,0.00386324973051423,0.0199089173039221,0.0350528562475379,1.18909125595494e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPD52L2,Tumor protein D54,37671,0.0748661870771993,0.0105275354295396,0.0542322176353017,0.095500156519097,1.20722362619644e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37671,0.0377336064054773,0.00531844041027193,0.0273094632013443,0.0481577496096102,1.36075024385141e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,0.0716792114542447,0.010112387167067,0.0518589326067933,0.0914994903016962,1.41522757386682e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFC,Platelet-derived growth factor C,39980,0.020408259098741,0.00288206344425602,0.0147594147479992,0.0260571034494828,1.49118040480561e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39961,0.0264764247252646,0.00374141514168078,0.0191432510475702,0.0338095984029589,1.54083186279013e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,0.0615564493849192,0.00869845068572932,0.0445074860408897,0.0786054127289487,1.54924553011066e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TWF2,Twinfilin-2,37998,0.0569785377137207,0.00805290548830444,0.041194842956644,0.0727622324707975,1.56199622855307e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DHPS,Deoxyhypusine synthase,37900,0.0282454769894554,0.00400506732076813,0.0203955450407499,0.0360954089381609,1.84403834852859e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGCC,Regulator of cell cycle RGCC,37959,0.0513407835194875,0.00728191102924127,0.0370682379021746,0.0656133291368004,1.86998928385937e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STK24,Serine/threonine-protein kinase 24,39961,0.0421673803189384,0.00598239419952753,0.0304418876878645,0.0538928729500124,1.88373087377571e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,0.0253201903170141,0.00359321338244244,0.0182774920874269,0.0323628885466013,1.9078245460623e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRY2,Protein sprouty homolog 2,40044,0.0625979856015495,0.00890594773217032,0.0451423280464957,0.0800536431566033,2.16977777522093e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALPI,Intestinal-type alkaline phosphatase,37598,0.0831042026511183,0.0118285079614075,0.0599203270467595,0.106288078255477,2.23397684589746e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFHR4,Complement factor H-related protein 4,37973,-0.0502674953905236,0.00715800485717469,-0.064297184910586,-0.0362378058704612,2.28250941959774e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBCC,Tubulin-specific chaperone C,40228,0.0551355056058415,0.0078622112558195,0.0397255715444353,0.0705454396672477,2.43211895078019e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP7,Retinoid-binding protein 7,37901,0.0398967584821772,0.00569356317295973,0.0287373746631761,0.0510561423011783,2.54448775105222e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,0.0194579416788247,0.00277759548509162,0.0140138545280451,0.0249020288296042,2.58451902218704e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37598,0.0621152055255435,0.00886845269354104,0.0447330382462031,0.0794973728048839,2.60738654337964e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEFL,Neurofilament light polypeptide,39903,0.0289935785922323,0.00414015760084422,0.0208788696945777,0.037108287489887,2.608441835805e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37598,0.0629213181791403,0.00898574392088968,0.0453092600941965,0.080533376264084,2.63937671568794e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD40LG,CD40 ligand,40516,0.0518359084837609,0.00740876983644054,0.0373147196043375,0.0663570973631844,2.72679716801417e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,0.0319051517166562,0.00456264151526173,0.0229623743467432,0.0408479290865692,2.80696074023892e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,0.0464795525475426,0.00664884915730901,0.0334478081992169,0.0595112968958682,2.86532160154904e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FSTL1,Follistatin-related protein 1,37628,0.0153092086199372,0.00219038109278836,0.011016061678072,0.0196023555618024,2.89576216346274e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYBB1,Beta-crystallin B1,37990,0.0440236614806131,0.00630024158704091,0.0316751879700129,0.0563721349912133,2.92673991093505e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,0.0609715221152834,0.00872817336503573,0.0438643023198134,0.0780787419107535,2.96891505556855e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MBL2,Mannose-binding protein C,37810,-0.0726552974373401,0.0104119497612248,-0.0930627189693407,-0.0522478759053395,3.1337596045291e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF1,Signaling lymphocytic activation molecule,40044,0.0401883319293835,0.00576600658554211,0.028886959021721,0.051489704837046,3.29943835254685e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,0.0677123374575128,0.00971978405465412,0.0486615607103907,0.0867631142046348,3.37807394846568e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRSF1,G-rich sequence factor 1,37402,0.0535632991353552,0.00768911804182215,0.0384926277733838,0.0686339704973266,3.41554298909711e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UROD,Uroporphyrinogen decarboxylase,37671,0.0477758976308076,0.00686546240374169,0.0343195913194739,0.0612322039421413,3.59165711482862e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,-0.0330123520809319,0.00475038320015472,-0.0423231031532352,-0.0237016010086287,3.84064369528383e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,0.0617578771064875,0.00888758306793542,0.0443382142933341,0.079177539919641,3.85775972187199e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL18,C-C motif chemokine 18,40172,0.0472466068782835,0.00681305369624419,0.0338930216336449,0.0606001921229221,4.22888995629574e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,0.0232558439098343,0.0033557345684044,0.0166786041557617,0.0298330836639069,4.36347923974003e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICA1,Islet cell autoantigen 1,40044,0.0531359050684388,0.00766796775789585,0.0381066882629629,0.0681651218739147,4.38579993007786e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDC,Nuclear migration protein nudC,40516,0.0423258027959392,0.00612010778577233,0.0303303915358254,0.0543212140560529,4.82567356472077e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADD1,Alpha-adducin,37671,0.0473564184962678,0.00684938728469069,0.0339316194182741,0.0607812175742616,4.92938151410002e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM2,Intercellular adhesion molecule 2,40536,0.0208759678912872,0.00302266732717005,0.0149515399300339,0.0268003958525405,5.15459635552301e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37598,0.0386427363508027,0.00559581683156539,0.0276749353609346,0.0496105373406709,5.2272078076679e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA3,Protein disulfide-isomerase A3,37671,0.0172221086218902,0.0024947157788855,0.0123324656952746,0.0221117515485057,5.3076773336472e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHGA,Chromogranin-A,37998,0.0606582096790257,0.00878708320557574,0.0434355265960972,0.0778808927619541,5.31405458712679e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB6,Serpin B6,40433,0.039870860576985,0.00577676120078845,0.0285484086234397,0.0511933125305304,5.32254367447756e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,-0.0137777301682098,0.00199590607624138,-0.0176897060776429,-0.00986575425877671,5.32486064757676e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH2B3,SH2B adapter protein 3,39980,0.065294183448279,0.00947652283450243,0.0467201986926542,0.0838681682039037,5.7896852499297e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GYS1,"Glycogen [starch] synthase, muscle",40042,0.0620933149888766,0.00901777250257889,0.0444184808838219,0.0797681490939312,5.9716966176672e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37998,-0.022097180897255,0.00320983595479316,-0.0283884593686496,-0.0158059024258604,6.06680248418632e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTX1,Neuronal pentraxin-1,40332,-0.0263178653590389,0.00382419983596356,-0.0338132970375275,-0.0188224336805504,6.12565684649119e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REEP4,Receptor expression-enhancing protein 4,37959,0.0415154695676341,0.0060450188000828,0.0296672327194718,0.0533637064157964,6.80913688816859e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBNL,Drebrin-like protein,40422,0.0613277007565495,0.00894054030521906,0.0438042417583202,0.0788511597547789,7.16347869097924e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEMIP2,Cell surface hyaluronidase,37598,0.022543831053841,0.00328733989529706,0.0161006448590588,0.0289870172486233,7.30686852274213e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37562,0.0451988518316101,0.00659394966189847,0.0322747104942891,0.0581229931689311,7.4714789129567e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37990,0.0422157182146049,0.00616318419839361,0.0301358771857534,0.0542955592434564,7.72217227896657e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRK1,NKG2-D type II integral membrane protein,37942,0.0307151597452795,0.00448726109682808,0.0219201279954965,0.0395101914950626,7.9798440417183e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD14,Monocyte differentiation antigen CD14,40048,0.0275940858709606,0.00403247500341057,0.0196904348642759,0.0354977368776453,8.04592642493063e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,0.038831174234141,0.00567574565772613,0.0277067127449978,0.0499556357232842,8.1194521892265e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,-0.0245276664194378,0.0035924288491606,-0.0315688269637925,-0.017486505875083,9.01305344124904e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF2,Fibroblast growth factor 2,40341,0.0437229107923216,0.00640685221924431,0.0311654804426027,0.0562803411420404,9.14863923843449e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37562,0.0254190311660338,0.0037352592340835,0.0180979230672301,0.0327401392648374,1.05325391526443e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,0.0567091967399489,0.00833891874759025,0.0403649159946721,0.0730534774852258,1.08713700607458e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA3,Annexin A3,40442,0.0459798710440751,0.0067690551910435,0.0327125228696298,0.0592472192185203,1.13968010319044e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX7,Syntaxin-7,37598,0.0332637839087896,0.0048986987907409,0.0236623342789374,0.0428652335386418,1.1668409285657e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37746,0.0368563379878918,0.00542896740805403,0.0262155618681059,0.0474971141076777,1.17844466578499e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37562,0.041242842052708,0.00609550773157034,0.0292956468988302,0.0531900372065859,1.37915645537222e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40341,0.0361130693138067,0.00533875899279682,0.0256491016879249,0.0465770369396884,1.38611720308204e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGF,Pro-epidermal growth factor,40324,0.0673473784050849,0.00996002949862505,0.0478257205877798,0.08686903622239,1.41076029326768e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK10,Kallikrein-10,40354,0.0257023721337832,0.00380202700251736,0.0182503992088492,0.0331543450587172,1.42618140804247e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,0.0135578577269095,0.00200909754356156,0.00962002654152886,0.0174956889122902,1.54908044535517e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39980,0.035280079936907,0.0052280363472761,0.0250331286962459,0.0455270311775682,1.54937250924162e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,0.0383744183170207,0.00568780624280906,0.0272263180811149,0.0495225185529264,1.57312578913944e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,0.0230720382946559,0.00342378770642329,0.0163614143900662,0.0297826621992455,1.66525658509353e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,0.0363166575107649,0.00539677379013358,0.0257389808821031,0.0468943341394267,1.76289364137256e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40283,0.0210198761545815,0.00312528590843222,0.0148943157740543,0.0271454365351086,1.8067769221487e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NXPH3,Neurexophilin-3,37598,-0.0198641019739706,0.00295413982846551,-0.025654216037763,-0.0140739879101782,1.83908690612443e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD69,Early activation antigen CD69,40288,0.0571556285465381,0.00851072898324248,0.0404745997393828,0.0738366573536933,1.93514280620155e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,0.057008978937236,0.00849953375800634,0.0403498927715435,0.0736680651029284,2.06173565126725e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL22,Interleukin-22,37900,0.0425412352968857,0.00635278688487092,0.0300897730025387,0.0549926975912327,2.21997046000221e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA2,Carbonic anhydrase 2,40291,0.0458049240121194,0.00685015977251131,0.0323786108579972,0.0592312371662415,2.3590090564924e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOST,Sclerostin,40330,0.0250249247515643,0.00374442420774302,0.017685853304388,0.0323639961987407,2.41478694880963e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,0.0608212738706577,0.00910935741705775,0.0429669333332246,0.0786756144080909,2.52325413796151e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RLN2,Prorelaxin H2,37643,0.0918463189264848,0.0137782551786904,0.0648409387762516,0.118851699076718,2.73261340455544e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PADI2,Protein-arginine deiminase type-2,40044,0.0362233641857017,0.00543513783952121,0.0255704940202402,0.0468762343511633,2.74167906126976e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,0.0166796981291639,0.00250265965316407,0.0117744852089623,0.0215849110493654,2.75308178201753e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,0.0233743326783813,0.00351416328883016,0.0164865726322742,0.0302620927244884,3.01570372313268e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,0.0197466531593494,0.00297075926358603,0.0139239650027208,0.0255693413159781,3.10571758194364e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,40228,0.0145708831389466,0.00219555633696037,0.0102675927185043,0.018874173559389,3.31610034593898e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40422,0.0671044443224926,0.0101139950870109,0.0472810139519512,0.0869278746930341,3.35364678277098e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAGED1,Melanoma-associated antigen D1,39980,0.0313151742948283,0.00472160460204439,0.0220608292748213,0.0405695193148353,3.41374239311145e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53,Cellular tumor antigen p53,39980,0.027717558930502,0.00418220382680127,0.0195204394299715,0.0359146784310325,3.52661696288039e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,0.0228228844108188,0.00344698254235721,0.0160667986277987,0.0295789701938389,3.679399299895e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,0.0433132104971843,0.00656067230762294,0.0304542927742434,0.0561721282201253,4.21421004191773e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFD,Vascular endothelial growth factor D,40483,-0.0212695513209724,0.00322545201331219,-0.0275914372670643,-0.0149476653748805,4.40664315016263e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTF1,Cardiotrophin-1,40042,0.0540365581521539,0.00819502301514413,0.0379743130424714,0.0700988032618364,4.42410579882567e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BDNF,Brain-derived neurotrophic factor,37998,0.0530270406450615,0.00804139536534802,0.0372659057289794,0.0687881755611436,4.43233956261295e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,0.0332938953854453,0.00505209510372954,0.0233917889821354,0.0431960017887552,4.53255321106679e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACYBP,Calcyclin-binding protein,37642,0.0658625260523924,0.00999846380219873,0.0462655370000828,0.0854595151047019,4.64999798406531e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37572,0.0388712659654072,0.00590572035462769,0.0272960540703369,0.0504464778604775,4.81911390823171e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL2A1,Collagen alpha-1(II) chain,37628,0.0527082132052734,0.00800983355390484,0.0370089394396199,0.0684074869709269,4.8680530841074e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LACTB2,Endoribonuclease LACTB2,40359,0.0420501024802866,0.00639567387352822,0.0295145816881713,0.0545856232724019,5.0244575920857e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,40042,0.0353605688821802,0.00538040862429341,0.0248149679785651,0.0459061697857953,5.11853004832187e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA12,Serpin A12,39903,0.0729738793196835,0.0111052907066431,0.051207509534663,0.094740249104704,5.15458376223574e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RSPO1,R-spondin-1,40228,0.0225346546965602,0.00343182487959812,0.0158082779325479,0.0292610314605725,5.31647036783776e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP4,Guanylate-binding protein 4,39961,0.0313785812881595,0.00478217993015252,0.0220055086250605,0.0407516539512584,5.49335347042307e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDN1,Endothelin-1,37628,0.0185714257631566,0.00283422863788417,0.0130163376329037,0.0241265138934096,5.86660973613896e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,0.0544678573703894,0.00831294858741322,0.0381744781390594,0.0707612366017193,5.8762539323209e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GMPR,GMP reductase 1,40516,0.0322555546481706,0.00494041978639482,0.0225723318668368,0.0419387774295045,6.82364008533103e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,0.039049809637196,0.00598140144339038,0.0273262628081509,0.0507733564662412,6.84748867619628e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PI16,Peptidase inhibitor 16,37987,-0.0156789491169095,0.00240539655304089,-0.0203935263608696,-0.0109643718729493,7.3658680731816e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPI,Mannose-6-phosphate isomerase,40305,0.0541219546761425,0.00831346313641011,0.0378275669287787,0.0704163424235063,7.73272180011782e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,0.0689270679478218,0.0105947267259894,0.0481614035648826,0.0896927323307611,8.00218922798145e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSNAX,Translin-associated protein X,37562,0.0248592543044133,0.00383240677708665,0.0173477370213235,0.0323707715875032,9.0952767567257e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37572,0.0272664736016307,0.0042055520216052,0.0190235916392845,0.0355093555639769,9.28604784347592e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCRIB,Protein scribble homolog,37628,0.0587228703275767,0.00905765054488794,0.0409698752595963,0.0764758653955571,9.29772700502056e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBLN4,Cerebellin-4,40489,-0.0197693334155637,0.00305022847860983,-0.025747781233639,-0.0137908855974884,9.36113084740228e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VNN2,Vascular non-inflammatory molecule 2,40305,0.0282043846002914,0.00435380988978816,0.0196709172163066,0.0367378519842762,9.56255260653104e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,0.0584498501419881,0.0090303514273838,0.0407503613443159,0.0761493389396604,9.96576739683887e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLIT2,Slit homolog 2 protein,39961,0.032911959476333,0.00508539703343411,0.0229445812908022,0.0428793376618639,9.97107549009392e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37671,-0.0157782009399438,0.00244393469018247,-0.0205683129327014,-0.0109880889471861,1.11215412200037e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37900,0.0317737618590655,0.00492919152757829,0.0221125464650121,0.0414349772531189,1.18729080067607e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA12,Carbonic anhydrase 12,40305,0.0201727437801645,0.00313131372896494,0.0140353688713932,0.0263101186889358,1.21097753506841e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FDX1,"Adrenodoxin, mitochondrial",37562,0.0394110528753918,0.00611695083698667,0.027421829234898,0.0514002765158857,1.21289146826802e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1B,Interleukin-1 beta,39946,0.035168103525675,0.00546356864991299,0.0244595089718456,0.0458766980795045,1.2557431592088e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEP,Leptin,40359,0.0398159100526391,0.00618737136063948,0.0276886621857857,0.0519431579194925,1.26979844649459e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,0.0619861565541837,0.00963400883334752,0.0431034992408226,0.0808688138675449,1.28397816101341e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB1,Leukocyte elastase inhibitor,40287,0.0553869713631097,0.00861527661243618,0.0385010292027347,0.0722729135234846,1.32186352915816e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CIAPIN1,Anamorsin,40411,0.039701176197278,0.00617648494243113,0.027595265710113,0.051807086684443,1.33141573265322e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST13,Hsc70-interacting protein,37671,0.03575110797303,0.00556127632715,0.024851006371816,0.046651209574244,1.33226666986821e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNPY4,Protein canopy homolog 4,40305,0.0465293445661871,0.00724011314074038,0.032338722810336,0.0607199663220383,1.34209814282074e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCN2,Transcobalamin-2,40497,0.0186119915251685,0.0028964199214997,0.0129350084790291,0.0242889745713079,1.34820684954863e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PREB,Prolactin regulatory element-binding protein,40044,0.0184379412264718,0.00287260778999961,0.0128076299580726,0.0240682524948711,1.41563272890027e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37990,0.0202004841257332,0.00314854915516635,0.0140293277816071,0.0263716404698592,1.44739062195474e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40359,0.0421811840818298,0.00657928239506583,0.0292857905875007,0.0550765775761588,1.48433231511544e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIT1,ARF GTPase-activating protein GIT1,37598,0.060957353238638,0.0095072899581949,0.042323064920576,0.0795916415567,1.48880927921255e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLK1,Protein delta homolog 1,40536,0.0329350594591493,0.00513763587591698,0.0228652931423521,0.0430048257759466,1.49035868121269e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSTN2,Calsyntenin-2,40516,-0.0242372259779543,0.00378241608276849,-0.0316507615001805,-0.016823690455728,1.51675778273299e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,0.0199975448701236,0.00312334191921871,0.013875794708455,0.0261192950317923,1.57074985451449e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,0.0450048071411777,0.00704230159565066,0.0312018960137024,0.058807718268653,1.69774151152036e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,0.0318880382069205,0.00500126832401151,0.022085552291858,0.0416905241219831,1.86919379643979e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HPCAL1,Hippocalcin-like protein 1,40516,0.0452650555352421,0.00710045026806904,0.0313481730098267,0.0591819380606574,1.8800787090352e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37900,0.030458901364275,0.00477780691814293,0.0210943998047148,0.0398234029238351,1.88839848886608e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IST1,IST1 homolog,37812,0.0621143914730832,0.00975219196450274,0.0430000952226578,0.0812286877235086,1.96145699978909e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,0.0525306840853708,0.00825247446611335,0.0363558341317886,0.068705534038953,2.00061373132894e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40305,0.0345511378007652,0.00543603054645191,0.0238965179297194,0.0452057576718109,2.12801421821078e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,0.0924865167289248,0.0145706333442394,0.0639280753742156,0.121044958083634,2.24833302237961e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEXN,Nexilin,37987,0.0422130482573706,0.00666189115811606,0.0291557415874631,0.0552703549272781,2.42494101925499e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C8B,Complement component C8 beta chain,38013,-0.0188684743455852,0.00297911622650389,-0.0247075421495328,-0.0130294065416375,2.47093986799119e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBCB,Tubulin-folding cofactor B,40228,0.0619764866022159,0.00978873919472116,0.0427905577805625,0.0811624154238694,2.49504622702858e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBC1D23,TBC1 domain family member 23,40305,0.0548911751384801,0.00867896715097332,0.0378803995225724,0.0719019507543878,2.60656167447129e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OTUD6B,Deubiquitinase OTUD6B,37901,0.0362286675106028,0.00573154765148226,0.0249948341136976,0.0474625009075081,2.68215348936937e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPP,Lipoma-preferred partner,37562,0.0411739377059375,0.0065156564395893,0.0284032510843425,0.0539446243275325,2.71375763771018e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTSL4,ADAMTS-like protein 4,37628,0.0144510378650538,0.00228825649392439,0.00996605513696204,0.0189360205931456,2.78289712690643e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,0.0137358778914165,0.00217796224005746,0.00946707190090385,0.0180046838819291,2.93794843469749e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIFBP,KIF-binding protein,40305,0.0502558134538923,0.00797681485680741,0.0346212563345498,0.0658903705732348,3.05034541602547e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHCY,Adenosylhomocysteinase,40359,0.041383501543805,0.00657054548586318,0.0285052323915132,0.0542617706960968,3.08759407645612e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CIRBP,Cold-inducible RNA-binding protein,37901,0.0584193956026842,0.00927578083456512,0.0402388651669366,0.0765999260384318,3.10779652422425e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED8,Protein TMED8,37901,0.0629474326076979,0.00999519393929174,0.0433568524866861,0.0825380127287097,3.1135355791333e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYO9B,Unconventional myosin-IXb,40044,0.0404100126628812,0.0064175772558682,0.0278315612413795,0.0529884640843828,3.12046635754433e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,0.0454871581246379,0.0072254304534144,0.0313253144359457,0.0596490018133301,3.16019129978582e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,0.0504339693075029,0.00801411234242105,0.0347263091163576,0.0661416294986481,3.20750361420866e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPART,Spartin,37671,0.0473250255955906,0.007531605120679,0.0325630795590598,0.0620869716321214,3.41368503582622e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,0.0312166550635553,0.00497128992765069,0.02147292680536,0.0409603833217507,3.48948559618891e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL3,C-X-C motif chemokine 3,40350,0.0565981815990431,0.00901938108376327,0.0389201946748671,0.0742761685232191,3.58288928735321e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KDR,Vascular endothelial growth factor receptor 2,40411,0.0153007955604307,0.00244495240012756,0.0105086888561806,0.0200929022646807,3.99600555045063e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIL1,Nucleotide exchange factor SIL1,37628,0.0194980228772322,0.00311852775812803,0.0133857084713013,0.0256103372831632,4.16892599174927e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA5,Annexin A5,39896,0.0185203592890454,0.00296826130745285,0.0127025671264378,0.024338151451653,4.50520734046736e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,0.0199094186137907,0.00319110115967947,0.013654860340819,0.0261639768867625,4.51282609735948e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPME1,Protein phosphatase methylesterase 1,40305,0.0370491027167137,0.00593998912409042,0.0254067240334965,0.0486914813999309,4.56668418576638e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37998,-0.0128588226193366,0.00206187614403157,-0.0169000998616385,-0.00881754537703477,4.60863281187754e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC1A,C-type lectin domain family 1 member A,40042,0.0199951312100237,0.00320813210699298,0.0137071922803174,0.0262830701397299,4.70434034146522e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLVRB,Flavin reductase,40332,0.0400113120624466,0.00643197426959927,0.027404642494032,0.0526179816308611,5.07374753865103e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,0.0579542586505424,0.00932243845743116,0.0396822792739773,0.0762262380271075,5.20590646425735e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39980,0.0558937714967421,0.00900409347197874,0.0382457482916638,0.0735417947018204,5.51684859103454e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37900,0.0200720345083073,0.00323344099010098,0.0137344901677094,0.0264095788489053,5.53673761210188e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRAP2,GRB2-related adapter protein 2,40359,0.0762590958747157,0.0122880028923828,0.0521746102056453,0.100343581543786,5.57038145423046e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,40042,0.0664509381851293,0.010716006705943,0.045447565041481,0.0874543113287776,5.74861507054154e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,0.0232684265961038,0.00375254765334621,0.0159134331955452,0.0306234199966624,5.78570191322552e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR3,Toll-like receptor 3,40516,0.0365412943397588,0.0058985454978227,0.0249801451640263,0.0481024435154912,5.97172219480044e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MESD,LRP chaperone MESD,40332,0.0725699915715668,0.0117192217397814,0.0496003169615953,0.0955396661815383,6.07165815461827e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,0.0620506104040673,0.0100338651943392,0.0423842346231625,0.0817169861849722,6.39700985765269e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESM1,Endothelial cell-specific molecule 1,40357,-0.0203141702590002,0.00328735966397433,-0.0267573952003898,-0.0138709453176105,6.58802205178342e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,0.048402887723528,0.00783756613932746,0.0330412580904462,0.0637645173566098,6.74500266063437e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD4,Sushi domain-containing protein 4,37900,0.0268158727026545,0.00434525236808811,0.0182991780612018,0.0353325673441072,6.96740803070998e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLG4,Disks large homolog 4,37942,0.0420294716522381,0.00681718226742903,0.0286677944080772,0.0553911488963989,7.23893501659059e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,0.0477528084137904,0.007751622276921,0.0325596287510252,0.0629459880765555,7.4326701699113e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STC2,Stanniocalcin-2,40309,0.0161963165571903,0.00263212643563144,0.0110373487433527,0.0213552843710279,7.77007838860634e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37671,0.0711296941457162,0.0115627104762658,0.0484667816122353,0.0937926066791971,7.88958359887862e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,-0.0195511852482248,0.00318074712379712,-0.0257854496108671,-0.0133169208855824,8.0991140579452e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE3,Eosinophil cationic protein,40288,0.064701828034898,0.0105296529167932,0.0440637083179834,0.0853399477518126,8.20187089766333e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB33A,Ras-related protein Rab-33A,37562,0.0397870682599153,0.00647465758076925,0.0270967394016076,0.052477397118223,8.2256560376959e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37628,0.0556579993306804,0.00907475858452305,0.0378714725050152,0.0734445261563456,8.8550493653736e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTPP1,dCTP pyrophosphatase 1,40359,0.0188446336015184,0.00307615836610788,0.012815363203947,0.0248739039990898,9.22204524057357e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DENR,Density-regulated protein,37598,0.0342796323533216,0.00560635383376817,0.023291178839136,0.0452680858675072,9.96506872455783e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,0.0336631382502645,0.00551540999129563,0.0228529346673251,0.0444733418332039,1.06709676833444e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,0.0390171392330689,0.00639307425566064,0.0264867136919741,0.0515475647741638,1.06934903402402e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,0.0573299072058619,0.00939961663631069,0.038906658598693,0.0757531558130309,1.09530787380027e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,0.0281044065474434,0.00460798157822394,0.0190727626541245,0.0371360504407623,1.09672244018504e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DMD,Dystrophin,37628,0.0308618269793629,0.00506371874421232,0.0209369382407068,0.040786715718019,1.12705177587565e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,0.0292890441314523,0.00480805605225893,0.0198652542690248,0.0387128339938798,1.14837313121831e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSPN,Persephin,40341,0.0586325422886236,0.00962762968762169,0.039762388100885,0.0775026964763621,1.15489483245029e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF3,Granulocyte colony-stimulating factor,40044,0.0288097173705543,0.00473188826422936,0.0195352163726647,0.0380842183684438,1.16704390983938e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,0.0681761520229371,0.0112263933901423,0.0461724209782581,0.090179883067616,1.28531111063388e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENAH,Protein enabled homolog,40044,0.0277490356087301,0.00458138485974144,0.0187695212836368,0.0367285499338233,1.41948196392827e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC5A,C-type lectin domain family 5 member A,40314,0.0165764160791167,0.0027380095028966,0.0112099174534393,0.021942914704794,1.44310397148925e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,0.0492006963678691,0.0081335150670551,0.0332590068364411,0.0651423858992971,1.48890721052227e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXNB3,Plexin-B3,40310,0.0273207474867734,0.00452048043102487,0.0184606058419646,0.0361808891315821,1.53923692443817e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,40044,0.0387083967140794,0.00641054333235289,0.0261437317826678,0.0512730616454911,1.59339768574009e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP6,Platelet glycoprotein VI,40311,0.051435485461613,0.00852129598431986,0.034733745332346,0.0681372255908799,1.61389361128117e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABHD14B,Protein ABHD14B,40171,0.0342152605810072,0.00566863008421631,0.0231047456159433,0.0453257755460712,1.61635419181461e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY6D,Lymphocyte antigen 6D,40268,0.0218348282268956,0.00362467528770869,0.0147304646629865,0.0289391917908046,1.73992659796224e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRR3,Small proline-rich protein 3,37942,0.0417091454411615,0.00692951263784059,0.0281273006709939,0.055290990211329,1.79984230902584e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH15,Cadherin-15,40435,0.0257973555262909,0.00428927470751992,0.0173903770995519,0.03420433395303,1.84503445659152e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDF1,Endothelial differentiation-related factor 1,37959,0.0407166629782994,0.00677677250436768,0.0274341888697388,0.0539991370868601,1.92339360034656e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SBSN,Suprabasin,37977,-0.0196362763934051,0.00327040334971235,-0.0260462669588413,-0.0132262858279689,1.97158782207957e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39925,0.0254818246709918,0.00424622947965131,0.0171592148908753,0.0338044344511084,2.00423763371162e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGMB,RGM domain family member B,40471,0.0150744933436619,0.0025138497036808,0.0101473479244475,0.0200016387628763,2.05849855737149e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BPIFB2,BPI fold-containing family B member 2,37951,0.0395659118350738,0.00660708591261421,0.02661602344635,0.0525158002237977,2.17290945463867e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA5,Protein disulfide-isomerase A5,37482,0.0357857225245029,0.00598578451583217,0.0240535848734718,0.0475178601755339,2.31160733172565e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RHOC,Rho-related GTP-binding protein RhoC,40152,0.0672563350945138,0.0112531965494785,0.045200069857536,0.0893126003314916,2.32712437365156e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GZMB,Granzyme B,40341,0.0363715242979269,0.00609561679728562,0.0244241153752471,0.0483189332206067,2.47042375831335e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMA4,Laminin subunit alpha-4,40422,0.0189580768135881,0.00318052184213006,0.0127242540030132,0.025191899624163,2.56475844700609e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37879,0.0408963423796646,0.00686061956649943,0.0274495280293257,0.0543431567300035,2.56944131247571e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGCT,Gamma-glutamylcyclotransferase,37978,0.0280272599714215,0.00470269908383855,0.0188099697670979,0.037244550175745,2.58791463917265e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRAL,GDNF family receptor alpha-like,37477,-0.0360767831807217,0.00605389676864377,-0.0479424208472635,-0.0242111455141799,2.59919156778329e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40278,0.0147846494105285,0.00248275530912333,0.0099184490046468,0.0196508498164103,2.65679101798017e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGN,Secretagogin,40044,0.0253221158471453,0.00425389109284406,0.016984489305171,0.0336597423891197,2.69420590551139e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39961,0.0303144814912708,0.0051092265842108,0.0203003973862176,0.0403285655963239,3.03260563603751e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37990,0.0408585738070785,0.00689078253868425,0.0273526400312574,0.0543645075828996,3.11349226351671e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,0.0297894281526218,0.00503745495854958,0.0199160164338646,0.039662839871379,3.42860122170634e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP7,Caspase-7,37942,0.0481365562036613,0.00814354109117722,0.0321752156649539,0.0640978967423686,3.48227117986068e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JPT2,Jupiter microtubule associated homolog 2,37901,0.050458804292431,0.00853811824046455,0.0337240925411205,0.0671935160437415,3.50756293758878e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37990,0.0614525823379528,0.0104067011392758,0.0410554481049722,0.0818497165709335,3.60886549398479e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MB,Myoglobin,40536,0.0280281814888267,0.00476706707439352,0.0186847300230154,0.037371632954638,4.1954447648471e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,0.0457906991484176,0.00779532989591355,0.0305118525524271,0.0610695457444082,4.33787156622669e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,0.0256762120903439,0.00437322369735958,0.0171046936435191,0.0342477305371687,4.41191598340761e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDHD2,Phospholipase DDHD2,37959,0.0377982721908488,0.00643913955659218,0.0251775586599281,0.0504189857217695,4.45804470921965e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,0.0538548768333234,0.00917557986917196,0.0358707402897464,0.0718390133769004,4.47760441491943e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THTPA,Thiamine-triphosphatase,37884,0.0505469227584612,0.00861267956443604,0.0336660708121666,0.0674277747047558,4.49051793588154e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAG6,Large proline-rich protein BAG6,40042,0.0203995561146676,0.00348212664406532,0.0135745878922996,0.0272245243370356,4.76874842788522e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GHRL,Appetite-regulating hormone,40359,0.0445458730405041,0.00764284018161409,0.0295659062845404,0.0595258397964677,5.7028808939569e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,0.0483865869879132,0.00831390920600675,0.0320913249441399,0.0646818490316864,6.00234369422522e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,0.0212657820979608,0.00365593948367339,0.014100140709961,0.0284314234859606,6.13534554461354e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,0.0452926092398737,0.00779330235269128,0.0300177366285987,0.0605674818511486,6.32237771045888e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLB,Beta-klotho,39961,-0.0414425016998787,0.00713411879350263,-0.0554253745351438,-0.0274596288646135,6.40566748911805e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,0.0608174346823953,0.0104816385682869,0.0402734230885529,0.0813614462762376,6.68847286751729e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,0.0488645775779881,0.00842778032011724,0.0323461281505583,0.0653830270054178,6.86025617187138e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX9,Sorting nexin-9,40359,0.0384817012083189,0.00665652663983202,0.0254349089942481,0.0515284934223897,7.56277965287121e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH7,Protocadherin-7,37901,0.0196349460433137,0.00339841180087872,0.0129740589135914,0.026295833173036,7.74135935849179e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PEPD,Xaa-Pro dipeptidase,37987,-0.0145522572849936,0.00252108222304352,-0.0194935784421589,-0.00961093612782829,7.99459370185107e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,0.0408477163622879,0.00707742041016566,0.0269759723583632,0.0547194603662126,8.02683146214065e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GMFG,Glia maturation factor gamma,37990,0.0402183159823097,0.00697527874395003,0.0265467696441677,0.0538898623204518,8.30270158715579e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSNK2A1,Casein kinase II subunit alpha,37959,-0.0253987344105987,0.00440901054253058,-0.0340403950739586,-0.0167570737472387,8.56206052284747e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLTA,Clathrin light chain A,40042,0.0264214622124316,0.00459863722689014,0.0174081332477269,0.0354347911771363,9.33615096411486e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIF1C,Kinesin-like protein KIF1C,37562,0.0210020016860411,0.00365573716555523,0.0138367568415528,0.0281672465305293,9.39953477853267e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASS1,Argininosuccinate synthase,37562,0.0448196107939865,0.00780196914383896,0.0295277512720621,0.0601114703159108,9.41557956654449e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEPR,Leptin receptor,40359,-0.0170423071528725,0.0029730853568712,-0.02286955445234,-0.0112150598534049,1.00935802627589e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OPHN1,Oligophrenin-1,37942,0.0595272417736265,0.0103938132894601,0.0391553677262847,0.0798991158209683,1.04291753118483e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40453,0.0366551242224253,0.00640888908365103,0.0240937016184693,0.0492165468263813,1.08797956301292e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MICALL2,MICAL-like protein 2,37572,0.038176135809705,0.00667450620979701,0.0250941036385029,0.0512581679809072,1.09044843749828e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLAU,Urokinase-type plasminogen activator,40332,-0.0162630036306351,0.0028481800921687,-0.0218454366112857,-0.0106805706499844,1.1502135872529e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOA2,Apolipoprotein A-II,37987,-0.0265122817987883,0.00464296116924234,-0.0356124856905033,-0.0174120779070733,1.15208021473273e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,0.0340641417985319,0.00596539350136956,0.0223719705358476,0.0457563130612162,1.15209264786954e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,0.0504141172023783,0.00884112928323941,0.033085503807229,0.0677427305975275,1.20729219058069e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPE,Ribulose-phosphate 3-epimerase,37714,0.0388791869704644,0.00681988156410052,0.0255122191048274,0.0522461548361014,1.2174520545441e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,0.0577836110856126,0.0101372388292336,0.0379146229803146,0.0776525991909105,1.22272217081315e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TTF2,Transcription termination factor 2,37572,0.027041510576966,0.00474597667437552,0.01773939629519,0.036343624858742,1.23990052886298e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39961,0.0356048266257715,0.00625363616281986,0.0233476997466446,0.0478619535048984,1.26744681071647e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC14A,C-type lectin domain family 14 member A,40332,0.0173429453048516,0.00305054139501023,0.0113638841706316,0.0233220064390717,1.32954910746253e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH5,Cadherin-5,40536,-0.0167267423812711,0.00294685585326355,-0.0225025798536676,-0.0109509049088745,1.40150960929629e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSNK1D,Casein kinase I isoform delta,37598,0.0352227734855753,0.00620554569063177,0.023059903931937,0.0473856430392135,1.40782215525285e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN3,CCN family member 3,40522,0.0185883816477901,0.00327611403439698,0.0121671981403721,0.0250095651552082,1.41978929149242e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNAS,Neuroendocrine secretory protein 55,37959,0.0498204188549265,0.00878728829685917,0.0325973337930825,0.0670435039167704,1.46060983211584e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,0.0368359323389267,0.00649953082680134,0.0240968519183961,0.0495750127594573,1.47879462922959e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40311,0.048176192781129,0.00850142517764535,0.0315133994329441,0.0648389861293139,1.47985845395699e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GTPBP2,GTP-binding protein 2,37572,0.0440837737419163,0.00778728146930886,0.028820702062071,0.0593468454217617,1.5365065557932e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPAG1,Sperm-associated antigen 1,37959,0.0316964034644563,0.00560734319455643,0.0207060108031257,0.0426867961257869,1.61180748788965e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCRG1,Scrapie-responsive protein 1,37990,0.0150929116874339,0.00267127038026631,0.00985722174211194,0.0203286016327559,1.63597968287004e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDHB,Succinate dehydrogenase,37901,0.0391637407667561,0.00693221211186177,0.0255766050275071,0.0527508765060052,1.64149806331497e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP2,Caspase-2,40341,0.0369467776864823,0.00654147049558407,0.0241254955151376,0.0497680598578271,1.65024107842307e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPB1,Heat shock protein beta-1,40116,0.0370554269181908,0.00656691817701181,0.0241842672912477,0.0499265865451339,1.70259739600059e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACTA2,"Actin, aortic smooth muscle",40042,0.02386961313211,0.00423998060549564,0.0155592511453385,0.0321799751188814,1.83686286259492e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD1,Sushi domain-containing protein 1,40042,0.0268312639036321,0.00477499312773118,0.017472277373279,0.0361902504339852,1.95215231180484e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALB1,Calbindin,40305,0.0230823717659196,0.00411284155091779,0.0150212023261208,0.0311435412057185,2.03034514076116e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37880,0.0478474345381765,0.00852606380631712,0.031136349477795,0.0645585195985581,2.04074378172724e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,0.0533468736232757,0.00951183298190719,0.0347036809787376,0.0719900662678138,2.07514527167485e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40411,0.0454222842107571,0.00810325256872169,0.0295399091760626,0.0613046592454516,2.11166658095207e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,-0.0203062920528238,0.00362370664329293,-0.027408757073678,-0.0132038270319697,2.13410412233741e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRGN,Neurogranin,37987,0.0494457457275012,0.00883750101598746,0.0321242437361658,0.0667672477188366,2.24912090634394e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FXN,"Frataxin, mitochondrial",40489,0.040061379755951,0.00716171857314776,0.0260244113525814,0.0540983481593206,2.2575357264547e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,0.0433920994990979,0.00775653818814522,0.0281892846503332,0.0585949143478625,2.25987308568119e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2,Apoptosis regulator Bcl-2,37901,0.0294196072708098,0.00527099989332694,0.019088447479889,0.0397507670617307,2.43191314076155e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,0.0225469232723157,0.00404306900990734,0.0146225080128973,0.030471338531734,2.49968571591663e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEDD9,Enhancer of filamentation 1,37598,0.0179661207459384,0.00322190268608002,0.0116511914812215,0.0242810500106552,2.50610407627787e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTN6,Dynactin subunit 6,39961,0.0382302387620416,0.00686083735802701,0.0247829975403086,0.0516774799837745,2.55669088769454e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,0.0594732775194312,0.0107121503911731,0.0384774627527318,0.0804690922861305,2.8700817294256e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,0.019210458017739,0.00347115867159855,0.0124069870214058,0.0260139290140721,3.1845880457648e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOC,Myocilin,40332,-0.024605843730664,0.00444673647116187,-0.0333214472141413,-0.0158902402471868,3.18937996921601e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDLIM5,PDZ and LIM domain protein 5,37959,0.0637294793518013,0.011517633070457,0.0411549185337056,0.0863040401698971,3.20275158568733e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,0.0291123459019396,0.0052662329915206,0.0187905292385593,0.03943416256532,3.28904623014932e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELOB,Elongin-B,37562,0.0214874880393586,0.00390134047061948,0.0138408607169444,0.0291341153617728,3.70359857531982e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXN,Thioredoxin,37819,0.0239540679727024,0.00435041393092196,0.0154272566680954,0.0324808792773094,3.73515635086147e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,0.0244222168207335,0.00443692177690602,0.0157258501379977,0.0331185835034693,3.77392791720031e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,0.0261769058364102,0.00475618230127433,0.0168547885259125,0.0354990231469079,3.78730636072436e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN9,Septin-9,40305,0.0149569983641068,0.00272865189726958,0.00960884064545844,0.0203051560827552,4.28268970348791e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,0.0399983492066251,0.00730343593395518,0.0256836147760729,0.0543130836371772,4.40200660692165e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,0.0231718760784265,0.00423159614574632,0.0148779476327637,0.0314658045240893,4.41978672200228e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP3,Caspase-3,40536,0.0466880360407631,0.00853497095114958,0.0299594929765099,0.0634165791050162,4.5622697411107e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL28,C-C motif chemokine 28,40278,0.0315678155557698,0.0057803673628119,0.0202382955246585,0.0428973355868812,4.80022163385654e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX6,Syntaxin-6,39980,0.0365244955582497,0.00669210056849187,0.0234079784440056,0.0496410126724937,4.89316470149442e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYAR,Cell growth-regulating nucleolar protein,39980,0.0278886923687534,0.00511141923442547,0.0178703106692794,0.0379070740682273,4.94006701162867e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFCAB2,Dynein regulatory complex protein 8,37714,0.018495043119824,0.00339182639934088,0.0118470633771159,0.0251430228625321,5.04628407982849e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,0.0257528653164044,0.00473387761427708,0.0164744651924213,0.0350312654403875,5.40311037741321e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AK1,Adenylate kinase isoenzyme 1,40359,0.0336581648406189,0.00619880759548871,0.021508501953461,0.0458078277277767,5.72507916896237e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,0.0243891933967765,0.00450553843561123,0.0155583380629784,0.0332200487305745,6.2843064189354e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFD,Complement factor D,38013,0.0100590486610545,0.00185814436434993,0.00641708570692865,0.0137010116151804,6.28593904777664e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEO1,RNA polymerase-associated protein LEO1,37959,0.0163313321244962,0.00302000068274219,0.0104121307863215,0.0222505334626709,6.49165752748221e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NME3,Nucleoside diphosphate kinase 3,40379,-0.0125438580214156,0.00232634562737498,-0.0171034954510706,-0.00798422059176068,7.06366667920312e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37942,0.055339198546712,0.0102657994376238,0.0352182316489693,0.0754601654444548,7.13898276451743e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD200,OX-2 membrane glycoprotein,40341,-0.0135628430371718,0.00251980766887859,-0.0185016660681739,-0.00862402000616981,7.45042059848815e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RCOR1,REST corepressor 1,40042,0.0233964078521128,0.00434810631236845,0.0148741194798706,0.0319186962243549,7.52154175592922e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APRT,Adenine phosphoribosyltransferase,40216,0.0252177083521534,0.00469689832168988,0.0160117876416412,0.0344236290626655,8.02899177963377e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CENPF,Centromere protein F,37714,0.0286032775521806,0.00533097021201101,0.018154575936639,0.0390519791677222,8.20859355069455e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40490,0.0235783981233342,0.00439556420923454,0.0149630922732345,0.0321937039734339,8.24663809304003e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NACC1,Nucleus accumbens-associated protein 1,37900,0.0286622789898845,0.00534525777189768,0.0181855737569651,0.039138984222804,8.35793193849421e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP2,Guanylate-binding protein 2,40044,0.0308354062686704,0.00576795696164309,0.0195302106238499,0.0421406019134908,9.11934239799232e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,0.0211154484568512,0.00395560498033288,0.0133624626953988,0.0288684342183037,9.54826075986434e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XRCC4,DNA repair protein XRCC4,39961,0.0192733115845672,0.00361289454904008,0.0121920382684486,0.0263545849006858,9.71051229647259e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,0.0179597143217493,0.00336821168210486,0.0113580194248238,0.0245614092186748,9.84091943893426e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,0.0196607097317503,0.00368786433678784,0.0124324956316461,0.0268889238318544,9.91410547164606e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,0.0178175288661026,0.00334475461756489,0.0112618098156754,0.0243732479165298,1.01209601601497e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,40044,0.0310634282889835,0.00583906393417408,0.0196188629780023,0.0425079935999647,1.05239735267603e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSR,Insulin receptor,37598,0.0087524859880592,0.00164589960199786,0.0055265227681434,0.011978449207975,1.06777726272807e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,0.0422877320741345,0.00797450756934261,0.026657697238223,0.0579177669100461,1.15525839255613e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,0.0151085693969871,0.00284970599510337,0.00952314564658447,0.0206939931473897,1.1618836305805e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1F,V-type proton ATPase subunit F,39925,0.0339081839994753,0.00640719697744609,0.0213500779236809,0.0464662900752696,1.22500683302778e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMTN,Smoothelin,37905,0.0495391513471998,0.00936990107593934,0.0311741452383587,0.0679041574560409,1.26248218570672e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKN3,Serine/threonine-protein kinase N3,37714,0.0397435684671883,0.00753005283937505,0.0249846649020132,0.0545024720323634,1.32665350682968e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SF3B4,Splicing factor 3B subunit 4,40305,0.0375266132426712,0.00711074856338157,0.0235895460584433,0.051463680426899,1.32719792407507e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1R1,Interleukin-1 receptor type 1,40303,0.0114280677994268,0.00216638652953939,0.00718195020152964,0.015674185397324,1.34373557619331e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37900,0.0207244157848528,0.00392963576539988,0.0130223296846691,0.0284265018850366,1.35641676254679e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1S,Complement C1s subcomponent,38013,0.0106568103592687,0.00202258208290566,0.00669254947677356,0.0146210712417638,1.39334942129703e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37901,0.058142003806543,0.0110397282307446,0.0365041364742835,0.0797798711388025,1.41103936741526e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,0.014324964993184,0.00272032446844467,0.00899312903503242,0.0196568009513355,1.41707105552936e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UNC79,Protein unc-79 homolog,37482,0.0290169948047556,0.0055104713200479,0.0182164710174617,0.0398175185920495,1.41806415341136e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,0.0151863752367958,0.00289010693881472,0.00952176563671893,0.0208509848368726,1.50277174023614e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMOX1,Heme oxygenase 1,40184,-0.0238720589921093,0.00454731697899665,-0.0327848002709427,-0.0149593177132759,1.54326299846104e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2L1,Bcl-2-like protein 1,37942,0.0508754041212609,0.00970669468533451,0.0318502825380052,0.0699005257045165,1.61880669167865e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40305,0.0111575332781833,0.00212973744460641,0.00698324788675474,0.0153318186696119,1.63582609459867e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39980,-0.0190874267151931,0.00365312085660328,-0.0262475435941355,-0.0119273098362507,1.76441520669796e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMP6,Bone morphogenetic protein 6,40024,0.0214477158207579,0.00410579814538644,0.0134003514558005,0.0294950801857153,1.77582483845324e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRADD,Death domain-containing protein CRADD,40192,0.0386991976719115,0.00741395511659631,0.0241678456433827,0.0532305497004402,1.81414822049979e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,0.0387757520076676,0.00743342213318275,0.0242062446266294,0.0533452593887058,1.8477207686508e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC51B,Organic solute transporter subunit beta,37562,0.0403947932075532,0.00775008758287918,0.02520462154511,0.0555849648699964,1.89476792586694e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37572,0.0313980378161344,0.00602593202783139,0.0195872110415848,0.0432088645906839,1.91201020654815e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP8,Caspase-8,40434,0.0312048334391986,0.00599011811074532,0.0194642019421378,0.0429454649362594,1.91820397821565e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROK1,Prokineticin-1,40341,0.0347600981656501,0.00667375604681077,0.021679536313901,0.0478406600173992,1.92774975762716e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFHR2,Complement factor H-related protein 2,37911,0.0290467049981816,0.00557913573214812,0.0181115989631713,0.0399818110331919,1.95470819859937e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPM1F,Protein phosphatase 1F,37990,0.026498088992226,0.00509069026282519,0.0165203360770886,0.0364758419073633,1.96616976618351e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMT,Catechol O-methyltransferase,39877,0.0428960808925927,0.00824684210397309,0.0267322703688054,0.05905989141638,2.00198701549466e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39980,0.0240632557106045,0.00462938506795424,0.0149896609774142,0.0331368504437949,2.04065852442019e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,0.032216977509872,0.00620406580746359,0.0200570085272433,0.0443769464925006,2.09682211489576e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELL,L-selectin,38013,-0.0117182383494811,0.00226117087325985,-0.0161501332610704,-0.00728634343789174,2.22221932099207e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TST,Thiosulfate sulfurtransferase,39923,0.0380466089674458,0.00735050417784454,0.0236396207788705,0.0524535971560211,2.29463941177364e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD84,SLAM family member 5,40341,0.0154258938564391,0.00298239482811445,0.00958039999333478,0.0212713877195434,2.34017288822775e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,-0.0205322845372617,0.0039704875814655,-0.0283144401969341,-0.0127501288775893,2.35416595236454e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CERT,Ceramide transfer protein,39961,0.0307491907039068,0.00596333999898914,0.0190610443058881,0.0424373371019255,2.5487974810264e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,0.0471911794426704,0.009154292110524,0.0292487669060434,0.0651335919792975,2.56559799377627e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F11,Coagulation factor XI,37810,-0.0152376077550433,0.00295601285444314,-0.0210313929497518,-0.00944382256033471,2.57548702882606e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37562,0.0348281656213868,0.00675680323810016,0.0215848312747105,0.0480714999680631,2.57962190995135e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNMA1,Paraneoplastic antigen Ma1,37628,0.0280678394280397,0.00544566381648624,0.0173943383477267,0.0387413405083527,2.58452239251879e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37921,0.0193639582584832,0.00376062050967239,0.0119931420595253,0.0267347744574411,2.65374047298262e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TYMP,Thymidine phosphorylase,40257,0.0332836405247953,0.00646742409451821,0.0206074892995396,0.045959791750051,2.6878262340958e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFB,Vascular endothelial growth factor B,37598,0.0142775109711647,0.0027805998942728,0.00882753517838997,0.0197274867639394,2.86652014789952e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,0.0381435286575188,0.00743061626008461,0.023579520787753,0.0527075365272847,2.88064130570061e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDGF,Hepatoma-derived growth factor,40471,0.0474166870163509,0.0092506824465751,0.0292853494210637,0.0655480246116381,2.99803724633023e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C7orf50,Uncharacterized protein C7orf50,37942,0.0109439076283474,0.00213705596882666,0.00675527792944712,0.0151325373272476,3.08073984334454e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX16,Syntaxin-16,39980,0.0293752221166684,0.00574218504311939,0.0181205394321543,0.0406299048011824,3.16325274729012e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40419,0.0157815437011502,0.00308558028060533,0.00973380635116374,0.0218292810511366,3.18026977937962e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,0.0272411200272426,0.00532631284383826,0.0168015468533196,0.0376806932011656,3.18337529364932e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,0.0245074474729754,0.00479609786442669,0.0151070956586991,0.0339077992872517,3.26107708974655e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH17,Cadherin-17,40359,0.0334788987354544,0.0065700256094896,0.0206016485408547,0.046356148930054,3.51429219997181e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,0.0303994896194499,0.00596713388587594,0.0187039072031331,0.0420950720357668,3.54542011566091e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA1,Annexin A1,37608,0.0205964043601275,0.00405561176734024,0.0126474052961406,0.0285454034241144,3.85641172641145e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40305,0.0264746927368656,0.0052156648948535,0.0162519895429527,0.0366973959307785,3.89836059975332e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37628,0.0241814644037233,0.00476449440183399,0.0148430553761287,0.0335198734313179,3.92059606230783e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR15L,Protein GPR15L,37901,0.0297939916069817,0.00587897321691804,0.0182712041018224,0.0413167791121411,4.07588251808297e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,0.0581805925570308,0.0115149733307441,0.0356112448287723,0.0807499402852893,4.40639391191921e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,0.0204507688429516,0.00405726530442172,0.012498528846285,0.0284030088396182,4.69444477414652e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37671,0.0154556304910317,0.00306607118238182,0.00944613097356336,0.0214651300085001,4.69579036556422e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERI1,3'-5' exoribonuclease 1,37714,0.0165110322234222,0.00328089546805582,0.0100804771060328,0.0229415873408116,4.90524649482777e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LBP,Lipopolysaccharide-binding protein,40403,0.0283816442629722,0.00565555257011531,0.0172967612255462,0.0394665273003982,5.2673226568628e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,0.0245402902877741,0.00489138932537425,0.0149531672100406,0.0341274133655076,5.31576921765158e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,0.0233227551050987,0.00465914176868722,0.0141908372384718,0.0324546729717257,5.63308137613091e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSCAM,Down syndrome cell adhesion molecule,37959,0.0171568622238063,0.00343103760826157,0.0104320285116136,0.023881695935999,5.79029181836532e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA1,Alpha-1-antitrypsin,37779,0.00396454740115775,0.000794147922791127,0.00240801747248714,0.00552107732982836,6.04488607887205e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RANBP1,Ran-specific GTPase-activating protein,37628,0.025738930167371,0.00517495169884706,0.0155960248376308,0.0358818354971113,6.64964543047147e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37671,0.0422828668134489,0.00852708601358713,0.0255697782268181,0.0589959554000796,7.18643442113374e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FADD,FAS-associated death domain protein,40359,0.0366115992136366,0.00740130937709552,0.0221050328345294,0.0511181655927438,7.6276988960584e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD6,Programmed cell death protein 6,40359,-0.0334928584000619,0.00677185137955538,-0.0467656871039904,-0.0202200296961333,7.65685755770571e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MIA,Melanoma-derived growth regulatory protein,40411,0.0177179963744349,0.00358379381954694,0.0106937604881229,0.0247422322607469,7.73438779099818e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOK1,Docking protein 1,37942,0.0655558416929417,0.013261603609275,0.0395630986187627,0.0915485847671208,7.77413707980385e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAT,Catalase,37786,0.0262975176032538,0.00532121850893725,0.0158679293257368,0.0367271058807708,7.826007667869e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RILPL2,RILP-like protein 2,37990,0.0467429943358636,0.00946322464747795,0.0281950740268068,0.0652909146449204,7.92839761674362e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37562,0.0324102118272857,0.00657030567426276,0.0195324127057307,0.0452880109488407,8.20399717342368e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MILR1,Allergin-1,40044,0.0238627449202826,0.0048406672031068,0.0143750372021933,0.0333504526383719,8.32281667087265e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,0.0352151704088506,0.00714357476842337,0.0212137638627408,0.0492165769549604,8.33823526606281e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37572,0.0331165504827092,0.00672247123292172,0.0199405068661827,0.0462925940992358,8.48461874165217e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK13,Kallikrein-13,40032,0.0206687623867364,0.00420880442710064,0.0124195057096191,0.0289180190638536,9.16065005386193e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,0.0113545735196349,0.00232076685443677,0.00680587048493887,0.015903276554331,1.00491790136168e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFAP,Glial fibrillary acidic protein,39959,-0.0222159664520133,0.00455748783681999,-0.0311486426121805,-0.0132832902918461,1.10103623707994e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA11,Annexin A11,40312,0.0317730837656032,0.00651888123144878,0.0189960765519636,0.0445500909792429,1.1041364528079e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37879,0.0197621904533257,0.00406061420333822,0.0118033866147828,0.0277209942918686,1.14709664397549e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,0.0293981276407405,0.0060407271239378,0.0175583024778224,0.0412379528036586,1.14818082894879e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39961,0.0345509987925767,0.00710180634292065,0.0206314583604522,0.0484705392247011,1.15522284200002e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPPB,Natriuretic peptides B,40042,0.0606310939779948,0.0124636245438399,0.0362023898720687,0.0850597980839209,1.15782821650867e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRK5,G protein-coupled receptor kinase 5,40042,0.0248412615678364,0.00510731973239922,0.0148309148923339,0.0348516082433388,1.16244862424035e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,0.0142846475697309,0.00293809691782829,0.00852597761078748,0.0200433175286744,1.17419077181886e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,-0.0148813181179068,0.00306521583045893,-0.0208891411456063,-0.0088734950902073,1.21578290622361e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCRN1,Secernin-1,40341,0.0263873877210273,0.00544603564139996,0.0157131578638834,0.0370616175781712,1.27647242982332e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37671,0.0388471561622271,0.00803329759420794,0.0231018928775795,0.0545924194468747,1.34126919310572e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNDP1,Beta-Ala-His dipeptidase,40403,-0.0214286703964775,0.00443810902599845,-0.0301273640874345,-0.0127299767055205,1.38956843307115e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37598,0.0181276663765099,0.00375698375617001,0.0107639782144167,0.0254913545386031,1.41533767331977e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TK1,"Thymidine kinase, cytosolic",37714,0.0210467787907927,0.00437031743561238,0.0124809566169925,0.029612600964593,1.481964208267e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL7,Interleukin-7,40341,0.0299492243482838,0.00623774064332881,0.0177232526873593,0.0421751960092082,1.59079708443151e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,0.0222599991458586,0.00463719541625696,0.013171096129995,0.0313489021617223,1.60113184878914e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37628,0.0266287103132768,0.005551127307886,0.0157485007898202,0.0375089198367334,1.62830659079364e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMNB1,Lamin-B1,37874,0.0266475512459842,0.00555599644487238,0.0157577982140344,0.0375373042779341,1.63458728855125e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK14,Kallikrein-14,40489,-0.0213520286155787,0.00445422289703317,-0.0300823054937637,-0.0126217517373937,1.65234693072196e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTRC,Chymotrypsin-C,40360,-0.0292032894072192,0.00609365507550541,-0.0411468533552098,-0.0172597254592286,1.66278652320599e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PER3,Period circadian protein homolog 3,37598,0.0548745003568921,0.011501463055872,0.0323316327673829,0.0774173679464013,1.85202790450845e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,0.0269872712435149,0.00565744636264091,0.0158986763727387,0.0380758661142911,1.85656335736274e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40471,0.0106257184683455,0.00223197849507422,0.00625104061800004,0.015000396318691,1.94635817077784e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTD,Deoxycytidylate deaminase,37671,0.0438073182174021,0.00922547701945903,0.0257253832592624,0.0618892531755418,2.07066566431318e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRP2,Neuropilin-2,40332,-0.0133787437472253,0.00281826883128204,-0.0189025506565381,-0.00785493683791251,2.08102912412434e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRAF2,TNF receptor-associated factor 2,40341,0.0326985670723794,0.0068915766357303,0.019191076866348,0.0462060572784107,2.1061678877765e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WAS,Wiskott-Aldrich syndrome protein,40044,0.0313391260906833,0.00660944624908476,0.0183846114424772,0.0442936407388894,2.1394809523257e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37714,0.0310599140874886,0.00655757390996169,0.0182070692239637,0.0439127589510135,2.19699507831868e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,-0.0133445298613607,0.00281862921407658,-0.0188690431209508,-0.00782001660177056,2.21574397962577e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN2,Contactin-2,40489,-0.0205733817101613,0.00434678639330393,-0.029093083041037,-0.0120536803792857,2.2310383988311e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD5L,CD5 antigen-like,37934,0.0214898432045222,0.00455201844637668,0.0125678870496239,0.0304117993594205,2.37110099157606e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,0.0452891314248414,0.00959846200618919,0.0264761458927106,0.0641021169569722,2.39809172743078e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYM,Ketimine reductase mu-crystallin,37541,0.0354714441562454,0.00753536120816924,0.0207021361882337,0.0502407521242571,2.53553454421595e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37714,0.0347653175205568,0.00740381162695564,0.0202538467317237,0.0492767883093898,2.6849266084858e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKAP12,A-kinase anchor protein 12,37671,-0.00999739430746503,0.00213271667472115,-0.0141775189899185,-0.00581726962501158,2.79142774559749e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DGCR6,Protein DGCR6,37541,0.0208026249587239,0.00444581431671075,0.0120888288979708,0.0295164210194769,2.90954560914971e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPSAB1,Tryptase alpha/beta-1,40498,0.0238545075157051,0.00511101396225147,0.0138369201496922,0.033872094881718,3.07688739607918e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP5,Platelet glycoprotein V,37671,0.016322801493357,0.00350723585462991,0.00944861921828241,0.0231969837684316,3.28662322755637e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,0.012202038051334,0.00263227989327715,0.00704276946051076,0.0173613066421572,3.59327042839706e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA6,Integrin alpha-6,40341,0.0238414753609314,0.00514736026035563,0.0137526492506343,0.0339303014712284,3.65398038971499e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37539,0.0185206429469094,0.00401473770757993,0.0106517570400527,0.026389528853766,4.00347201484242e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37900,0.0195107322447205,0.00423578244588995,0.0112085986507762,0.0278128658386648,4.13917628642918e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,0.0457044985517189,0.00993769159499764,0.0262266230255235,0.0651823740779142,4.28177890030915e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37714,0.0308246682579969,0.00670276610280043,0.017687246696508,0.0439620898194857,4.28865179871044e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIF22,Kinesin-like protein KIF22,37562,0.0545446394237878,0.0118853567984639,0.0312493400987987,0.077839938748777,4.49012456250008e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,-0.0200877212292443,0.00438207815370075,-0.0286765944104977,-0.0114988480479908,4.59473950108126e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP170,Centrosomal protein of 170 kDa,37628,0.0344898391103049,0.00752700735563415,0.019736904693262,0.0492427735273479,4.64455413690279e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD2,T-cell surface antigen CD2,37562,0.0170412635511275,0.00371965727958592,0.00975073528313904,0.0243317918191159,4.66116745123396e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STK4,Serine/threonine-protein kinase 4,40359,0.038147489241917,0.00833526745950212,0.0218103650212928,0.0544846134625411,4.76085583013277e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC12A,C-type lectin domain family 12 member A,37598,0.00913090155495895,0.00199678731325463,0.00521719842097988,0.013044604688938,4.85651385534744e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40293,0.0256629231534856,0.00561314051310625,0.0146611677477973,0.0366646785591738,4.86892984121378e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKG1,cGMP-dependent protein kinase 1,37671,0.0558809428297147,0.0122274874960501,0.0319150673374565,0.079846818321973,4.91887499524032e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMIGO2,Amphoterin-induced protein 2,40305,0.00997365804608135,0.00218696286334473,0.00568721083392569,0.014260105258237,5.14125158383154e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNLY,Granulysin,40332,0.0224530806734723,0.00492499899297034,0.0128000826472505,0.0321060786996942,5.17809643167473e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,0.0275153209387429,0.00604267138928083,0.0156716850157525,0.0393589568617334,5.32198069854199e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,0.0478024877219819,0.0105019273548273,0.0272187101065204,0.0683862653374434,5.36596664252767e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBA,Lysosomal acid glucosylceramidase,37572,0.0234933004092377,0.00516151523740339,0.0133767305439271,0.0336098702745484,5.37105488533573e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMS,Spermine synthase,37541,0.0284013160278318,0.00624989752138252,0.016151516885922,0.0406511151697415,5.56154087529742e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREML1,Trem-like transcript 1 protein,37987,0.0233733160975163,0.00515011119177039,0.0132790981616463,0.0334675340333862,5.71681103611436e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,0.0154222675095725,0.00339934073800307,0.00875955966308652,0.0220849753560586,5.75293993031738e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37987,0.0318231681504735,0.00704153918783883,0.0180217513423094,0.0456245849586376,6.25559158578541e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRA3,GDNF family receptor alpha-3,40194,-0.0125121998050675,0.00276961584745494,-0.0179406468660791,-0.00708375274405577,6.29796515864815e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,0.032173434942208,0.00712440642656736,0.018209598346136,0.0461372715382801,6.34855560415792e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD101,Immunoglobulin superfamily member 2,37901,0.0187263712434581,0.00414734777378778,0.010597569606834,0.0268551728800821,6.37752954952695e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX5,Sorting nexin-5,37628,0.0131616558391174,0.00292127495185216,0.00743595693348715,0.0188873547447476,6.68025026508041e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR1,Toll-like receptor 1,37598,0.0115119495674493,0.0025552810294113,0.00650359874980317,0.0165203003850954,6.68947454635251e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.0113862406983544,0.00252745851621062,0.00643242200658159,0.0163400593901272,6.69387525001398e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BIN2,Bridging integrator 2,40332,0.0396080762180269,0.00879260191574792,0.0223745764631609,0.0568415759728928,6.69391473456411e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CORO1A,Coronin-1A,39990,0.039152532994892,0.0087196826714852,0.022061954958781,0.056243111031003,7.16910694276935e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB10,Ras-related protein Rab-10,37990,0.0234428653271018,0.00522281795242476,0.0132061421403493,0.0336795885138544,7.23022994638412e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MGLL,Monoglyceride lipase,40396,0.0375081889913264,0.00836876985632091,0.0211054000729374,0.0539109779097153,7.44883200416432e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,0.00970397155669363,0.00217005005459331,0.00545067344969075,0.0139572696636965,7.8111664375701e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,0.0384902781422679,0.00861759727585163,0.0215997874815987,0.0553807688029371,8.01630839126967e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OPTC,Opticin,40305,-0.0195034805605417,0.00437259050568799,-0.0280737579516902,-0.0109332031693933,8.23712902685754e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37942,-0.0285021520035122,0.00639518832824986,-0.0410367211268819,-0.0159675828801424,8.38579511317011e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FIS1,Mitochondrial fission 1 protein,40354,0.0333051486666935,0.00748216001724348,0.0186401150328963,0.0479701823004907,8.59426915828577e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFIC,Nuclear factor 1 C-type,37959,0.018923466076675,0.00425347878809331,0.0105866476520121,0.0272602845013379,8.69855966985289e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WNT9A,Protein Wnt-9a,40044,0.0123706558260487,0.00278109532235681,0.00691970899422935,0.0178216026578681,8.72229464581729e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMOTL2,Angiomotin-like protein 2,37855,0.0208144472697843,0.00468456744020594,0.0116326950869807,0.029996199452588,8.93433102262265e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMG4,Proteasome assembly chaperone 4,37598,0.0244500168381881,0.00550333449039641,0.0136634812370112,0.0352365524393651,8.95362425394339e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNGR1,Interferon gamma receptor 1,40422,0.00880930760510884,0.00198796996589859,0.00491288647194761,0.0127057287382701,9.42865898569374e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39980,0.0330587046923387,0.00746225263045654,0.0184326895366439,0.0476847198480335,9.48230564828145e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39980,0.0174942675269293,0.0039508507962175,0.009750599966343,0.0252379350875156,9.57714303427491e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G4A,Cytosolic phospholipase A2,40422,0.037360577097951,0.00844223468271435,0.0208137971198308,0.0539073570760711,9.68847178139088e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD1C,T-cell surface glycoprotein CD1c,40411,-0.0102287507662895,0.00232009836396442,-0.0147761435596597,-0.00568135797291919,1.04644557542189e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,0.0151153071700786,0.00342953767919715,0.00839341331885224,0.021837201021305,1.05453249637679e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,0.0382944607657572,0.00868909354225109,0.0212638374229451,0.0553250841085694,1.05546903890508e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,0.0163847349390483,0.00372091271879185,0.00909174601021633,0.0236777238678804,1.07379890145086e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD22,B-cell receptor CD22,40516,0.0174780706570177,0.00397041516782109,0.00969605692808836,0.025260084385947,1.07911596459229e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSL4,Early placenta insulin-like peptide,37900,0.023213568277868,0.00527727963880437,0.0128701001858115,0.0335570363699246,1.09700382407935e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,0.0233857200961611,0.00532811729251274,0.0129426102028361,0.033828829989486,1.14680540935513e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBC1D5,TBC1 domain family member 5,40341,0.0332951212373366,0.00758736257437365,0.0184238905915642,0.0481663518831089,1.15011374867553e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSDE1,Cold shock domain-containing protein E1,37562,0.0499093979797589,0.0113799865444892,0.0276046243525601,0.0722141716069578,1.16505951082803e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37942,-0.0157043953999006,0.0035815219549612,-0.0227241784316246,-0.00868461236817668,1.16950747154919e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,0.0129867271875775,0.00297041987842185,0.00716470422587065,0.0188087501492843,1.24049686122842e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMBS,Porphobilinogen deaminase,40489,0.0192203339956643,0.00440666829771156,0.0105832641321497,0.027857403859179,1.29892019243868e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,0.0358262426775732,0.00821501178011232,0.019724819588553,0.0519276657665934,1.30261419615084e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C5,Complement C5,38013,0.00650294369443764,0.00149246567828088,0.00357771096500712,0.00942817642386817,1.32716679252437e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,-0.00855594587982355,0.00196732494308592,-0.012411902768272,-0.00469998899137515,1.37776548557768e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAPK2,Death-associated protein kinase 2,37598,0.0221914372869273,0.00510272256114811,0.0121901010670771,0.0321927735067776,1.37826832151822e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,0.016699917673325,0.00384444661368215,0.00916480231050797,0.024235033036142,1.40996544722822e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARA5,Scavenger receptor class A member 5,40471,0.0123226086897086,0.00283882621118332,0.00675850931578932,0.0178867080636279,1.42873923178185e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL26,C-C motif chemokine 26,40341,0.0373295992090079,0.00860592661454069,0.0204619830445082,0.0541972153735077,1.44894377325e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37541,0.0422090878231016,0.00973732591361537,0.0231239290324155,0.0612942466137877,1.47001077306048e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUCA1,Tissue alpha-L-fucosidase,40437,0.0340426913360015,0.00787613313722325,0.0186054703870439,0.0494799122849591,1.55373059409552e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,-0.04892131651803,0.0113263234562402,-0.0711209104922608,-0.0267217225437991,1.57510953715323e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,0.0280167075486529,0.00649654547461841,0.0152834784184008,0.040749936678905,1.62566206694857e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PADI4,Protein-arginine deiminase type-4,39934,0.0289619077223945,0.00674291252099556,0.0157457991812432,0.0421780162635458,1.75628942219477e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSH,Pro-cathepsin H,40013,0.0301741717407729,0.00702977071139349,0.0163958211464416,0.0439525223351041,1.77868579712702e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,0.044267870746032,0.0103610097036006,0.0239602917269748,0.0645754497650891,1.94603268637898e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLYR1,Putative oxidoreductase GLYR1,37900,0.025204856175323,0.005905087680313,0.0136308843219095,0.0367788280287365,1.98292352476191e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGS10,Regulator of G-protein signaling 10,37959,0.0248568124318574,0.00583659121217125,0.0134170936560018,0.036296531207713,2.06927361303224e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37562,0.0238593795559713,0.00560540426157072,0.0128727872032926,0.0348459719086499,2.09100270915534e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HLA_DRA,,40288,0.0148302878219947,0.00349389826514069,0.00798224722231893,0.0216783284216704,2.20206170011225e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPO,Lactoperoxidase,39831,0.02432972693462,0.00574389432375417,0.0130716940600618,0.0355877598091782,2.29110545822736e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAFB2,Scaffold attachment factor B2,37959,0.011433903563818,0.00270059682506759,0.00614073378668549,0.0167270733409504,2.31250631462507e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTC,Probetacellulin,39980,0.0309588686327197,0.00732392799696635,0.0166039697586656,0.0453137675067737,2.38091249427345e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37942,0.015439189257961,0.00366282780449498,0.00826004676115086,0.0226183317547712,2.51292089614925e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,0.0281525917323886,0.00668359944117565,0.0150527368276844,0.0412524466370929,2.54588198414975e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAMR1,Inactive serine protease PAMR1,40332,0.0113995002473072,0.00270673165400051,0.00609430620546618,0.0167046942891482,2.55037083727194e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,0.024551288982068,0.00585082718769125,0.0130836676941931,0.0360189102699429,2.7290133300449e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,40042,0.0255252321951569,0.00608709789494303,0.0135945203210686,0.0374559440692452,2.76402764551965e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF21,Immunoglobulin superfamily member 21,37628,-0.0159801320217235,0.00381323884807328,-0.0234540801639472,-0.00850618387949991,2.79911218457743e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40489,0.0153442658528331,0.00367303314581714,0.00814512088703155,0.0225434108186347,2.96230049394234e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,0.0164497456221488,0.00394965218846937,0.00870842733274881,0.0241910639115487,3.1352243815987e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,0.0118558665573649,0.00285001105570849,0.00626984488817621,0.0174418882265535,3.19988116214911e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MKI67,Proliferation marker protein Ki-67,37598,0.0153185577295692,0.00368454778601015,0.00809684406898929,0.0225402713901491,3.23770109231675e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMPD3,AMP deaminase 3,37942,0.0293147672315643,0.00706602377188223,0.0154653606386751,0.0431641738244535,3.36427498694784e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBN1,Drebrin,37598,0.0208984203456226,0.00503976320562453,0.0110204844625985,0.0307763562286466,3.39409174345581e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDZD2,PDZ domain-containing protein 2,37562,0.0247023878506699,0.0059705479421132,0.013000113884128,0.0364046618172117,3.53496535926322e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS53,Serine protease 53,37942,-0.0148021181053859,0.00357912818753219,-0.021817209352949,-0.00778702685782283,3.56053047957981e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,0.0185904246164985,0.00449762615425052,0.00977507735416745,0.0274057718788295,3.5966962231708e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRUNE2,Protein prune homolog 2,37714,0.0119292628711578,0.0028884569664276,0.00626788721695968,0.0175906385253559,3.65021741159932e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA9,Carbonic anhydrase 9,40489,0.0179820353653346,0.00436394518314835,0.00942870280636382,0.0265353679243054,3.79798879208385e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,0.0254307778374294,0.00617445997682322,0.0133288362828559,0.0375327193920029,3.83326176963901e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXDC2,Plexin domain-containing protein 2,37942,-0.0107150295480824,0.00260446974129392,-0.0158197902410185,-0.00561026885514629,3.91013128505876e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,0.0201457978844563,0.00490769407716022,0.0105267174932223,0.0297648782756903,4.06805046710446e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,0.0311184889316851,0.00759335394502262,0.0162355151994408,0.0460014626639294,4.19010827731619e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37959,0.0499043265002772,0.0122286819153039,0.0259361099462815,0.0738725430542728,4.51148487177183e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM3,Intercellular adhesion molecule 3,40536,0.00995351102456409,0.00245050836068767,0.00515051463761626,0.0147565074115119,4.89235815969934e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37628,0.0290239905067784,0.00715073406862588,0.0150085517322717,0.0430394292812851,4.95927950682099e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAS2,Growth arrest-specific protein 2,37714,0.0211883175503958,0.00522638854880152,0.0109445959947448,0.0314320391060468,5.06144567683596e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA3,Carbonic anhydrase 3,40500,0.0239319061965841,0.00592404312098469,0.0123207816794541,0.0355430307137141,5.37474983201906e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA2,Integrin alpha-2,37671,-0.0133458267272707,0.00330861351833027,-0.019830709223198,-0.0068609442313434,5.52230824393328e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,0.0179096088518099,0.00444185269623403,0.00920357756719125,0.0266156401364286,5.56140064466716e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBC1D17,TBC1 domain family member 17,39961,0.0179588852647608,0.00446524691062076,0.00920700131994412,0.0267107692095775,5.79980225446715e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA3G,Semaphorin-3G,37671,0.0169890144358018,0.0042289575850157,0.00870025756917104,0.0252777713024326,5.91932064463557e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RCC1,Regulator of chromosome condensation,37900,0.0199795482852764,0.00497997928926559,0.0102187888783159,0.029740307692237,6.0539016089496e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,0.0269318827020841,0.00672850166081109,0.0137440194468944,0.0401197459572739,6.29201152320773e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.00876152221686672,0.0021897845908267,0.0044695444188464,0.013053500014887,6.33369026925254e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK4,Kallikrein-4,40489,0.0235637055842344,0.00589821716347351,0.0120031999438263,0.0351242112246425,6.49678925569483e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37567,0.0231542450256261,0.00579875600908711,0.0117886832478153,0.0345198068034368,6.56071979993631e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,0.046088700732367,0.0115935720428454,0.02336529952839,0.0688121019363439,7.05808683112444e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37628,0.0319853129038071,0.00805852123738411,0.0161906112785343,0.0477800145290799,7.25183650906636e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,0.0287390839206707,0.00724126593665782,0.0145462026848214,0.04293196515652,7.26182324736384e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UROS,Uroporphyrinogen-III synthase,37572,0.0271782739745375,0.00685863809464762,0.0137353433090281,0.0406212046400468,7.45197494991438e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP3,Stromelysin-1,40332,0.0185662536589213,0.00468838768607594,0.00937701379421249,0.0277554935236302,7.52606495224104e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRTN,Neurturin,40044,0.0189949252880364,0.00480305498782963,0.0095809375118903,0.0284089130641824,7.6950441824664e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMB1,Laminin subunit beta-1,37628,0.0113579161604416,0.0028758390693881,0.00572127158444091,0.0169945607364423,7.87463092460841e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37628,0.0237257461973103,0.00601756444359043,0.0119313198878731,0.0355201725067476,8.09695720126321e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP6,Gastrotropin,40017,0.0213563146018242,0.00542514163972497,0.0107230369879632,0.0319895922156851,8.30227658189239e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINI2,Serpin I2,37901,0.0214708174504792,0.00545713811426813,0.0107748267465136,0.0321668081544447,8.3807833558458e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMM2,Phosphomannomutase 2,37562,0.0231057140073559,0.00587893876093928,0.0115829940359149,0.0346284339787969,8.52925139238421e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPMT,Thiopurine S-methyltransferase,39980,0.028233015087238,0.00719414269584845,0.0141324954033751,0.042333534771101,8.73047711907482e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYGD,Gamma-crystallin D,37942,0.0366345556254488,0.00934485302818043,0.0183186436902152,0.0549504675606824,8.88788233721922e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F3,Tissue factor,40393,-0.0106678846071859,0.00272198306581631,-0.0160029714161859,-0.00533279779818593,8.92296775909768e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMVK,Phosphomevalonate kinase,39951,0.0420972572842506,0.010741706187217,0.0210435131573054,0.0631510014111958,8.92815341900249e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPK13,Mitogen-activated protein kinase 13,37482,0.0157817507575961,0.00403167456441804,0.00787966861133674,0.0236838329038555,9.10751940425808e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPA33,Cell surface A33 antigen,40305,0.0517426558237902,0.0132192350695202,0.0258329550875307,0.0776523565600498,9.10857614051605e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,0.0136612927836627,0.00349411574190697,0.00681282592952499,0.0205097596378003,9.27565694391948e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPING1,Plasma protease C1 inhibitor,37981,-0.00709729921328657,0.00181587247990552,-0.0106564092739014,-0.00353818915267176,9.33316829571884e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,-0.00914302440330441,0.00234036305265284,-0.013730135986504,-0.00455591282010483,9.39648247186035e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEZ6,Seizure protein 6 homolog,37572,-0.0119406307268283,0.00305724415427896,-0.017932829269215,-0.00594843218444152,9.44299840182972e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATRN,"Attractin, Isoform 2",38013,0.00622916679557704,0.00159512310153322,0.00310272551657192,0.00935560807458216,9.46301943393787e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,0.0152309314273223,0.00390211390804803,0.00758278816754816,0.0228790746870964,9.53839464030527e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,0.00921092614132764,0.00236074963871586,0.00458385684944455,0.0138379954332107,9.5915363966014e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PARD3,Partitioning defective 3 homolog,37714,0.0282621091458239,0.00724717220010459,0.0140576516336189,0.0424665666580289,9.67695301647587e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSBP1,Heat shock factor-binding protein 1,37628,0.0362390014049112,0.00931199928525107,0.0179874828058191,0.0544905200040033,0.000100056749577059
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPHS1,Nephrin,37598,-0.0131516716389804,0.0033827811536613,-0.0197819227001566,-0.00652142057780425,0.000101642430010718
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANSC1,MANSC domain-containing protein 1,40411,0.0103260385076042,0.00265827626703387,0.00511581702421781,0.0155362599909906,0.000102960129426495
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCP1,Plastin-2,37998,0.0177950484927663,0.00458714580446607,0.00880424271601278,0.0267858542695198,0.000105240499612423
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA6,Corticosteroid-binding globulin,38013,0.00676405836256435,0.00174461606364945,0.00334461087781143,0.0101835058473173,0.000106205550909486
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39980,0.0156004320077017,0.00404020674892707,0.00768162677980466,0.0235192372355988,0.000113244692245778
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSMB,Beta-microseminoprotein,40236,0.0259442470703614,0.00671961737272541,0.0127737970198196,0.0391146971209032,0.000113387672056994
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX2,Sorting nexin-2,37900,0.0292974448260864,0.00759504662688207,0.0144111534373976,0.0441837362147753,0.000115114790904515
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL3,Myosin light chain 3,37628,0.0257050418647521,0.00666716666568726,0.0126373952000051,0.0387726885294991,0.000116057767720356
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSR,"Glutathione reductase, mitochondrial",37944,0.00834097572207972,0.00216446301994632,0.00409862820298493,0.0125833232411745,0.00011693262034424
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,0.0164164478219023,0.00426263311298492,0.00806168692045187,0.0247712087233527,0.000118060983308778
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,0.0163861656379586,0.0042573461739459,0.00804176713702461,0.0247305641388926,0.000119117148251711
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2RG,Cytokine receptor common subunit gamma,37900,0.0144935741950871,0.0037658411717815,0.00711252549839539,0.0218746228917789,0.000119297951983901
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,0.024367475744672,0.00634228631346633,0.011936594570278,0.036798356919066,0.000122496048777614
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,0.0212214090819673,0.00553021696703117,0.0103821838265862,0.0320606343373484,0.000124846638434245
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTSL5,ADAMTS-like protein 5,37990,0.0144945521336851,0.00377862641865018,0.00708844435313077,0.0219006599142395,0.000125656794396707
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,0.0417223990351011,0.0108892703929869,0.0203794290648468,0.0630653690053554,0.000127858882287213
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,0.0224988451749532,0.00588392979582868,0.010966342775129,0.0340313475747775,0.000131927374219256
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP10,Stromelysin-2,40341,0.0222550943281149,0.0058233417666313,0.0108413444655175,0.0336688441907122,0.000133037250892021
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RP2,Protein XRP2,40305,0.0153045467031576,0.00400525770925468,0.00745424159301844,0.0231548518132968,0.000133357308593313
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COPB2,Coatomer subunit beta',37562,0.0160552681235065,0.00420249108523685,0.00781838559644225,0.0242921506505707,0.00013384099900937
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROC,Vitamin K-dependent protein C,40372,0.00935209154837789,0.00245033170711756,0.00454944140242747,0.0141547416943283,0.000135780401108934
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSTN3,Calsyntenin-3,37942,0.0113657456453836,0.00297791252838175,0.00552903708975538,0.0172024542010118,0.000135862486496816
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,0.0186299963359816,0.00489527449777251,0.00903525832034745,0.0282247343516157,0.000141932046611493
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENG,Endoglin,40536,-0.00629195055286918,0.00165508517412008,-0.00953591749414453,-0.00304798361159383,0.000144302731728304
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEZ6L,Seizure 6-like protein,40411,-0.0101157733114763,0.00266221977546195,-0.0153337240713817,-0.00489782255157085,0.000145379061302632
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,0.0175590846667986,0.00462674974293099,0.00849065517065382,0.0266275141629433,0.000148132757859553
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB7,Integrin beta-7,40489,-0.0167287683566239,0.00441398772317895,-0.0253801842940546,-0.00807735241919314,0.000151232273141923
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37942,0.0263132216856345,0.00694605408760108,0.0126989556739364,0.0399274876973326,0.000152385863715896
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,0.0198975650834217,0.00525296953391499,0.00960174479694832,0.0301933853698951,0.000152622700147382
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,0.0271343659600648,0.00718145271145761,0.0130587186456079,0.0412100132745217,0.000158423984780997
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37942,0.0877195398027924,0.0232585846884466,0.0421327138134371,0.133306365792148,0.000162968218523755
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAA10,N-alpha-acetyltransferase 10,37562,0.01879215848022,0.00499129865151525,0.0090092131232501,0.0285751038371899,0.000167287219278669
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,0.015264007466179,0.00407650402813917,0.0072740595710262,0.0232539553613318,0.000181485190698369
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,0.0318509582261798,0.00851735009811719,0.0151569520338701,0.0485449644184895,0.000185134187067018
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBH,Dopamine beta-hydroxylase,37967,-0.0385226553291995,0.0103235537081428,-0.0587568205971594,-0.0182884900612397,0.000191099476665407
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL1,Fc receptor-like protein 1,40359,0.0162735395799345,0.00436868910393851,0.00771090893621501,0.024836170223654,0.000195959605837095
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFRP1,Secreted frizzled-related protein 1,40178,0.0156767046595559,0.00422426165906141,0.00739715180779555,0.0239562575113163,0.000207062803366522
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,0.00992947013923894,0.00268032190333825,0.00467603920869596,0.0151829010697819,0.000212475549371859
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G1B,Phospholipase A2,40514,-0.0150245613740862,0.0040700021572788,-0.0230017656023526,-0.00704735714581973,0.00022364095134315
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,0.0174738013274432,0.00473573694614703,0.00819175691299504,0.0267558457418914,0.000225334666713722
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN10,Ataxin-10,39961,0.0259204663514194,0.00703107626633108,0.0121395568694104,0.0397013758334283,0.000228083176607029
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C4BPB,C4b-binding protein beta chain,40411,-0.0147273904197903,0.00399864043525995,-0.0225647256728998,-0.00689005516668077,0.000231175939717098
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL33,Interleukin-33,40044,0.0137959154064293,0.00375310868045192,0.00643982239274358,0.0211520084201151,0.000237841372719118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTA4H,Leukotriene A-4 hydrolase,40489,0.0205624402038034,0.00561779817599284,0.00955155577885741,0.0315733246287493,0.000252796534458268
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CILP,Cartilage intermediate layer protein 1,37998,0.0191554386187004,0.00524415590654837,0.00887689304186558,0.0294339841955352,0.000260454632408888
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH22,Cadherin-22,37714,-0.0105283904674503,0.0028843046341453,-0.0161816275503751,-0.00487515338452553,0.00026300692293145
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C2orf69,UPF0565 protein C2orf69,37572,0.0214984753832568,0.00588959778621287,0.00995486372227962,0.0330420870442341,0.00026300777692364
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,0.0363953958397454,0.00997706402786333,0.0168403503451333,0.0559504413343575,0.000265405952433118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUC16,Mucin-16,40305,0.0661167112870942,0.0181826901305418,0.0304786386312322,0.101754783942956,0.000277517834431545
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTN,Neuroplastin,39980,-0.0298318758187174,0.00822489625198712,-0.0459526724726121,-0.0137110791648226,0.00028762784298591
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,-0.0101329311958934,0.00279630506110184,-0.0156136891156531,-0.00465217327613384,0.000291534457123511
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,0.0258655461325102,0.00714752894845427,0.0118563893935398,0.0398747028714805,0.000297039734864018
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUGT1,Protein SGT1 homolog,39980,0.0285645337543819,0.00791001878825237,0.0130608969294073,0.0440681705793566,0.00030576276367945
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STXBP3,Syntaxin-binding protein 3,39980,0.0154891121547186,0.00429646684137144,0.00706803714563054,0.0239101871638066,0.000313032420794936
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LIPF,Gastric triacylglycerol lipase,37628,-0.020972929283515,0.00582368522062905,-0.032387352315948,-0.00955850625108208,0.000317774826885805
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRG2,Bone marrow proteoglycan,37998,0.0182948823849549,0.00508532030565594,0.00832765458586921,0.0282621101840405,0.000322327162192967
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37562,-0.0141159327518459,0.00392499325591059,-0.0218089195334307,-0.0064229459702612,0.000323810138145343
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB9,Serpin B9,40228,0.011682641509149,0.00325260692687927,0.00530753193246565,0.0180577510858324,0.000329428101581287
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEK,Angiopoietin-1 receptor,40411,0.00748676723966145,0.00208691916225377,0.00339640568164405,0.0115771287976788,0.000334896436516561
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40359,0.0230571238984944,0.00644529766696922,0.0104243404712347,0.0356899073257541,0.000348118102507297
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALM,Paralemmin-1,37824,0.0102206972369628,0.00285730019073079,0.00462038886313045,0.0158210056107951,0.000348725016545046
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRK1,Protein BRICK1,39961,0.0153348108410658,0.00428819877422964,0.00692994124357572,0.0237396804385559,0.000349886731718232
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HBQ1,Hemoglobin subunit theta-1,40489,-0.0204862112010589,0.00572983613385342,-0.0317166900234117,-0.00925573237870625,0.000350777998475277
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37901,0.0339079674915548,0.00953515814290501,0.015219057531461,0.0525968774516486,0.000377695224881336
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37598,0.0303385617883302,0.00853335419458636,0.013613187566941,0.0470639360097195,0.000378886123214248
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEP1B,Meprin A subunit beta,40359,-0.0407781602983748,0.0114858588698614,-0.0632904436833031,-0.0182658769134465,0.000385913830377042
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHGB,Secretogranin-1,40406,0.0138693690010789,0.00390813223121627,0.00620942982789498,0.0215293081742628,0.000388031519905808
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40536,0.0101494881693476,0.00286417169575276,0.00453571164567222,0.0157632646930231,0.000395817498497061
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPQ,Carboxypeptidase Q,37986,0.0125716845893477,0.00355788097822538,0.00559823787202592,0.0195451313066694,0.000411501511332313
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB1A1,Uteroglobin,40384,0.0194038523126887,0.00551134082006458,0.00860162430536208,0.0302060803200152,0.000431589409623022
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MATN2,Matrilin-2,40379,0.0101399117588098,0.00288182097394803,0.0044915426498717,0.015788280867748,0.000435075806935154
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAG3,BAG family molecular chaperone regulator 3,40203,0.0135179826664989,0.0038456452175688,0.00598051804006402,0.0210554472929337,0.000440756082165391
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMS1,PMS1 protein homolog 1,37572,0.0178438588572496,0.00508477286881875,0.00787770403436483,0.0278100136801343,0.000450838444944706
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,0.00934667008510314,0.002664864311314,0.00412353603492769,0.0145698041352786,0.000453790728509276
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMI,N-myc-interactor,37857,0.0244389305015068,0.00697650271010151,0.0107649851897079,0.0381128758133058,0.000461488503996345
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,-0.0225722334660688,0.00644735879042271,-0.0352090566952973,-0.00993541023684024,0.000465047453278346
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37482,0.0263792954996437,0.0075525271265206,0.0115763423316633,0.041182248667624,0.000479609959185362
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPP1,Osteopontin,40497,-0.0161337995188202,0.00462357521037146,-0.0251960069311482,-0.00707159210649211,0.000485288514951226
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,0.00971267423025634,0.00278566381488492,0.0042527731530819,0.0151725753074308,0.000490678336187343
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD177,CD177 antigen,40316,0.0432347237312155,0.0124051095813516,0.0189207089517663,0.0675487385106646,0.000493032867236138
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD99,CD99 antigen,40332,-0.00655552117523935,0.00188472183556114,-0.0102495759729392,-0.00286146637753952,0.00050606322004715
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,40044,0.0155925153509556,0.00448809298484335,0.00679585310066268,0.0243891776012486,0.000513777899607464
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC39A14,Zinc transporter ZIP14,39961,0.0112628765549259,0.00324505910802557,0.0049025607031958,0.017623192406656,0.000520366525941712
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA7,Carbonic anhydrase 7,37714,-0.0119251263092998,0.00343787612055108,-0.0186633635055799,-0.00518688911301971,0.000524549550287688
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECM1,Extracellular matrix protein 1,37655,-0.0125504143267462,0.00361989485618883,-0.0196454082448763,-0.00545542040861605,0.000527847669865132
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STXBP1,Syntaxin-binding protein 1,37959,0.0261158794749201,0.00753398632764223,0.0113492662727413,0.0408824926770989,0.000529099943480189
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,0.0106134416704105,0.00306474165810241,0.00460654802052983,0.0166203353202913,0.000535732149554983
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP9,Caspase-9,37598,0.0210414884873851,0.0060873234300328,0.00911033456452083,0.0329726424102494,0.000548750049610363
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,0.0250008898163137,0.00723712220841484,0.0108161302878206,0.0391856493448068,0.000552989603129373
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RLN1,Prorelaxin H1,37959,0.0277818832422786,0.00805367207623429,0.0119966859728594,0.0435670805116978,0.000563148614976975
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,0.0193285264737373,0.00562873989348646,0.00829619628250383,0.0303608566649708,0.000596518469637993
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL4,Myosin light chain 4,37628,0.0176250773681804,0.00513261970861356,0.00756514273929783,0.027685011997063,0.000596719893058363
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA1,Carbonic anhydrase 1,40003,0.0208542501216773,0.00607633834534861,0.00894462696479406,0.0327638732785606,0.00060061285108047
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROCR,Endothelial protein C receptor,37562,-0.0123409396488485,0.00359885639198678,-0.0193946981771425,-0.00528718112055437,0.000607386879719457
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40341,-0.0112980489259664,0.00330076195673494,-0.0177675423611669,-0.00482855549076587,0.000621220185825709
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,-0.00934367713074757,0.00274082434477071,-0.0147156928464982,-0.00397166141499697,0.000653451483744098
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PODXL,Podocalyxin,40305,-0.00502753484568553,0.00147494334985384,-0.00791842381139906,-0.002136645879972,0.000654526297228357
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX18,Sorting nexin-18,37901,0.0151248006935997,0.00443794235833893,0.00642643367125535,0.023823167715944,0.000656168473143802
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,0.0108557393686722,0.00320511508320217,0.00457371380559597,0.0171377649317485,0.000708617635119157
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL36G,Interleukin-36 gamma,37551,0.0227987746410345,0.0067370342388753,0.00959418753283893,0.0360033617492301,0.000716222488701178
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40359,-0.0253235416135609,0.00750129569253383,-0.0400260811709272,-0.0106210020561946,0.000737536148761477
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA4,Annexin A4,40279,0.0234412667568264,0.00696270938997155,0.00979435635248213,0.0370881771611706,0.0007625791319921
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37572,0.0162701282056199,0.00483604902813318,0.00679147211047883,0.0257487843007609,0.00076945853826106
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,40044,0.0103982288328903,0.00309094387823684,0.00433997883154614,0.0164564788342345,0.000769801134549303
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,0.0399009335277183,0.0118688779384956,0.0166379327682669,0.0631639342871697,0.000776154829614955
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,0.0307041964115965,0.00913857863445994,0.012792582288055,0.048615810535138,0.00078171530665066
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAM,Signal transducing adapter molecule 1,37900,0.0122626384626918,0.00365633717755978,0.00509621759467468,0.019429059330709,0.000799289349630824
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,0.0116767629001082,0.00348257152116544,0.00485092271862392,0.0185026030815924,0.000801845854149076
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA13,Carbonic anhydrase 13,40173,0.0335715473001386,0.0100473620776148,0.0138787176280135,0.0532643769722636,0.0008357246880426
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39961,0.0132526125373337,0.00397791607314688,0.00545589703396577,0.0210493280407015,0.000865666214515756
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB37,Ras-related protein Rab-37,40044,0.0268413786242039,0.00808241775855037,0.0109998398174452,0.0426829174309626,0.000899147036829374
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDK2,Protein sidekick-2,37671,0.0123881867226179,0.00373333009786148,0.00507085973080937,0.0197055137144264,0.000908224437185744
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,0.0218868744476391,0.00659620816888276,0.00895830643662891,0.0348154424586493,0.000908405482237789
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGMA,Repulsive guidance molecule A,40471,-0.00994303297558044,0.00299899677422593,-0.0158210666530633,-0.00406499929809761,0.000916979686508295
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARFIP1,Arfaptin-1,37959,0.0221767599340748,0.00669334382465862,0.00905780603774387,0.0352957138304057,0.000924590063322054
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,-0.0117228790063199,0.0035415387513896,-0.0186642949590436,-0.00478146305359632,0.000935100891242655
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37959,0.0125938105253779,0.00382848529914116,0.00508997933906118,0.0200976417116945,0.00100621671771361
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,0.011826674690065,0.00359906103530467,0.00477251506086785,0.0188808343192622,0.00101865133699518
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK7,Kallikrein-7,37352,-0.0124718500145849,0.00379927466334017,-0.0199184283547316,-0.00502527167443818,0.00103094243562915
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,0.00887372845862371,0.00271195143457552,0.0035583036468557,0.0141891532703917,0.00106984901740785
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,0.0254266902514948,0.00778686157810527,0.0101644415584085,0.0406889389445812,0.00109571638791924
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,0.0377226187365516,0.0115548548248095,0.015075103279925,0.0603701341931782,0.00109829168139815
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39897,0.0181775116827277,0.00557069668117646,0.00725894618762184,0.0290960771778335,0.00110456000570852
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,0.0211864386883065,0.00650643159683047,0.00843383275851876,0.0339390446180942,0.00113185635613466
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,0.00909593743576862,0.00279568905255346,0.00361638689276383,0.0145754879787734,0.00114256586865756
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAD1,Glutamate decarboxylase 1,37482,-0.00817253978126865,0.00252716137401574,-0.0131257760743395,-0.0032193034881978,0.00122424422606642
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYZL2,Lysozyme-like protein 2,37482,0.0112826056285369,0.00350008724576988,0.00442243462682796,0.0181427766302459,0.0012693660815224
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37714,0.0135290867876012,0.00420472843312882,0.00528781905866869,0.0217703545165337,0.00129583574393644
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40273,0.010498313856809,0.00326949176425198,0.00409010999887514,0.0169065177147429,0.00132541659785473
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,0.0260179508383876,0.00812882981676414,0.0100854443975299,0.0419504572792453,0.00137370049097828
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,-0.0197143980878129,0.00621118091496227,-0.031888312681139,-0.00754048349448689,0.00150630098888907
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,0.0127515897986457,0.00403268184016551,0.00484753339192133,0.0206556462053701,0.00156947204340991
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G10,Group 10 secretory phospholipase A2,40228,0.0183307896104233,0.00580026266372978,0.00696227478951291,0.0296993044313336,0.00157884111604786
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD5,Sushi domain-containing protein 5,37604,-0.0105578904824652,0.00335193522306198,-0.0171276835196667,-0.00398809744526375,0.00163754018370369
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FMR1,Synaptic functional regulator FMR1,39980,0.0107453855255386,0.00341861691654198,0.00404489636911631,0.0174458746819609,0.00167427993213127
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSG4,Desmoglein-4,40250,-0.0155353819539789,0.00494317730955087,-0.0252240094806986,-0.00584675442725916,0.00167653677715588
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,0.00866465723264601,0.00277160960032955,0.00323230241600009,0.0140970120492919,0.00177447168579424
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGN,Cingulin,37572,0.0127882734497523,0.00410753406085681,0.00473750669047291,0.0208390402090316,0.00185361802300762
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDC4,Syndecan-4,40359,0.0136587894071706,0.00438754580311975,0.00505919963305587,0.0222583791812853,0.00185472950718455
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SATB1,DNA-binding protein SATB1,37959,0.00914610645998701,0.00293874830647257,0.00338615977930077,0.0149060531406733,0.00186057370707074
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GC,Vitamin D-binding protein,38013,0.00784130928275572,0.0025374039290019,0.002867997581912,0.0128146209835995,0.00200367299947431
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37598,-0.0128711862270593,0.00416856071533309,-0.0210415652291122,-0.00470080722500643,0.00202144869769095
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40272,0.00693319654629487,0.00224692839396419,0.00252921689412505,0.0113371761984647,0.00203469905899938
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37562,0.0290531456159579,0.00941840139171988,0.0105930788881869,0.0475132123437289,0.00204166753611109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,0.0143404597058859,0.00465518786335733,0.00521629149370555,0.0234646279180663,0.00206991637854623
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTNNA1,Catenin alpha-1,37541,-0.0109403855047784,0.00355661287167777,-0.0179113467332668,-0.00396942427628998,0.00210182178478877
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DRAXIN,Draxin,40228,0.012917621285342,0.00420227558193412,0.00468116114475109,0.0211540814259329,0.00211599299530433
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,0.021553875394133,0.00701448996566189,0.00780547506143573,0.0353022757268304,0.00212515896949037
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD86,T-lymphocyte activation antigen CD86,37901,-0.00875993385481389,0.00285310952009821,-0.0143520285142064,-0.0031678391954214,0.00214262239090797
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRH,Corticoliberin,39947,-0.0259097008066883,0.00845371671266408,-0.0424789855635099,-0.00934041604986673,0.00218125376180909
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD33,Myeloid cell surface antigen CD33,40411,0.0235804261733005,0.0076989421616855,0.00849049953639694,0.0386703528102041,0.00219631552569613
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MZT1,Mitotic-spindle organizing protein 1,39980,0.0156965847379436,0.00512584241105827,0.00564993361226941,0.0257432358636178,0.00220059333004846
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37562,0.0301856145158605,0.00985772140044594,0.0108644805709865,0.0495067484607346,0.00220213853793497
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGH,Gamma-glutamyl hydrolase,40077,0.0101803158325821,0.00332553266163952,0.00366227181576861,0.0166983598493955,0.00220782705721674
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,-0.0140654582107045,0.00461142642310519,-0.0231038539999907,-0.00502706242141837,0.00229184248241868
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCHE,Cholinesterase,37748,0.00842682474056179,0.00276284428187837,0.00301164994808018,0.0138419995330434,0.00229250462059019
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37901,0.00773895991282403,0.0025398073042466,0.0027609375965007,0.0127169822291474,0.00231535222267977
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LXN,Latexin,40183,-0.0195529620428674,0.00643930639418978,-0.0321740025754794,-0.00693192151025547,0.00239732827391857
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENO2,Gamma-enolase,40471,0.0193440467908301,0.0063712274767483,0.00685644093640338,0.0318316526452567,0.0023999953586003
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39980,0.0177577269979909,0.00584957789504631,0.00629255432370011,0.0292228996722816,0.00240353278901574
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37900,0.0156694070190253,0.00516153549135207,0.00555279745597524,0.0257860165820753,0.00240354665189138
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,0.0258465002251976,0.00852529001916431,0.00913693178763557,0.0425560686627596,0.00243544258042987
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37900,0.012097954542609,0.00399347538323714,0.00427074279146415,0.0199251662937538,0.0024548073567054
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOS2,"Nitric oxide synthase, inducible",37562,0.0115912722210546,0.00382873703882986,0.00408694762494811,0.0190955968171612,0.00247113693413621
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17RA,Interleukin-17 receptor A,40332,0.0128793553495289,0.00425821808821891,0.0045332478966198,0.0212254628024379,0.00249369928994356
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39980,0.01461743253969,0.00483555843002486,0.00513973801684123,0.0240951270625387,0.00250769397548225
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL4,Angiopoietin-related protein 4,40396,0.0133819691511915,0.00443027399275753,0.00469863212538676,0.0220653061769963,0.0025269594155071
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,0.0294040469824053,0.00974281883422187,0.0103081220673305,0.0484999718974802,0.00254833147518587
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANPEP,Aminopeptidase N,40370,-0.00829187184379262,0.00274855917599622,-0.0136790478287452,-0.00290469585884002,0.00255856087164923
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST5,Cystatin-D,40070,0.016123207162306,0.0053456592202875,0.00564571509054246,0.0266006992340695,0.00256434634647069
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,-0.0152969441588836,0.00507430380656874,-0.0252425796197583,-0.00535130869800887,0.00257819278782323
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBX2,Chromobox protein homolog 2,37562,-0.0120816458037823,0.0040080408879305,-0.0199374059441261,-0.00422588566343854,0.00258021324756657
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK1,Kallikrein-1,40209,-0.0371895293642387,0.0123565487933334,-0.0614083649991722,-0.0129706937293051,0.00261917809425365
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37714,0.0159916713555039,0.00531486621054229,0.00557453358284097,0.0264088091281668,0.00262725076881628
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL9A1,Collagen alpha-1(IX) chain,40341,-0.0137457197581751,0.00457204681093137,-0.0227069315076006,-0.00478450800874966,0.00264713470055285
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARTN,Artemin,40044,0.0129537499127898,0.00432091086280829,0.00448476462168558,0.0214227352038941,0.00272256395089771
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,0.0223751105355056,0.00747245898995674,0.00772909091519042,0.0370211301558208,0.00275469248086571
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARF2,Scavenger receptor class F member 2,40471,-0.00862454441885616,0.00288139346742429,-0.0142720756150078,-0.00297701322270456,0.00276503154185448
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EHD3,EH domain-containing protein 3,37628,0.0340685647316697,0.0114099599235048,0.0117050432816004,0.0564320861817391,0.00283299987824974
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40465,0.0184891001809553,0.00619250193698325,0.00635179638446815,0.0306264039774425,0.00283335769787933
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,0.0196474069136597,0.00658870584792327,0.00673354345173011,0.0325612703755893,0.00286910290218655
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNN,Tenascin-N,37998,0.012717889480522,0.00426659689125121,0.00435535957366964,0.0210804193873744,0.00288003378875687
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOS,Proto-oncogene c-Fos,37457,0.0102296498172227,0.00343245326887318,0.00350204141023122,0.0169572582242141,0.00288523612991689
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENSA,Alpha-endosulfine,37900,0.0153192547204711,0.00514278721466153,0.00523939177973456,0.0253991176612077,0.0028991083745098
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NELL2,Protein kinase C-binding protein NELL2,40422,-0.00816818677575918,0.00274291342188399,-0.0135442970826518,-0.00279207646886655,0.00290643992824044
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERC2,ERC protein 2,37572,0.0223723938533304,0.0075239701956063,0.00762541226994207,0.0371193754367188,0.00294976426474353
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40451,0.00861056618336426,0.00289655638037698,0.00293331567782539,0.0142878166889031,0.00295641375169681
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMPA1,Inositol monophosphatase 1,40228,0.0174941940458238,0.00590669540792705,0.0059170710462868,0.0290713170453608,0.00306345295202468
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,0.0105288803330787,0.0035606867906605,0.00354993422338411,0.0175078264427733,0.00311217328029713
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHIT1,Chitotriosidase-1,40398,0.0427857006276231,0.0144882100954861,0.0143888088404704,0.0711825924147758,0.003150189404141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC11A,C-type lectin domain family 11 member A,40296,0.0136805286620329,0.00465125858197829,0.00456406184135545,0.0227969954827103,0.00327360208840375
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,-0.016548565526746,0.00562638315031312,-0.0275762765013597,-0.0055208545521323,0.00327472008733264
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNPO1,Transportin-1,37714,-0.0102103327345472,0.00347200492613897,-0.0170154623897795,-0.00340520307931478,0.00327973781430799
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCN15,Lipocalin-15,37959,0.0182692581671572,0.00622666247949625,0.00606499970734455,0.0304735166269699,0.00335147046875029
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,0.0154057200006169,0.00528437753972876,0.00504834002274851,0.0257630999784852,0.00355893847564742
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWF,von Willebrand factor,40536,0.0202370691271929,0.00694245838457448,0.00662985069342692,0.0338442875609589,0.0035621151918551
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSAPL1,Proactivator polypeptide-like 1,37901,-0.0143939238455064,0.00493911955727152,-0.0240745981777586,-0.00471324951325421,0.00357109957849592
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QL2,Complement C1q-like protein 2,37598,-0.0121959611516205,0.00419222669717953,-0.0204127254780924,-0.00397919682514865,0.00362980021137834
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17D,Interleukin-17D,40044,0.0096595066002596,0.00332250350840776,0.0031473997237804,0.0161716134767388,0.00365079889601421
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL9A2,Collagen alpha-2(IX) chain,37714,0.0131816866763847,0.00453633993465812,0.00429046040445477,0.0220729129483146,0.00366923880165364
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FZD8,Frizzled-8,37541,0.0127850346161868,0.00440138142904693,0.00415832701525482,0.0214117422171188,0.00368129069771104
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHNAK2,Protein AHNAK2,37628,0.00810606690491071,0.00279244085964663,0.00263288282000331,0.0135792509898181,0.00370384302008371
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFHR5,Complement factor H-related protein 5,37785,0.0118515580074612,0.00408575261588171,0.00384348288033308,0.0198596331345894,0.00372934255412495
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGS8,Regulator of G-protein signaling 8,40044,0.0186993659065816,0.00645197722397859,0.00605349054758356,0.0313452412655796,0.00375788506079833
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH1,Protocadherin-1,40475,0.00609135180858446,0.00211117677159101,0.00195344533626607,0.0102292582809028,0.00391578106487674
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DIPK2B,Divergent protein kinase domain 2B,37671,-0.00752851356962035,0.00261369228767917,-0.0126513504534715,-0.00240567668576917,0.00397792681750327
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABO,Histo-blood group ABO system transferase,37987,-0.0406239335611157,0.0141055255516951,-0.0682707636424382,-0.0129771034797933,0.00398297261969212
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TG,Thyroglobulin,37900,-0.032865337262565,0.011451959754479,-0.0553111783813438,-0.0104194961437863,0.00411314624131367
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,-0.0167533799101771,0.00583915328431242,-0.0281981203474294,-0.00530863947292473,0.00412240090727132
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAT1,Diamine acetyltransferase 1,37562,-0.0146022028722762,0.00509096186535536,-0.0245804881283727,-0.0046239176161797,0.00413394728047163
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB5,Integrin beta-5,40411,-0.0102986451407373,0.00359323706296714,-0.0173413897841529,-0.00325590049732168,0.00416081219646742
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDK1,Cyclin-dependent kinase 1,37482,0.0102485001853347,0.0035760899526586,0.00323936387812381,0.0172576364925455,0.00416570693506813
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL3,Fc receptor-like protein 3,40044,0.0152102402111871,0.00530833197804121,0.00480590953422634,0.0256145708881479,0.0041710264674629
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,0.00904648625134851,0.00315753733930117,0.00285771306631823,0.0152352594363788,0.00417509591094395
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN3,Neuronal-specific septin-3,37959,0.0205973009239626,0.00719484229167624,0.0064954100322772,0.034699191815648,0.00420578737008341
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL4,Interleukin-4,40044,0.024897158604532,0.00871968579309832,0.00780657445005926,0.0419877427590047,0.00430554354059249
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA4,Ephrin type-A receptor 4,37671,0.00787078902702446,0.00275794791252813,0.00246521111846932,0.0132763669355796,0.00432590899555005
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,0.00838060095864296,0.00294248620488812,0.00261332799706223,0.0141478739202237,0.00440339515713636
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,0.00748581355577264,0.00263290748560401,0.00232531488398879,0.0126463122275565,0.0044724769801585
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APPL2,DCC-interacting protein 13-beta,37671,0.0309834926654079,0.0109060012857485,0.00960773014534089,0.052359255185475,0.00450469859010311
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,0.0106787251654618,0.00376009294269862,0.00330894299777251,0.0180485073331511,0.00451801164605538
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37901,0.0142863902538391,0.00505380649240472,0.00438092952872586,0.0241918509789524,0.00470766330599214
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELAVL4,ELAV-like protein 4,37541,0.0240304757331986,0.00853563889949721,0.0073006234901841,0.0407603279762132,0.00488029055198636
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37482,-0.00829094735541841,0.00295116413927008,-0.0140752290683878,-0.00250666564244905,0.00497106527851734
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37562,0.0151962195865511,0.0054094036595306,0.00459378841387111,0.0257986507592311,0.00497347880542437
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,0.0115806249304851,0.00412644885882304,0.00349278516719195,0.0196684646937783,0.00501659854239068
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37714,0.0162234139468675,0.00578502891806754,0.00488475726745513,0.0275620706262799,0.00504869052299007
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK8,Kallikrein-8,39801,0.00963331225221245,0.00343695627352788,0.00289687795609781,0.0163697465483271,0.00507149353180084
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,0.0187845856394468,0.00672072223323132,0.00561197006231344,0.0319572012165802,0.00519572761752268
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LUZP2,Leucine zipper protein 2,37900,0.012092812459417,0.00435433970087722,0.00355830664569766,0.0206273182731364,0.00549076582542279
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FRMD4B,FERM domain-containing protein 4B,37562,0.0188847759500758,0.00684833379949821,0.00546204170305934,0.0323075101970923,0.00583129409509392
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CX3CL1,Fractalkine,40228,-0.00913211830398001,0.0033155572933258,-0.0156306105988986,-0.00263362600906144,0.00588809235776539
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,0.0109268880246131,0.00396707296800168,0.00315142500732977,0.0187023510418963,0.00588817261124295
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX5,Syntaxin-5,37598,0.0112446962600644,0.00408869152769413,0.00323086086578393,0.0192585316543449,0.00596413702795157
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,0.0239504702780974,0.00871100307612347,0.00687690424889539,0.0410240363072994,0.00597777389606865
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,0.0128580303210085,0.00468234636814354,0.00368063143944712,0.0220354292025698,0.00603948790520418
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UNC5D,Netrin receptor UNC5D,37598,-0.00715422771400844,0.00261136718296094,-0.0122725073926119,-0.00203594803540499,0.00615879013936838
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF5,Eukaryotic translation initiation factor 5,37562,0.0121143912178579,0.00442476767042503,0.00344184658382487,0.020786935851891,0.00619239612962467
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,-0.0184895069292948,0.00675859649915373,-0.0317363560676361,-0.00524265779095345,0.00623169274718229
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,40042,0.0155675122746637,0.00570546339077943,0.00438480402873604,0.0267502205205914,0.00636891268552179
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,-0.0112499765374719,0.00412735833480621,-0.0193395988736921,-0.0031603542012517,0.00642462843381134
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD109,CD109 antigen,40332,-0.00883409728168509,0.00324355467844091,-0.0151914644514293,-0.00247673011194091,0.00646481543058404
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MST1,Hepatocyte growth factor-like protein,37787,0.0164099232869111,0.00602656493925747,0.00459785600596645,0.0282219905678557,0.00647896322627256
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,0.014585369401241,0.00536968969465804,0.00406077759971127,0.0251099612027708,0.00661010880569153
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,0.00861316928328527,0.0031960459640945,0.00234891919366004,0.0148774193729105,0.00704894634818049
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD55,Complement decay-accelerating factor,39802,0.00686482863639755,0.00255202770639107,0.00186285433187106,0.011866802940924,0.00715398655659867
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NXPH1,Neurexophilin-1,39961,0.00984600793934414,0.00366206287064142,0.00266836471288697,0.0170236511658013,0.00718180994567155
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINC1,Antithrombin-III,37981,-0.00386197202225395,0.00143694403321142,-0.00667838232734834,-0.00104556171715956,0.00720493931756975
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLH1,Glutamate carboxypeptidase 2,37598,0.0282370411600953,0.0105135853697129,0.00763041383545815,0.0488436684847325,0.0072454394873165
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,0.015874669217833,0.00591370345392737,0.00428381044813535,0.0274655279875307,0.00727540037455026
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB2B,Ras-related protein Rab-2B,37900,0.0160006448705056,0.00597715561908605,0.00428541985709696,0.0277158698839143,0.00743822149053216
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDNRB,Endothelin receptor type B,37598,0.0123420718314805,0.00462970074118863,0.00326785837875073,0.0214162852842102,0.00768886346659746
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HLA_A,,37959,0.00850600933400583,0.00319117388041917,0.00225130852838425,0.0147607101396274,0.0076970009716599
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR2,Toll-like receptor 2,37714,0.00598978221233062,0.00224918233211552,0.00158138484138419,0.010398179583277,0.00775194616167639
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,-0.00813936935554046,0.00305989245388965,-0.0141367585651642,-0.00214198014591675,0.00782147889599433
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,-0.00890081002221168,0.00335650299249697,-0.0154795558875057,-0.00232206415691762,0.00801579362300629
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLL4,Delta-like protein 4,37628,0.0217439336026759,0.00822840347461563,0.00561626279242926,0.0378716044129225,0.00823826046877108
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,0.007772051461047,0.00294635609397665,0.00199719351685275,0.0135469094052412,0.00835158113031311
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARB1,Scavenger receptor class B member 1,39961,0.0151871941116882,0.00576129924980148,0.00389504758207734,0.0264793406412991,0.00839556770780379
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRCAM,Neuronal cell adhesion molecule,40359,0.00715829026131244,0.00271589587889482,0.00183513433867859,0.0124814461839463,0.00840450755108411
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,0.026347079673344,0.00999805342798195,0.00675089495449937,0.0459432643921886,0.00841642113993555
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40422,0.00526914254732052,0.00200015237893637,0.00134884388460523,0.00918944121003582,0.00843747521590709
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP3,Microfibril-associated glycoprotein 3,40042,0.0125591905588435,0.00484053104095097,0.00307174971857955,0.0220466313991074,0.00947926252678533
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37942,0.00835776290905563,0.00322746347150272,0.00203193450491031,0.014683591313201,0.00961973653477857
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,QSOX1,Sulfhydryl oxidase 1,37761,0.0113280906414617,0.00438419467533426,0.00273506907780659,0.0199211122051169,0.00978105366246121
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VCAN,Versican core protein,40471,-0.007525503422863,0.00291462113584748,-0.0132381608491241,-0.00181284599660195,0.00983222576568991
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,-0.017412847116073,0.00674700837295675,-0.0306369835270682,-0.00418871070507773,0.0098669510451504
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,0.010576244175636,0.00410791297112211,0.0025247347522367,0.0186277535990354,0.0100461203628047
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYH7B,Myosin-7B,37482,-0.0114828096090647,0.00446699111602351,-0.0202381121964708,-0.00272750702165864,0.0101634999871682
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,0.00980026315326655,0.00381863095105648,0.00231574648919584,0.0172847798173373,0.0102859989811816
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,0.0343545609961665,0.013430736748399,0.00803031696930438,0.0606788050230286,0.0105412426043503
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,0.00913921552016743,0.00357401802376004,0.00213414019359776,0.0161442908467371,0.0105652366611563
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FBN2,Fibrillin-2,37572,0.0152469179276279,0.00596313214815189,0.00355917891725022,0.0269346569380056,0.0105732024975442
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39961,0.0353358888556164,0.0138271375859648,0.00823469918712548,0.0624370785241073,0.0106115812993432
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC12A2,Solute carrier family 12 member 2,37562,-0.00711729488366109,0.00278670262809003,-0.0125792320347175,-0.00165535773260463,0.0106599150191552
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,0.0154831916442694,0.00606238078653228,0.0036009253026661,0.0273654579858726,0.0106612026177877
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37714,-0.00713656886433819,0.00284202937363009,-0.0127069464366532,-0.00156619129202321,0.012047966099258
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BGLAP,Osteocalcin,37998,-0.0222878530766569,0.00888750550129521,-0.0397073638591956,-0.00486834229411833,0.0121610433844802
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,38013,0.00624505466748044,0.00249661734176504,0.00135168467762097,0.0111384246573399,0.0123818052906414
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,-0.0150559172869159,0.00602107254105912,-0.0268572194673918,-0.00325461510644005,0.0124126318927013
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPC5,Glypican-5,40228,-0.0135520960177557,0.00542863252112343,-0.0241922157591576,-0.00291197627635374,0.0125558488653462
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM26,Tripartite motif-containing protein 26,37482,0.0133846259324322,0.00537516670920036,0.00284929918239948,0.0239199526824649,0.0127835926478992
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL14,C-X-C motif chemokine 14,40044,0.0147322474905281,0.00596283719530275,0.00304508658773474,0.0264194083933215,0.013496352180445
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLHL41,Kelch-like protein 41,37959,0.011417570874824,0.0046353191768249,0.00233234528824723,0.0205027964614008,0.0137839069484129
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40359,-0.00417400028940158,0.00169640096480547,-0.0074989461804203,-0.000849054398382871,0.0138847754254076
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100G,Protein S100-G,37959,-0.0106661610452738,0.00434057745128084,-0.0191736928497842,-0.00215862924076334,0.0140105107707727
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,-0.00739479168383766,0.00301235569424915,-0.013299008844566,-0.00149057452310932,0.014106395332078
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHRDL1,Chordin-like protein 1,40396,0.00725853813195456,0.00296375573167089,0.00144957689787961,0.0130674993660295,0.0143320018983281
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,-0.00610779590323127,0.00250074576221236,-0.0110092575971675,-0.00120633420929505,0.0146034986705692
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FRZB,Secreted frizzled-related protein 3,40176,-0.00631031866477884,0.00258407067376258,-0.0113750971853535,-0.00124554014420418,0.01461680332938
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39980,0.0112516151030084,0.00462375821889723,0.00218904899396985,0.020314181212047,0.0149675247272016
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCND2,G1/S-specific cyclin-D2,37714,-0.00871442052663537,0.00358997744042911,-0.0157507763098764,-0.00167806474339433,0.0152194255504349
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCB,Calcitonin gene-related peptide 2,37942,0.00943418450223473,0.00389095771425664,0.00180790738229172,0.0170604616221777,0.0153364820836556
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF9,Fibroblast growth factor 9,37457,-0.00960984156176982,0.00396886806122223,-0.0173888229617654,-0.00183086016177426,0.0154784726493751
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,0.0245601052178395,0.0101506590217566,0.00466481353519655,0.0444553969004824,0.015552899434979
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDI2,Protein DDI1 homolog 2,37671,0.0184960544578369,0.00765111249946542,0.00349987395888469,0.0334922349567891,0.0156438367405211
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RASA1,Ras GTPase-activating protein 1,39961,0.00764611349391513,0.00316584198664147,0.00144106320009785,0.0138511637877324,0.0157384432999111
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBR1,TGF-beta receptor type-1,37598,0.00507548618519509,0.00210379901865497,0.000952040108631353,0.00919893226175883,0.0158556704038693
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA11,Serpin A11,40536,0.0093676006844546,0.00390103003765709,0.00172158181064671,0.0170136195582625,0.0163475586857952
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECE1,Endothelin-converting enzyme 1,39961,-0.00822219917012669,0.00342407162249125,-0.0149333795502095,-0.00151101879004384,0.016348945650169
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37998,-0.011603561407035,0.00485216301297875,-0.0211138009124734,-0.00209332190159666,0.0167968842178653
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOH,Beta-2-glycoprotein 1,40332,0.00823455942236555,0.00344371013132644,0.00148488756496573,0.0149842312797654,0.0168055062342116
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,0.0131869037975524,0.00554130080506789,0.00232595421961932,0.0240478533754854,0.0173364474033735
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RALB,Ras-related protein Ral-B,37598,0.0068407998203683,0.00289198102678908,0.00117251700786171,0.0125090826328749,0.018023222603265
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40357,-0.00611435398365637,0.00258534513745509,-0.0111816304530683,-0.00104707751424439,0.0180417646230834
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,0.0157629929510967,0.0066696520225839,0.00269047498683221,0.0288355109153611,0.0181227138448029
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BSND,Barttin,37482,-0.00791599118226378,0.00335296851277839,-0.0144878094673094,-0.00134417289721813,0.0182457579063132
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,0.0104110284252209,0.00441469029569372,0.0017582354456612,0.0190638214047806,0.0183746004136832
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37987,0.00803685167233213,0.00341864978989768,0.00133629808413267,0.0147374052605316,0.0187430994550138
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STEAP4,Metalloreductase STEAP4,37541,-0.0173480976518213,0.00738651614494295,-0.0318256692959095,-0.00287052600773314,0.018858068678533
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLC,Galectin-10,40333,0.0149342961155476,0.0063876752965331,0.00241445253434276,0.0274541396967525,0.0194003159788616
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,0.0166095114531748,0.00711763462462391,0.0026589475889119,0.0305600753174376,0.0196331788192358
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40305,-0.00466771534341912,0.00200293665019978,-0.00859347117781068,-0.000741959509027557,0.0197956075769598
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCG3,Secretogranin-3,40379,-0.00755126825355237,0.00324186128626207,-0.013905316374626,-0.00119722013247871,0.0198556044862477
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THPO,Thrombopoietin,40042,0.00860359401857078,0.00370476282598593,0.00134225887963835,0.0158649291575032,0.0202292608360641
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP164,Centrosomal protein of 164 kDa,40044,0.0144142430906053,0.00620816551295439,0.00224623868521472,0.0265822474959959,0.0202554452134739
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40536,-0.00741415267427969,0.0032089302859047,-0.0137036560346529,-0.00112464931390647,0.0208744695327739
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCIN,Adseverin,37541,0.016630005968005,0.00719975170620487,0.00251849262384342,0.0307415193121665,0.0209145617889155
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,0.0107680058428176,0.00466641690196079,0.00162182871497449,0.0199141829706608,0.0210391008874114
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DIABLO,"Diablo homolog, mitochondrial",40314,0.0244596267158852,0.0106110443150492,0.00366197985838881,0.0452572735733816,0.0211732453683813
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37572,-0.00847490015582453,0.00368196306807678,-0.015691547769255,-0.00125825254239405,0.021365757417351
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTLA,B- and T-lymphocyte attenuator,37482,0.0199795176091416,0.00868673874376116,0.00295350967136969,0.0370055255469134,0.0214638266367547
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37544,-0.00905168839545872,0.00394966523051768,-0.0167930322472734,-0.00131034454364406,0.0219352422097646
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN7,Septin-7,37714,0.0117575203841987,0.00513625204978093,0.00169046636662802,0.0218245744017693,0.0220877624281985
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,0.0109814906081815,0.00480967002999515,0.00155453734939102,0.020408443866972,0.0224314179998098
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EVPL,Envoplakin,37714,-0.00770990663887508,0.00337718867581948,-0.0143291964434813,-0.00109061683426889,0.0224498712223781
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TJP3,Tight junction protein ZO-3,37541,-0.00979646087184224,0.00430912948109718,-0.0182423546547927,-0.00135056708889176,0.0230170131202229
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOSB,Protein fosB,39961,0.00860996308731776,0.00379843268700593,0.00116503502078613,0.0160548911538494,0.0234213723343117
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBPMS,RNA-binding protein with multiple splicing,37598,0.0142670571409497,0.00631079594661446,0.00189789708558532,0.026636217196314,0.0237917569692597
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN2,Ataxin-2,37541,0.0254800209874286,0.0112761240162853,0.00337881791550947,0.0475812240593477,0.0238597524013547
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNW1,Interferon omega-1,37562,-0.00809644590009369,0.00358739620679453,-0.015127742465411,-0.00106514933477641,0.0240298207972783
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,-0.00570777486315181,0.00254328983422545,-0.0106926229382337,-0.000722926788069926,0.0248329366283144
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMA1,Laminin subunit alpha-1,37562,-0.0122701934965047,0.00547172725259831,-0.0229947789115974,-0.00154560808141203,0.0249475482973789
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDRG1,Protein NDRG1,39961,0.0149609575003528,0.00668242776551777,0.00186339907993799,0.0280585159207676,0.0251797620884405
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,-0.00415547760163971,0.00185636359635221,-0.00779395025049004,-0.000517004952789382,0.0252043567809086
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,40128,-0.0379264872359142,0.0169720687471413,-0.0711917419803111,-0.00466123249151722,0.0254549368512452
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP112,Centrosomal protein of 112 kDa,37562,0.010273088686453,0.0046004545297059,0.00125619780822943,0.0192899795646766,0.0255618313545121
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,0.00923212777334957,0.00413651272528663,0.00112456283178777,0.0173396927149114,0.0256408682006807
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DGKZ,Diacylglycerol kinase zeta,40044,0.00757028961084158,0.00339872544946345,0.000908787729893216,0.01423179149179,0.0259353878145488
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC13A1,Solute carrier family 13 member 1,37900,0.0134632849120122,0.00605597389378559,0.00159357608019249,0.025332993743832,0.0262228384175713
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,-0.0117020523825702,0.0052710414929404,-0.0220332937087334,-0.00137081105640705,0.0264314226993016
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,0.023464955676075,0.010575190599719,0.00273758210062587,0.0441923292515242,0.0265131902531174
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37572,0.00841462644610795,0.00379610735205711,0.000974256036076018,0.0158549968561399,0.0266643698848812
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB2,Integrin beta-2,40221,-0.00616735923867834,0.00278583767928214,-0.0116276010900713,-0.000707117387285351,0.0268550206763792
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYB5A,Cytochrome b5,37482,0.0158448716819194,0.00717348672071095,0.00178483770932592,0.0299049056545128,0.0272051730059732
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,0.018920012797974,0.00857020139494785,0.00212241806387625,0.0357176075320718,0.0272858230690048
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKLR,Pyruvate kinase PKLR,40374,0.0142263185419545,0.00646226018575491,0.00156028857787485,0.0268923485060341,0.0277187401311425
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFDN2,Prefoldin subunit 2,39961,0.0119804894117496,0.00545437586437507,0.00128991271757447,0.0226710661059248,0.0280715396164844
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCN,Decorin,40042,-0.00485936742359974,0.00221530971582166,-0.00920137446661021,-0.00051736038058928,0.0282833071914683
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37863,0.00923085632264761,0.00422404032079337,0.000951737293892609,0.0175099753514026,0.0288830397846447
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,0.0142659709964488,0.00653317962142623,0.0014609389384534,0.0270710030544442,0.0290079969218348
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,0.00822247786172439,0.00377669181193584,0.000820161910330144,0.0156247938131186,0.0294855287960262
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNL1,Thioredoxin-like protein 1,37525,0.0203365180191804,0.00934621921727935,0.00201792835331293,0.038655107685048,0.0295799492096208
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPA2,Replication protein A 32 kDa subunit,37598,0.00692864457625059,0.00318530375287528,0.000685449220615052,0.0131718399318861,0.0296335547244056
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACTN4,Alpha-actinin-4,40044,0.0068580427620664,0.00315332646299163,0.000677522894602814,0.01303856262953,0.0296556079108613
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JCHAIN,Immunoglobulin J chain,40044,0.0130065636259474,0.00599358012181868,0.00125914658718279,0.024753980664712,0.0300156402761876
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF20,Fibroblast growth factor 20,37598,-0.00945380519310284,0.0043681838765244,-0.0180154455910907,-0.000892164795115009,0.030463759362682
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB39B,Ras-related protein Rab-39B,37562,0.0187474169978248,0.00867826193125843,0.00173802361255824,0.0357568103830913,0.0307695858492763
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKK3,Dickkopf-related protein 3,40536,-0.00617409384746095,0.00285956212457567,-0.0117788356116293,-0.000569352083292641,0.0308567883208883
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,0.00617693433098095,0.00287429089436762,0.000543324178020417,0.0118105444839415,0.0316498205140859
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB2A2,Mammaglobin-A,37562,-0.006711549600853,0.00312356830720663,-0.012833743482978,-0.000589355718728007,0.0316780109430973
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,0.0138137010392112,0.00643067357983847,0.00120958082272784,0.0264178212556947,0.0317244360765232
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,-0.00555906441741407,0.00258898741326697,-0.0106334797474173,-0.000484649087410813,0.0317926987935317
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,-0.00616235319833695,0.00287242309517406,-0.0117923024648781,-0.000532403931795788,0.0319431279164285
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOB,Apolipoprotein B-100,37987,-0.00468041688153101,0.00218334919138796,-0.00895978129665141,-0.000401052466410608,0.0320757540727965
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCLRE1C,Protein artemis,37482,-0.00665002586770337,0.00310492009265483,-0.0127356692493068,-0.0005643824860999,0.0322304502743237
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VGF,Neurosecretory protein VGF,37959,0.00634235306827492,0.00297313687904113,0.0005150047853543,0.0121697013511955,0.0329247088577667
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39980,0.00947962808233065,0.00446073641357161,0.000736584711730302,0.018222671452931,0.0335918238929764
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPB2,Carboxypeptidase B2,37981,0.00462679375733335,0.00218006457622598,0.000353867187930426,0.00889972032673628,0.0338290256215968
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLASP1,CLIP-associating protein 1,37482,0.0148019315990647,0.00697517632024153,0.0011305860113913,0.0284732771867381,0.0338492393478344
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNU13,NHP2-like protein 1,37562,0.0128794304239201,0.00607455207134241,0.000973308364089006,0.0247855524837512,0.0340056206284272
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LIFR,Leukemia inhibitory factor receptor,40341,0.00502407103752179,0.00237433303093586,0.000370378296887506,0.00967776377815607,0.0343609508558266
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TUBB3,Tubulin beta-3 chain,37541,-0.00573184313122644,0.00272636368427847,-0.0110755159524122,-0.000388170310040629,0.0355393530099193
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHP1,Calcineurin B homologous protein 1,37541,0.0150226500456038,0.00715865579035471,0.000991684696508561,0.029053615394699,0.0358775139050137
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRRT3,Proline-rich transmembrane protein 3,37628,0.00766733496272458,0.00366929242068925,0.000475521818173639,0.0148591481072755,0.0366733292152641
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,0.0140875979103654,0.00674193602103423,0.000873403309138321,0.0273017925115925,0.0366770972224109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX6,Peroxiredoxin-6,40489,-0.0121101883184448,0.00579772158798053,-0.0234737226308866,-0.000746654006002974,0.0367428953315674
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,0.00991965625135974,0.00475799580285116,0.000593984477771469,0.019245328024948,0.0371031995495564
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37482,-0.00519683944311629,0.00249721186020888,-0.0100913746891257,-0.00030230419710689,0.0374481987430745
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD276,CD276 antigen,40357,0.00725411309817651,0.00349764801287199,0.000398722992947413,0.0141095032034056,0.038095598228038
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53BP1,TP53-binding protein 1,37598,0.0180088505699357,0.00868521145392498,0.000985836120242729,0.0350318650196286,0.0381445076466127
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37998,0.011890283425654,0.00574240081592544,0.000635177826440132,0.0231453890248679,0.0384139784025782
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIF20B,Kinesin-like protein KIF20B,37541,0.0158419522313828,0.00766076434714823,0.000826854110972254,0.0308570503517933,0.0386658649851182
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKKL1,Dickkopf-like protein 1,40305,-0.0176194022630353,0.00853738159391264,-0.0343526701871041,-0.000886134338966553,0.039053429212505
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP6,Guanylate-binding protein 6,37562,-0.0095390979706008,0.0046274210536102,-0.0186088432356768,-0.000469352705524811,0.0392818420967835
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUSP29,Dual specificity phosphatase 29,37572,0.013408538681637,0.00652404035740876,0.000621419581115787,0.0261956577821581,0.0398745452603118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPS10,40S ribosomal protein S10,37562,-0.00846137282376417,0.00411960692953418,-0.0165358024056512,-0.00038694324187718,0.0400025228505636
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17F,Interleukin-17F,40044,0.0158424868092447,0.00772169169666748,0.000707971083776411,0.0309770025347129,0.0402168534858217
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD93,Complement component C1q receptor,39725,-0.00625710750069921,0.00306653838666159,-0.0122675227385559,-0.000246692262842496,0.0413230367315263
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37541,-0.00664147640089018,0.00325815159545916,-0.0130274535279901,-0.000255499273790229,0.0415281565474078
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSTN1,Calsyntenin-1,39961,-0.0104081530638805,0.00510814449977798,-0.0204201162834454,-0.000396189844315706,0.0416108509983358
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REST,RE1-silencing transcription factor,37482,-0.00714139578334122,0.00350552484895714,-0.0140122244872972,-0.000270567079385222,0.0416518681598323
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40357,0.0579387410972904,0.0284476940843086,0.00218126069204552,0.113696221502535,0.0416990292581918
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKCQ,Protein kinase C theta type,40044,0.00875951914954442,0.00430627377662453,0.00031922254736033,0.0171998157517285,0.0419554166180399
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRD1,Bromodomain-containing protein 1,37714,-0.006167809866611,0.00303276959039679,-0.0121120382637887,-0.000223581469433286,0.041999509717709
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARG1,Arginase-1,40227,0.0103350827415415,0.00512478194819624,0.000290510123076859,0.0203796553600061,0.0437450657826427
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPLA2,Acyl-protein thioesterase 2,37541,0.0213807380615925,0.01060705818133,0.000590904026185748,0.0421705720969993,0.0438508551792293
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX1,Peroxiredoxin-1,39953,-0.0173989998892176,0.00865704408990307,-0.0343668063054276,-0.000431193473007577,0.0444687673966802
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37942,0.00553848621494689,0.00275681718072704,0.000135124540721894,0.0109418478891719,0.0445554609431529
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,0.0126922539958978,0.0063381548327299,0.000269470523747165,0.0251150374680484,0.0452493451480199
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NINJ1,Ninjurin-1,39980,0.0109525531049715,0.00548383371808844,0.000204239017518166,0.0217008671924249,0.0458161199832806
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37541,-0.0124343040215444,0.00624182383663376,-0.0246682787413466,-0.000200329301742224,0.0463814099815261
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMA1,Proteasome subunit alpha type-1,39980,0.00902651216135266,0.00453391413454792,0.000140040457638742,0.0179129838650666,0.0465107722293945
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,0.0173079598984251,0.00869524690755825,0.000265275959610945,0.0343506438372393,0.0465558416974765
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST1,Cystatin-SN,36179,0.0202067057526156,0.0101801186520853,0.000253673194528369,0.0401597383107029,0.0471768019373106
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,-0.00614105796925238,0.00310035469463839,-0.0122177531707436,-6.43627677611395e-05,0.0476390817415816
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEX33,Testis-expressed protein 33,37714,-0.00761683307783157,0.00386461544598401,-0.0151914793519602,-4.21868037029181e-05,0.0487542268120265
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB6B,Ras-related protein Rab-6B,39961,0.00934167482951055,0.00474083615899997,4.96359578706033e-05,0.0186337137011505,0.0488023031293636
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TERF1,Telomeric repeat-binding factor 1,37598,-0.00571405643722173,0.00290233790597437,-0.0114026387329315,-2.54741415119586e-05,0.0489996661037642
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40536,-0.00665242799081195,0.00338198159424421,-0.0132811119155306,-2.37440660933062e-05,0.0491979805084693
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGER,Advanced glycosylation end product-specific receptor,40311,0.00773845688483232,0.00393918126880145,1.76615979814807e-05,0.0154592521716832,0.0494914743926217
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37959,0.015025132343708,0.00765637003910142,1.86470670692201e-05,0.0300316176203468,0.0497323012089787
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK6,Kallikrein-6,40387,0.00577053643712887,0.00295212998413034,-1.56383317665935e-05,0.0115567112060243,0.0506356321604047
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CABP2,Calcium-binding protein 2,37572,0.0124871724661403,0.00639198930432907,-4.11265703447235e-05,0.0250154715026252,0.0507737962822483
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37901,0.0082483984789572,0.00424604749807043,-7.38546172608517e-05,0.0165706515751752,0.0520845935869908
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP1,Retinol-binding protein 1,37572,0.0130956147881244,0.00674398924089118,-0.000122604124022282,0.0263138337002712,0.0521802435246995
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCLN,Nicalin,40044,0.0100591011325286,0.00518467207380147,-0.000102856132122298,0.0202210583971795,0.0523780725498542
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPSD1,Tryptase delta,37959,0.0072243307658702,0.0037295727061994,-8.56317382806251e-05,0.014534293270021,0.0527613040121486
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,-0.00601033597702728,0.00310289901320008,-0.0120920180428994,7.13460888448715e-05,0.0527660232780877
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COPE,Coatomer subunit epsilon,39961,0.00909369660292913,0.00469740977365199,-0.000113226553428771,0.018300619759287,0.0528985943551292
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPA,Apolipoprotein(a),37735,-0.0332674277650141,0.0172164165203053,-0.0670116041448124,0.000476748614784236,0.0533426785346297
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUMF1,Formylglycine-generating enzyme,37598,0.0126638046248073,0.0065552437918399,-0.000184473207198959,0.0255120824568135,0.0533984150480312
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFNB2,Ephrin-B2,37572,0.0109483038701185,0.00566790915240289,-0.000160798068591201,0.0220574058088281,0.0534266887209685
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3GL3,Endophilin-A3,37643,0.0156245426038312,0.00811489268702219,-0.000280647062732299,0.0315297322703947,0.0541988331420597
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,-0.00566281348627164,0.00294962473701599,-0.011444077970823,0.000118450998279698,0.0548996674737819
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,-0.00904895817184314,0.00472565401855561,-0.0183112400482121,0.000213323704525856,0.0555323056870752
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRELP,Prolargin,40357,0.00430391821877499,0.00225569117212174,-0.000117236478583613,0.00872507291613359,0.0564057967450199
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP13,Collagenase 3,39961,-0.00611012676256025,0.00320348228892034,-0.0123889520488441,0.000168698523723603,0.0564951545904039
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,-0.00974369136811694,0.00510885200791855,-0.0197570413036373,0.000269658567403408,0.056514258800299
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MASP1,Mannan-binding lectin serine protease 1,40192,0.0043941066351876,0.0023045775024696,-0.000122865269652816,0.00891107854002801,0.0565793958553849
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,-0.0067428064617266,0.0035400917176767,-0.0136813862283729,0.000195773304919723,0.0568371506197232
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37628,0.0486592844642782,0.0256413171728007,-0.00159769719441112,0.0989162661229675,0.0577587001084774
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFHD1,EF-hand domain-containing protein D1,37959,0.006415256532201,0.00338650946093559,-0.000222302011232756,0.0130528150756347,0.0581990347606914
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC1A4,Neutral amino acid transporter A,37572,0.00967169401469112,0.00514227998509963,-0.000407174756104155,0.0197505627854864,0.0600187764445876
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AFP,Alpha-fetoprotein,40182,-0.012675628436037,0.00674346526538096,-0.0258928203561837,0.000541563484109678,0.0601687220755355
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37598,-0.00927123746083477,0.004932555957565,-0.0189390471376622,0.000396572215992637,0.0601845663748658
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FN1,Fibronectin,38013,0.00479904945783374,0.00255723868528031,-0.00021313836531568,0.00981123728098315,0.0605871340660071
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C7,Complement component C7,37678,0.00577817643502916,0.00308356586179382,-0.000265612654086728,0.011821965524145,0.0609714990420457
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPB41L5,Band 4.1-like protein 5,37572,0.0116765947337975,0.00623465580856853,-0.000543330650996855,0.0238965201185918,0.0611108867303573
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,-0.00539383010905241,0.00288035191714574,-0.0110393198666581,0.000251659648553247,0.061141177488754
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37541,0.0218641796087657,0.0117158739678298,-0.00109893336818066,0.0448272925857121,0.0620355497287308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSTN,Growth/differentiation factor 8,40042,-0.0092596776595658,0.00496669368185427,-0.0189943972760002,0.000475041956868561,0.0622907187575089
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAD2,Glutamate decarboxylase 2,37598,-0.00859887871804224,0.00462900885153392,-0.0176717360670487,0.000473978630964248,0.0632472041198035
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,0.0040238408816766,0.00216951405108982,-0.000228406658459439,0.00827608842181264,0.0636579678672017
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAPS,Calcyphosin,37942,0.0171490284858991,0.00925592885127976,-0.000992592062609186,0.0352906490344075,0.0639383780156993
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAG,S-arrestin,37541,-0.00967156724467091,0.005235177691524,-0.0199325155200579,0.000589381030716126,0.064708974212942
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANSC4,MANSC domain-containing protein 4,37562,0.0118222480746141,0.00640405282505124,-0.000729695462486293,0.0243741916117146,0.0649064237861133
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37959,0.0060911502113833,0.00330246442239309,-0.000381680056507143,0.0125639804792737,0.0651430099899017
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN4B,Sodium channel subunit beta-4,37628,0.00750916241294455,0.00408952694865475,-0.000506310406418754,0.0155246352323079,0.0663515755004275
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLPS,Colipase,40311,0.0121929555801734,0.00665519706547757,-0.000851230668162608,0.0252371418285095,0.0669559590516235
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCP2,Non-specific lipid-transfer protein,39980,0.0138327319063051,0.00759590795851852,-0.00105524769239125,0.0287207115050014,0.0686144148487671
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HCG22,Protein PBMUCL2,37562,-0.00948149585794126,0.00520693403930759,-0.0196870865749841,0.000724094859101604,0.0686393047989233
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,-0.0131334144567896,0.00721883988127313,-0.0272823406240849,0.00101551171050573,0.0688844290718135
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBM25,RNA-binding protein 25,37482,-0.00823209512759061,0.00453048592562561,-0.0171118475418168,0.00064765728663559,0.0692332409911504
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,0.0102760248093298,0.00566366290851588,-0.000824754491361329,0.0213768041100209,0.0696425529026684
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,0.0150686599597415,0.008316235181004,-0.00123116099502635,0.0313684809145093,0.0700151467878184
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37598,0.0120507148856236,0.00667005388302796,-0.00102259072511117,0.0251240204963584,0.0708335955719973
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOM2,Myomesin-2,37562,0.00826569684855881,0.00457675227260148,-0.000704737605740084,0.0172361313028577,0.0709384580467213
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,-0.0078533598051928,0.00436491953434265,-0.0164086020925044,0.000701882482118797,0.0720103024141955
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,40203,-0.00584402533477088,0.00325918637732249,-0.0122320306343229,0.000543979964781192,0.0729771819262392
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX1B,Syntaxin-1B,37572,0.00752946378654038,0.00420455019227763,-0.000711454590323768,0.0157703821634045,0.0733501471925726
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN2B,Sodium channel subunit beta-2,37572,-0.00517188922985965,0.00290270631961158,-0.0108611936162984,0.000517415156579055,0.0748135684719436
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,-0.00798407258156864,0.00448356822365028,-0.0167718662999232,0.000803721136785913,0.0749779010586764
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY75,Lymphocyte antigen 75,40341,0.00670541748106574,0.00377234706386379,-0.00068838276410728,0.0140992177262388,0.0755020584651118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF6,Fibroblast growth factor 6,37598,-0.00745577402616771,0.00420326757781684,-0.0156941784786887,0.000782630426353298,0.0761186734963208
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GJA8,Gap junction alpha-8 protein,37482,0.0107737766415116,0.0060902887745521,-0.00116318935661052,0.0227107426396337,0.0769157347783862
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP2,Retinol-binding protein 2,40305,-0.0130537487994801,0.00738676982256658,-0.0275318176517106,0.00142432005275037,0.0772173944986636
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39530,0.00489614534968485,0.00278245098509754,-0.000557458581106331,0.010349749280476,0.078487111124008
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAPN3,Calpain-3,37900,0.0063695961228898,0.00362194198319518,-0.000729410164172749,0.0134686024099523,0.0786659179091469
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,-0.0207335575742135,0.0117965319523995,-0.0438547602009165,0.00238764505248944,0.078835685192632
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,-0.00618602149478846,0.00352762938123678,-0.0131001750820126,0.000728132092435633,0.0795238662320313
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,0.00763726627276002,0.00436026644913858,-0.0009088559675516,0.0161833885130716,0.0798728936925245
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A16,Protein S100-A16,39934,0.0105661985292116,0.00604145983372427,-0.00127506274488799,0.0224074598033111,0.0803198405156549
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNC,Tenascin,40403,-0.00803301495219922,0.00459460402644251,-0.0170384388440265,0.000972408939628099,0.0804212081346689
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRDT,Bromodomain testis-specific protein,37562,0.00633032756852997,0.00362212566385364,-0.000769038732623165,0.0134296938696831,0.0805423389260196
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN7,Tetraspanin-7,37541,-0.0156810223977132,0.00898371648547592,-0.033289106709246,0.00192706191381964,0.0809223961353225
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAMDC2,MAM domain-containing protein 2,37990,0.00576456024995361,0.00331173868587283,-0.000726447574357141,0.0122555680742644,0.081768604341457
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTX3,Pentraxin-related protein PTX3,40341,0.00828098210982776,0.00476324237495875,-0.0010549729450914,0.0176169371647469,0.082138969959343
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,0.00553573056822047,0.00319047129673296,-0.000717593173376136,0.0117890543098171,0.0827497506748387
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,0.00840760540406771,0.00484835435503102,-0.00109516913179309,0.0179103799399285,0.0829170081118427
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,0.0148328948515121,0.00864499897768899,-0.00211130314475832,0.0317770928477825,0.0862263980802564
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KEL,Kell blood group glycoprotein,39961,0.00590799919462274,0.00346058205793711,-0.000874741638933998,0.0126907400281795,0.0877998805415187
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL12,Stromal cell-derived factor 1,40044,0.00669650259525845,0.00394087988925164,-0.00102762198767476,0.0144206271781917,0.089293831922825
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEO1,Neogenin,37959,-0.00353392774294625,0.002081623902522,-0.00761391059188936,0.000546055105996863,0.0895915298759982
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUK1,Guanylate kinase,37562,-0.00662163564350725,0.00391455079817512,-0.0142941552079305,0.00105088392091598,0.0907566827308696
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,-0.0295018335617496,0.0174612664174814,-0.0637259157400131,0.00472224861651393,0.09113211070445
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENO1,Alpha-enolase,40299,0.0129690704531559,0.00768706342231361,-0.00209757385457875,0.0280357147608906,0.0915981600795359
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRG3,Proteoglycan 3,37998,-0.00822544942755381,0.0048842452720267,-0.0177985701607261,0.00134767130561851,0.0921896576009454
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEB,Nebulin,37562,0.00595215774600357,0.00354990027835584,-0.00100564679957387,0.012909962291581,0.0936228004752952
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPN1,Epsin-1,37714,0.00725592976310075,0.00432837284236006,-0.00122768100792497,0.0157395405341265,0.0936904247130462
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPCAM,Epithelial cell adhesion molecule,40358,0.0162157723488453,0.0096954805691256,-0.00278736956664086,0.0352189142643315,0.0944437867793171
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKD2,Serine/threonine-protein kinase D2,37562,0.00771363488432461,0.00461928976035409,-0.00134017304596941,0.0167674428146186,0.0949680396152251
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCN1,Transcobalamin-1,37766,0.00540063594514376,0.00323548053317211,-0.000940905899873566,0.0117421777901611,0.0951029850579022
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUSP3,Dual specificity protein phosphatase 3,39961,0.0136324100993752,0.00823846138601601,-0.00251497421721619,0.0297797944159666,0.0979999843002443
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCS,Copper chaperone for superoxide dismutase,40228,0.00771490334811799,0.00468231472342188,-0.0014624335097889,0.0168922402060249,0.0994405918724681
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B4,Protein ATP1B4,37482,-0.00680488246895032,0.00413424478397932,-0.0149080022455498,0.00129823730764914,0.0997920821779327
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX3,Syntaxin-3,37942,0.00620323471275479,0.00377420627275504,-0.00119420958184509,0.0136006790073547,0.100284935223922
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,0.0091548564018997,0.00558388309379382,-0.0017895544619362,0.0200992672657356,0.101130161669646
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICOSLG,ICOS ligand,40305,-0.00303865477796639,0.00185563442016577,-0.0066756982414913,0.000598388685558517,0.101539876613543
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40330,0.00773006079320612,0.00472083067088883,-0.00152276732173599,0.0169828889081482,0.101559097948629
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,0.0107464235060153,0.00657937529139357,-0.00214915206511608,0.0236419990771467,0.102415677344016
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRR4,Proline-rich protein 4,37577,0.0110049887830478,0.00674428294373505,-0.00221380578667293,0.0242237833527685,0.102755993953594
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1D,V-type proton ATPase subunit D,40305,0.00416683186750106,0.0025536937704062,-0.000838407922495089,0.00917207165749722,0.102765059917102
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYO6,Unconventional myosin-VI,37959,0.00596492705545374,0.00365593037568988,-0.00120069648089842,0.0131305505918059,0.102792219643234
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNNI3,"Troponin I, cardiac muscle",40042,0.0134236444436016,0.00823308753887226,-0.00271320713258801,0.0295604960197912,0.103026449187097
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,-0.00696515843627853,0.00430230731331555,-0.015397680770377,0.00146736389781995,0.105485176263511
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,0.00891149002256881,0.00550747039781829,-0.00188315195715505,0.0197061320022927,0.105670211164299
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP4,Caspase-4,37714,0.0269427752547959,0.0167204510226433,-0.00582930874958492,0.0597148592591768,0.107123653152405
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNF75D,Zinc finger protein 75D,37714,0.00934478218321499,0.00582288057639629,-0.00206806374652174,0.0207576281129517,0.108553189684389
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCNE1,G1/S-specific cyclin-E1,37598,0.0146613691487026,0.00915197206648312,-0.00327649610160428,0.0325992343990095,0.109181812932265
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,-0.00470917115683098,0.00294045644094926,-0.0104724657810915,0.00105412346742957,0.109288081481515
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLU,Clusterin,38013,-0.00516573551849118,0.00323231506737713,-0.0115010730505503,0.00116960201356799,0.110032125647997
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA1549,UPF0606 protein KIAA1549,37714,0.0110778111082962,0.00693427200404371,-0.00251336201962946,0.0246689842362219,0.110168114194505
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37562,0.0185642127090912,0.0116482762373022,-0.00426640871602113,0.0413948341342035,0.111020524351864
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1A,Interleukin-1 alpha,40044,0.00833307081052344,0.00522908036924928,-0.00191592671320515,0.018582068334252,0.111045566862838
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDA1,DET1- and DDB1-associated protein 1,37562,0.00631219155059694,0.00397209230367716,-0.00147310936461031,0.0140974924658042,0.112053994284115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNL2,Interferon lambda-2,37541,0.0100835357168194,0.0063502743448966,-0.0023630019991779,0.0225300734328168,0.112335419516397
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTB,Lymphotoxin-beta,37900,0.00548395770977442,0.00345508961247458,-0.00128801793067577,0.0122559333502246,0.112488278021874
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,0.0130550225712065,0.0082288803803326,-0.00307358297424538,0.0291836281166584,0.112652697911845
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,0.0124931886648646,0.0078764823281918,-0.00294471669839137,0.0279310940281205,0.112728374250897
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,0.00455678745066718,0.0028784781464739,-0.00108502971642166,0.010198604617756,0.113432428160611
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37541,-0.0140664331081878,0.00892929317431981,-0.0315678477298546,0.00343498151347903,0.115208344246306
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACTN2,Alpha-actinin-2,37562,0.00837416700343544,0.00532535792177659,-0.00206353452324668,0.0188118685301176,0.115856957377299
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDM1,Nuclear protein MDM1,37572,0.00480535746031119,0.00305731947370609,-0.00118698870815275,0.0107977036287751,0.116031473006332
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,0.00566064044827473,0.0036032207210949,-0.00140167216507127,0.0127229530616207,0.116207316571959
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNLZ,DNL-type zinc finger protein,37541,-0.0146041209738865,0.00932934052639089,-0.0328896284056127,0.00368138645783961,0.117514043510792
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37562,-0.00794387823827919,0.00508875295990353,-0.0179178340396901,0.00203007756313174,0.118532362579747
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPA4,Carboxypeptidase A4,37410,0.00669768520374435,0.00430125185476725,-0.00173276843159946,0.0151281388390882,0.119459801094636
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOP56,Nucleolar protein 56,37562,0.0167678904282371,0.0107853675985022,-0.0043714300648272,0.0379072109213015,0.120044336962342
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,-0.0120011464377497,0.00774109429895074,-0.0271736912636932,0.00317139838819372,0.121089092024458
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH23,Cadherin-23,37942,-0.00399405031306015,0.00257845989196263,-0.00904783170130691,0.00105973107518661,0.121403692074729
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,0.0124266893949415,0.00802815642354343,-0.00330849719520363,0.0281618759850866,0.121673478154734
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSCA,Prostate stem cell antigen,37901,0.0392966868638891,0.0253941664366361,-0.0104758793519176,0.0890692530796958,0.121773708925186
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAS6,Growth arrest-specific protein 6,40429,-0.00384440808685099,0.00249403084034733,-0.00873270853393176,0.00104389236022978,0.123228643624562
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALLD,Palladin,37598,-0.00624880819315153,0.00405672909292111,-0.0141999972152769,0.00170238082897384,0.123497597472025
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OTOA,Otoancorin,37541,0.00826826774140079,0.00537450019677667,-0.00226575264428148,0.0188022881270831,0.1239688024914
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFL4,Insulin growth factor-like family member 4,37598,0.0117701327031004,0.00769137417569627,-0.00330496068126425,0.0268452260874651,0.125965816193366
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSPN,Claspin,39925,0.00504681384532366,0.00331582125816978,-0.0014521958206891,0.0115458235113364,0.128019398388478
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST6,Cystatin-M,39992,0.0070585606835964,0.00464355352762658,-0.0020428042305517,0.0161599255977445,0.128511873506011
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,0.0078592463200848,0.00519111944757639,-0.00231534779716492,0.0180338404373345,0.13005497222957
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IKZF2,Zinc finger protein Helios,39980,0.0137783765993594,0.00912318471831857,-0.00410306544854502,0.0316598186472638,0.130997563411352
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HRG,Histidine-rich glycoprotein,37934,0.00463965851633863,0.00307823084513924,-0.00139367394013427,0.0106729909728115,0.131770428611426
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MATN3,Matrilin-3,40203,0.00456152704386504,0.00303381423214489,-0.00138474885113894,0.010507802938869,0.132714294504645
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEG1,Protein LEG1 homolog,37231,-0.0102353407275441,0.00681721106487327,-0.0235970744146957,0.00312639295960751,0.133277598137564
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNPY2,Protein canopy homolog 2,40042,0.00889613995802926,0.00593965022104889,-0.00274557447522657,0.0205378543912851,0.134217199569625
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAP1A,Ras-related protein Rap-1A,37598,0.0101840939593904,0.00681161671191422,-0.00316667479596147,0.0235348627147423,0.134910594307412
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EP300,Histone acetyltransferase p300,37598,0.0043525315882883,0.00291234678494652,-0.00135566811020687,0.0100607312867835,0.135066354742993
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2RB,Interleukin-2 receptor subunit beta,40044,0.00562082794121229,0.00376902570491776,-0.00176646244042651,0.0130081183228511,0.13589741547775
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM5,Intercellular adhesion molecule 5,40359,0.00638285761046801,0.00428342659212124,-0.00201265851008962,0.0147783737310256,0.136210182656163
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CR1,Complement receptor type 1,37959,0.00527491427006371,0.00354348460574009,-0.00167031555718687,0.0122201440973143,0.136609899898606
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL11,Interleukin-11,40044,0.00922584907887971,0.00619854389504228,-0.00292329695540315,0.0213749951131626,0.136668367093896
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37572,0.00782865000588444,0.00526669877083666,-0.00249407958495541,0.0181513795967243,0.137185887540668
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,-0.00552668900457233,0.00372296459526582,-0.0128236996112933,0.00177032160214867,0.137704063449134
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLMH,Bleomycin hydrolase,40536,0.00463852840996032,0.00313544333860576,-0.00150694053370698,0.0107839973536276,0.139056983140711
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR4,Toll-like receptor 4,37598,-0.00410645207327397,0.00277668256253633,-0.00954874989584518,0.00133584574929724,0.139189440855642
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLINT1,Clathrin interactor 1,37482,-0.00663656702574704,0.0044910386613694,-0.0154390028020311,0.00216586875053698,0.139502772327082
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1R,Complement C1r subcomponent,38013,0.00286233739663913,0.0019439231688179,-0.000947752014243957,0.00667242680752222,0.140921534195167
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GH1,Somatotropin,40330,-0.0249828733029518,0.0169870837156986,-0.058277557385721,0.00831181077981741,0.14139257144508
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39980,0.00832949594659784,0.00571052336614531,-0.00286312985104697,0.0195221217442426,0.144689356091406
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINI1,Neuroserpin,37642,0.00455003985682007,0.00312064430563785,-0.00156642298223011,0.0106665026958702,0.144851946123566
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,-0.00932124992860062,0.00639409811630691,-0.0218536822365622,0.00321118237936092,0.144922529165614
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CADPS,Calcium-dependent secretion activator 1,37572,-0.00642379020231121,0.00440879327434805,-0.0150650250200334,0.00221744461541097,0.145129142816486
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALY,Neuron-specific vesicular protein calcyon,37562,-0.00542545712748756,0.00372987002869236,-0.0127360023837246,0.00188508812874947,0.14580484934535
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLI2,Zinc finger protein GLI2,37598,-0.00478155514452245,0.00328901346765302,-0.0112280215411224,0.00166491125207747,0.146026700863386
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,0.00619360556285757,0.00426856347503141,-0.002172778848204,0.0145599899739191,0.146808942167131
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMEM132A,Transmembrane protein 132A,37628,-0.00888086994425545,0.00613549541831577,-0.0209064409641544,0.00314470107564346,0.147792573425315
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,0.00333230857572734,0.00230685992566791,-0.00118913687858176,0.00785375403003644,0.148615555001983
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,-0.00853224081111872,0.00591677966306767,-0.0201291289507313,0.00306464732849391,0.149314640561058
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPSG1,Tryptase gamma,37598,-0.00383872218302472,0.00266703577689044,-0.00906611230572997,0.00138866793968054,0.150083237489032
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX2,Peroxiredoxin-2,37763,0.00881939647276558,0.00613904970558198,-0.0032131409501751,0.0208519338957063,0.150853441496173
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTTG1,Securin,37714,0.00580574970425791,0.00404530318989134,-0.00212304454792911,0.0137345439564449,0.151258585755409
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,0.0175970578447354,0.0123235229583687,-0.00655704715366727,0.0417511628431381,0.153333760594038
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40403,0.00380594609205923,0.00267512887682536,-0.00143730650651848,0.00904919869063694,0.154838333915412
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TET2,Methylcytosine dioxygenase TET2,37697,0.0139998856799804,0.00985863546220684,-0.00532303982594504,0.0333228111859058,0.155612811800821
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,-0.00462704529413362,0.00326775894882715,-0.0110318528338348,0.0017777622455676,0.15680834476757
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TTN,Titin,37562,0.00905390423136133,0.0063986503610979,-0.00348745047639055,0.0215952589391132,0.157100771826602
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,0.0078030313671038,0.00552042101415591,-0.00301699382064178,0.0186230565548494,0.15753710707533
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTF4,Neurotrophin-4,39980,0.00560192946282145,0.00397434297713267,-0.00218778277235859,0.0133916416980015,0.15870048326377
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37482,-0.00646069972391636,0.00459409910645256,-0.0154651339725634,0.00254373452473067,0.159657734612454
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C9orf40,Uncharacterized protein C9orf40,37901,0.0112601716846851,0.00804547549171469,-0.00450896027907567,0.0270293036484459,0.161666470350911
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37714,0.00615583905521333,0.00440086841018491,-0.00246986302874909,0.0147815411391758,0.161902872558709
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,-0.00513295670554525,0.00368857722421909,-0.0123625680650147,0.00209665465392416,0.164072702345656
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLITRK6,SLIT and NTRK-like protein 6,40042,0.00461462233997542,0.00331739592512446,-0.00188747367326853,0.0111167183532194,0.164233888339351
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,0.00618745423352185,0.00445279946071237,-0.00254003270947439,0.0149149411765181,0.164684610625554
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,-0.00640733060725945,0.00463158351439912,-0.0154852342954817,0.00267057308096282,0.166565200953132
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37901,0.00356084993805688,0.00257780236346263,-0.00149164269432987,0.00861334257044363,0.167194004924591
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37562,0.00553807570151846,0.00401395781615704,-0.00232928161814933,0.0134054330211862,0.167701174294952
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCT,Secretin,37572,0.00617515149296253,0.00449151376302086,-0.00262821548255836,0.0149785184684834,0.16920185990418
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NLGN1,Neuroligin-1,37572,0.00934881764073186,0.00682319310248956,-0.00402464084014768,0.0227222761216114,0.170662629986234
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,-0.0115089037702093,0.0084121630716837,-0.0279967433907094,0.00497893585029076,0.171292461145644
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFR4,Fibroblast growth factor receptor 4,37671,0.0071292743912019,0.00523635507863085,-0.00313398156291457,0.0173925303453184,0.17338032817669
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITM2A,Integral membrane protein 2A,40341,0.00779521761112208,0.00573438089056822,-0.00344416893439163,0.0190346041566358,0.174044673444253
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSLP,Thymic stromal lymphopoietin,40042,0.00802550059909808,0.005922830149421,-0.00358324649376708,0.0196342476919632,0.175433653525919
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPNMB,Transmembrane glycoprotein NMB,39957,-0.00371440759255161,0.0027421988221078,-0.0090891172838829,0.00166030209877967,0.175585107602243
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRL,Prolactin,40471,0.00998886927549457,0.00743735624008168,-0.00458834895506553,0.0245660875060547,0.179269240677774
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,-0.00313569924385029,0.0023497797698109,-0.00774126759267967,0.00146986910497908,0.182070495749883
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,0.00471137563429043,0.00353241458036224,-0.00221215694321956,0.0116349082118004,0.182307065677091
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37562,0.00497557151478132,0.00373644950740652,-0.00234786951973546,0.0122990125492981,0.183004667045055
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLMP,CXADR-like membrane protein,40489,0.00262403844964285,0.0019780020745369,-0.00125284561644948,0.00650092251573518,0.184656429080955
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRNN,Cornulin,39857,-0.00854695204373385,0.00644665697485979,-0.021182399714459,0.00408849562699134,0.184926936260254
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MELTF,Melanotransferrin,37990,0.00376939045047551,0.00284702542840221,-0.00181077938919282,0.00934956029014383,0.185533706178716
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,40042,-0.00432013678132506,0.00328002026466328,-0.0107489765000651,0.00210870293741497,0.187822208143062
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,0.01180342306713,0.00896821861048459,-0.00577428540941983,0.0293811315436798,0.188150110908815
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37482,-0.00339310246955143,0.00257939473630639,-0.00844871615271195,0.0016625112136091,0.188376952584794
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,-0.00801159910758949,0.00610422147948684,-0.0199758732073837,0.00395267499220472,0.189385045603355
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL20,Interleukin-20,40044,0.00646828484935922,0.00495235971468568,-0.00323834019142471,0.0161749098901431,0.191537283277303
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,0.00453516738057875,0.00347499153839967,-0.00227581603468459,0.0113461507958421,0.191885446975965
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LACRT,Extracellular glycoprotein lacritin,37863,0.00675413965772731,0.00518805307462047,-0.00341444436852882,0.0169227236839834,0.192985232648147
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,-0.0219408779812866,0.016939732562566,-0.0551427538039159,0.0112609978413427,0.195262557535563
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOX9,Transcription factor SOX-9,37572,0.00343482828072681,0.0026563562848958,-0.00177163003766896,0.00864128659912258,0.196013047025143
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARG2,"Arginase-2, mitochondrial",37900,0.00558932194144164,0.00433706813623073,-0.00291133160557059,0.0140899754884539,0.197513166205503
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37482,0.00744846117810503,0.00580907232442907,-0.00393732057777595,0.018834242933986,0.199791163633544
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALMS1,Alstrom syndrome protein 1,37714,-0.00564417241524896,0.00441123670479251,-0.0142901963566423,0.00300185152614436,0.200743818323151
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EXTL1,Exostosin-like 1,37562,-0.00593985231069477,0.0046507313139546,-0.0150552856860458,0.00317558106465624,0.20155895001206
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PODXL2,Podocalyxin-like protein 2,40411,0.00337108756658374,0.00264769219562215,-0.00181838913683568,0.00856056427000315,0.202959480937463
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,0.00603638906913328,0.00474197540924144,-0.00325788273297993,0.0153306608712465,0.203051450637921
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL21R,Interleukin-21 receptor,37598,-0.00694255670130432,0.00547303071424109,-0.0176696969012168,0.00378458349860821,0.204640788508003
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,0.0076276174955975,0.00603825239896565,-0.00420735720637518,0.0194625921975702,0.206533940380737
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSG3,Desmoglein-3,40419,-0.00409856757586326,0.00324826624625788,-0.0104651694185287,0.00226803426680219,0.20704969540717
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,0.00670381371658782,0.00532957406466001,-0.0037421514501458,0.0171497788833215,0.208467786238855
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,-0.0050791915470647,0.00404764987829413,-0.0130125853085212,0.0028542022143918,0.209555793357443
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,0.00624479080938408,0.00497930965093869,-0.00351465610645575,0.0160042377252239,0.209810591697831
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYTL1,Cytokine-like protein 1,37998,0.00281004853964168,0.00224116870779827,-0.00158264212764293,0.00720273920692628,0.209924794753783
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40403,-0.0032838179353294,0.00264201391930283,-0.00846216521716293,0.00189452934650414,0.213914748359544
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP73,Tumor protein p73,37572,-0.00424321201000872,0.00342303681722132,-0.0109523641717625,0.00246594015174507,0.215143869192695
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OBP2B,Odorant-binding protein 2b,40184,0.00796268899492042,0.00642879960167388,-0.00463775822436038,0.0205631362142012,0.215513427683954
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPC1,Glypican-1,40489,-0.00352408828799144,0.00284743885327235,-0.00910506844040524,0.00205689186442237,0.215869771260572
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FBLN2,Fibulin-2,37998,0.00372191532714315,0.003007321885243,-0.00217243556793312,0.00961626622221943,0.215879233941749
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OMP,Olfactory marker protein,37541,-0.00614272451282864,0.00496725137005522,-0.0158785371981369,0.00359308817247959,0.216241248126765
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,0.00338516521531313,0.00274831844164606,-0.00200153893031315,0.00877186936093941,0.218071181848046
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGLON5,IgLON family member 5,37482,-0.011321573927884,0.00921192026156635,-0.0293769376405541,0.00673378978478604,0.219088956589983
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POMC,Pro-opiomelanocortin,37628,-0.00814605801098165,0.00664976537273207,-0.0211795981415365,0.00488748211957321,0.220591712263818
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37572,-0.00866343796535786,0.00709361504992452,-0.0225669234632099,0.0052400475324942,0.221994083708109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F13B,Coagulation factor XIII B chain,37934,0.00306582926921344,0.00252045083868659,-0.00187425437461227,0.00800591291303917,0.223860998925521
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PVALB,Parvalbumin alpha,40417,0.013312851099043,0.0109455728624181,-0.00814047171129652,0.0347661739093824,0.223897312466726
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIF1L,Allograft inflammatory factor 1-like,37628,0.00688060684073374,0.00565894737436131,-0.00421093001301443,0.0179721436944819,0.224052023333679
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37692,0.00662731782550204,0.00545392180609674,-0.00406236891444757,0.0173170045654517,0.224331621717548
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PXDNL,Peroxidasin-like protein,37900,-0.00694525485257311,0.00571575104354476,-0.0181481268979208,0.00425761719277462,0.224346233414618
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD82,CD82 antigen,37714,-0.00496392175784767,0.00409891594919698,-0.0129977970182738,0.00306995350257842,0.225904404764332
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CENPJ,Centromere protein J,37714,0.0086822716234525,0.00717300778596068,-0.00537682363703044,0.0227413668839354,0.226143645227491
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,-0.00366939268123162,0.00305685526658963,-0.00966082900374728,0.00232204364128405,0.230012388226487
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.00586300196308645,0.00488585795924345,-0.00371327963703071,0.0154392835632036,0.230163252513754
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FZD10,Frizzled-10,37572,0.00715245989333635,0.0059630320222597,-0.00453508287029265,0.0188400026569654,0.230368085194933
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHH,Sonic hedgehog protein,37598,-0.00506436884132588,0.00424600388580775,-0.0133865364575091,0.00325779877485732,0.232993649466554
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK15,Kallikrein-15,37880,-0.00588436849154497,0.00499778806984792,-0.0156800331084469,0.00391129612535695,0.239058927505893
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RUVBL1,RuvB-like 1,39980,0.0122766581563926,0.0104623571464949,-0.00822956185073746,0.0327828781635226,0.240648520838748
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL4A1,Collagen alpha-1(IV) chain,40359,-0.00450576619427453,0.00384383088971707,-0.01203967473812,0.00302814234957092,0.241131438903654
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECTIN1,Nectin-1,37598,0.00365443091939291,0.00311762301176165,-0.00245611018365993,0.00976497202244575,0.241144032628054
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F2,Prothrombin,38013,-0.0016806465170783,0.00143634915675361,-0.00449589086431537,0.00113459783015877,0.241988471776531
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYH4,Myosin-4,37562,-0.00541340118850417,0.00463855862535389,-0.0145049760941978,0.00367817371718946,0.243213899391873
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37598,0.0046793553668771,0.00400963280185831,-0.00317952492476518,0.0125382356585194,0.243220067598645
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,0.00978941162406858,0.00841704228827607,-0.00670799126095251,0.0262868145090897,0.244831933064646
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,-0.00371307123234919,0.00319944144110225,-0.00998397645690961,0.00255783399221122,0.245847874411336
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH6,Cadherin-6,40359,-0.00426609844430953,0.00368164105832758,-0.0114821149186316,0.00294991803001254,0.246575845559639
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DHODH,Dihydroorotate dehydrogenase,37562,0.00545949463627866,0.00471280336249881,-0.00377759995421899,0.0146965892267763,0.246706083223389
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37562,-0.00548016024347539,0.00477772823517071,-0.01484450758441,0.0038841870974592,0.251393387838599
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37883,0.00470709468716987,0.00410595225250616,-0.0033405717277422,0.0127547611020819,0.251646981025131
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40359,0.00315764547947268,0.00276456285810525,-0.00226089772241361,0.00857618868135896,0.253393832868295
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPON1,Spondin-1,40379,0.00364141572116627,0.00319717420731149,-0.00262504572516425,0.00990787716749678,0.254741901550321
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOP1,DNA topoisomerase 1,37901,-0.0117673407754798,0.0104282648050162,-0.0322067397933116,0.00867205824235206,0.259167643880112
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPM1B,Protein phosphatase 1B,37598,0.00697904403948204,0.00619694119860063,-0.0051669607097752,0.0191250487887393,0.260098095173025
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,0.0124662015436823,0.0111176154258031,-0.0093243246908917,0.0342567277782563,0.262179378788264
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMOD1,Leiomodin-1,37959,0.00395800393361802,0.00353635742136818,-0.00297325661226362,0.0108892644794997,0.263061134923748
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP290,Centrosomal protein of 290 kDa,37714,0.00583147362530977,0.00521578662725693,-0.00439146816411381,0.0160544154147333,0.263568889265514
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,0.00275588826011785,0.00247003441176811,-0.00208537918694764,0.00759715570718335,0.264558896289144
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XG,Glycoprotein Xg,40458,0.00323171906849851,0.00290709405775714,-0.00246618528470549,0.00892962342170251,0.266298267040199
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37541,-0.00774018460889866,0.0069641759412139,-0.0213899694536779,0.00590960023588057,0.266404304009357
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37598,-0.00676958185947802,0.00610669355843608,-0.0187387012340127,0.0051995375150567,0.267644163606133
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,0.00402701197356174,0.00364261448773291,-0.00311251242239476,0.0111665363695182,0.268947966506227
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,-0.00372818420135898,0.00337603444918685,-0.0103452117217652,0.00288884331904723,0.269479643821367
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,-0.00528985810217595,0.00479781498394486,-0.0146935754707079,0.00411385926635597,0.270240395239588
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37541,-0.00458701053209629,0.00417223824374426,-0.012764597489835,0.00359057642564247,0.271608437778357
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMMD9,COMM domain-containing protein 9,37900,0.00420404538554423,0.00382807207775281,-0.00329897588685128,0.0117070666579397,0.272130369936938
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NENF,Neudesin,37900,0.0115223019722734,0.0105608263239547,-0.00917691762267789,0.0322215215672246,0.275274078663791
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,-0.00241839063145268,0.00222262392694059,-0.00677473352825623,0.00193795226535087,0.276576495390051
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTPN,Myotrophin,40042,0.00349923372123443,0.00321979264501743,-0.00281155986299973,0.00981002730546859,0.277147079730028
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00155646140414529,0.00143948266013987,-0.00126492460972884,0.00437784741801943,0.279598809036895
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF12,Fibroblast growth factor 12,37598,-0.00506147238924366,0.00471064866410876,-0.0142943437708968,0.0041713989924095,0.282629738952679
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HBZ,Hemoglobin subunit zeta,37990,-0.010926532952582,0.0102386529213289,-0.0309942926783866,0.00914122677322262,0.285907505080662
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37572,0.00872041279710907,0.00818496615172795,-0.00732212086027771,0.0247629464544958,0.28670628115054
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,0.00274205903846274,0.0025901933551713,-0.00233471993767301,0.00781883801459849,0.289787477419419
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSB,Lupus La protein,39961,0.00620849167390025,0.00587135820941568,-0.00529937041655449,0.017716353764355,0.290336411727004
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPGN,Epigen,37900,0.00509781067020692,0.00482730127366825,-0.00436369982618286,0.0145593211665967,0.29097010045281
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL15A1,Collagen alpha-1(XV) chain,37998,0.00266602025548889,0.00252608340737286,-0.00228510322296191,0.00761714373393968,0.291262724605389
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UPK3A,Uroplakin-3a,37541,-0.00517477668035176,0.00491001623738771,-0.0147984085056317,0.00444885514492815,0.291937846311102
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,-0.00355572073061348,0.00338222466150348,-0.0101848810671603,0.00307343960593334,0.293138509612979
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,0.00903282599117082,0.00861390595806619,-0.0078504296866389,0.0259160816689805,0.294362959556365
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,40042,0.00647274428350411,0.00617482288544664,-0.00562990857197131,0.0185753971389795,0.29454071962303
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37562,-0.00399016674516887,0.00380682303393626,-0.0114515398916839,0.0034712064013462,0.294583358177208
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRA2,GDNF family receptor alpha-2,40305,-0.00215685354011167,0.00206133515112344,-0.00619707043631362,0.00188336335609028,0.295420905967049
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTXR,Neuronal pentraxin receptor,40359,-0.00344673542081391,0.00329666550558011,-0.00990819981175093,0.0030147289701231,0.295797790138453
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,-0.00712401621388408,0.00681517471591828,-0.0204817586570839,0.00623372622931574,0.295892312794015
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENOPH1,Enolase-phosphatase E1,37900,-0.00583976763510783,0.00559270230326856,-0.0168014641495142,0.00512192887929855,0.296422562734258
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,0.00891140159457242,0.00860636873808807,-0.0079570811320802,0.025779884321225,0.300478005009868
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTNAP4,Contactin-associated protein-like 4,37572,0.0102826638868752,0.00993896468883081,-0.00919770690323317,0.0297630346769836,0.300883706298444
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPT,Dermatopontin,40536,0.00265215848432604,0.00257130249379799,-0.00238759440351801,0.0076919113721701,0.302347444620224
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIRREL1,Kin of IRRE-like protein 1,37541,-0.0062156479046666,0.00605442742649345,-0.0180823256605938,0.00565102985126056,0.304614388134555
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN15,Tetraspanin-15,37562,-0.00508201755162341,0.00497711138439302,-0.0148371558650337,0.00467312076178692,0.307236458717221
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37562,0.00400724280128933,0.00392956331242958,-0.00369470129107266,0.0117091868936513,0.307857335069903
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRING1,SREBP regulating gene protein,37482,0.00566449570821477,0.00563227160916552,-0.00537475664574966,0.0167037480621792,0.314568314284332
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN3B,Sodium channel subunit beta-3,37541,-0.0045143799703412,0.0045020593129311,-0.0133384162236862,0.00430965628300376,0.316006468036451
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LHB,Lutropin subunit beta,39980,0.00827123272249597,0.00826209988025243,-0.00792248304279879,0.0244649484877907,0.316791459334525
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AFAP1,Actin filament-associated protein 1,37671,0.00826155288619014,0.00828652699500408,-0.00798004002401785,0.0245031457963981,0.318789467767789
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL31,Interleukin-31,37598,-0.00567015447667801,0.00568764700707067,-0.0168179426105365,0.00547763365718049,0.318819522566195
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SULT1A1,Sulfotransferase 1A1,40471,-0.012411643352437,0.0124684743318485,-0.03684985304286,0.0120265663379861,0.319536363259852
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,0.00921271401062362,0.00925505450460972,-0.00892719281841144,0.0273526208396587,0.319547442293309
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP2BP,LRP2-binding protein,37572,0.0084557397197106,0.0085042889398726,-0.0082126666024397,0.0251241460418609,0.320099451950483
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37482,-0.00316042547797488,0.00318223815436614,-0.00939761226053252,0.00307676130458275,0.320657499255642
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,-0.00923927258287131,0.00933052051718413,-0.0275270927965522,0.00904854763080958,0.322084747787729
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,-0.00534513860267536,0.00539994459392819,-0.0159290300067746,0.0052387528014239,0.322265427230316
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,0.00670585878579338,0.00679819277661913,-0.00661859905638011,0.0200303166279669,0.323946098953755
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A3,Protein S100-A3,37900,-0.00441683456213168,0.00448068992279483,-0.0131989868108096,0.00436531768654619,0.324274147249541
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37572,-0.00378268148167753,0.00383806641617553,-0.0113052916573816,0.00373992869402651,0.324362549348547
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,0.00409811302129876,0.00416107847939063,-0.00405760079830688,0.0122538268409044,0.324706556825077
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLNS1A,Methylosome subunit pICln,37572,0.00323576684961343,0.00328900115108884,-0.0032106754065207,0.00968220910574756,0.325224896175106
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOL1,Apolipoprotein L1,37987,-0.00623558296731585,0.00635851126537318,-0.0186982650474473,0.00622709911281558,0.326774448532754
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DENND2B,DENN domain-containing protein 2B,37562,-0.00500730992318227,0.00511659771202394,-0.0150358414387492,0.00502122159238465,0.327775681602787
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALM3,Paralemmin-3,37562,0.00686781185729734,0.00706749383814305,-0.00698447606546304,0.0207200997800577,0.331194643706173
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL25,Interleukin-25,37429,0.00331201460277716,0.00341440438761481,-0.00338021799694787,0.0100042472025022,0.33205838870586
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,0.00527217803190247,0.00549047107446175,-0.00548914527404255,0.0160335013378475,0.336951516124433
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRTAP,Cartilage-associated protein,37572,0.00454726103946231,0.00473731699963862,-0.00473788027982938,0.013832402358754,0.337132749385403
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDAC8,Histone deacetylase 8,37598,0.00585500567541174,0.00611238721064058,-0.00612527325744381,0.0178352846082673,0.33813493014608
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,-0.00473510580871162,0.00494925657411235,-0.0144356486939718,0.00496543707654859,0.338720627586867
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RANGAP1,Ran GTPase-activating protein 1,39980,0.00463931241506978,0.00485052598083333,-0.00486771850736353,0.0141463433375031,0.338857029658481
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THBS4,Thrombospondin-4,40355,0.00419053037402899,0.00438636925046647,-0.0044067533568853,0.0127878141049433,0.339413809906639
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,0.00416501901682617,0.00436574008058273,-0.00439183154111598,0.0127218695747683,0.340086248763498
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL24,Interleukin-24,40044,0.00455989785541052,0.00478873681969914,-0.00482602631119979,0.0139458220220208,0.34100368724242
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NXPE4,NXPE family member 4,37562,-0.00337078807450585,0.00354570753681516,-0.0103203748466636,0.00357879869765186,0.341790837497505
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,0.00365858919945634,0.0038489960729065,-0.00388544310344041,0.0112026215023531,0.34185743903611
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINF2,Alpha-2-antiplasmin,37755,0.00125725366275812,0.00132587065461336,-0.00134145282028406,0.0038559601458003,0.343020646106746
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORN4,MORN repeat-containing protein 4,37482,0.0072937649843702,0.00771541971873477,-0.00782845766434995,0.0224159876330903,0.344498215216781
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MLLT1,Protein ENL,37482,-0.00660271206418085,0.00700615870762339,-0.0203347831311227,0.00712935900276099,0.345997463138288
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CR2,Complement receptor type 2,40403,0.00423577654439608,0.00451977487705748,-0.00462298221463658,0.0130945353034288,0.348687683222734
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCL2,Phosducin-like protein 2,37482,0.00491768476133203,0.00527389095058044,-0.00541914150180564,0.0152545110244697,0.351116870405337
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP350,Centrosome-associated protein 350,37482,-0.00341528635302606,0.00366519714671627,-0.0105990727605899,0.00376850005453782,0.351449310806162
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37482,-0.005134724507536,0.00552046522010166,-0.0159548363389353,0.00568538732386326,0.352323431101991
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPT,Microtubule-associated protein tau,39961,0.00478773308767578,0.00516429779482928,-0.00533429059018962,0.0149097567655412,0.353897828845707
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BEX3,Protein BEX3,37482,-0.00432311992299048,0.00467105310317561,-0.0134783840052147,0.0048321441592337,0.354716314873079
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDAN1,Codanin-1,37942,-0.0020884037520709,0.00226541144143685,-0.00652861017728713,0.00235180267314533,0.356615429961874
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,-0.002892113168606,0.00314367895647379,-0.00905372392329463,0.00326949758608263,0.357601554041474
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,0.00600695920375545,0.00653120367289534,-0.00679419999511942,0.0188081184026303,0.357729573009787
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK12,Kallikrein-12,39980,0.0128146237067082,0.0139441558336439,-0.0145159217272338,0.0401451691406502,0.358111929019547
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC2L,C-type lectin domain family 2 member L,37572,0.00445800239193306,0.0048583679197627,-0.00506439873080183,0.013980403514668,0.358849066945085
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.00137816384788557,0.00150738686325134,-0.00157631440408706,0.00433264209985819,0.360586862291296
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSLNL,Mesothelin-like protein,37572,-0.00335780469205362,0.00368062898481237,-0.0105718375022859,0.00385622811817862,0.361632313946338
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC44A4,Choline transporter-like protein 4,37572,0.00622867277627783,0.00685911782073015,-0.00721519815235326,0.0196725437049089,0.363849164498301
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRTG,Protogenin,40489,-0.00220658281614677,0.00244183323999833,-0.0069925759665435,0.00257941033424996,0.366190203306831
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37572,0.00690549015354381,0.0076432855565152,-0.00807534953722599,0.0218863298443136,0.366292330682477
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC4A1,Band 3 anion transport protein,37998,-0.00402757465564044,0.00450476650823363,-0.0128569170117783,0.00480176770049746,0.371300553788271
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL13,Interleukin-13,40044,0.0041616265863184,0.00465685496222744,-0.00496580913964738,0.0132890623122842,0.371519743256797
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTX2,Neuronal pentraxin-2,37998,-0.00284209202013297,0.00318421603979079,-0.00908315545812292,0.00339897141785697,0.372110696630746
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH4,Cadherin-4,37541,0.00432469596505903,0.00485709538422715,-0.00519521098802619,0.0138446029181443,0.373274333389839
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMRK2,Nicotinamide riboside kinase 2,37482,-0.00378415312056719,0.00426341464528072,-0.0121404458253174,0.00457213958418302,0.37477911658954
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37942,-0.00267426737239804,0.00302568703079326,-0.00860461395275283,0.00325607920795674,0.376790464093782
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,0.00371051786326338,0.0041986765731076,-0.00451888822002751,0.0119399239465543,0.37685542084608
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEF,Thyrotroph embryonic factor,37562,0.00367406510928775,0.00419768617699153,-0.00455339979761565,0.0119015300161912,0.381448707577366
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37541,-0.00673694428654276,0.00770589545558972,-0.0218404993794986,0.0083666108064131,0.381993556782514
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAPPA,Pappalysin-1,40044,0.00398802196318843,0.00456422379653063,-0.00495785667801161,0.0129339006043885,0.382264122159039
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,-0.00494665401931109,0.00566187408080909,-0.0160439272176969,0.00615061917907474,0.382309741043288
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MN1,Transcriptional activator MN1,37572,-0.00506728971029321,0.00584078502658937,-0.0165152283624084,0.00638064894182195,0.385645657421395
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTKN2,Rhotekin-2,37562,-0.00441616945849682,0.00513614576196677,-0.0144830151519517,0.00565067623495804,0.389903070888485
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,-0.00563116805970428,0.00655082942829733,-0.018470793739167,0.00720845761975848,0.390018972834069
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,-0.00217242045050894,0.0025435720458974,-0.00715782166046783,0.00281298075944996,0.393074428413348
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL3,Interleukin-3,37482,-0.00501113047265227,0.00588759848121121,-0.0165508234958262,0.00652856255052171,0.394711011661239
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.00293574538492928,0.00347759715315365,-0.00388034503525188,0.00975183580511044,0.398579393348187
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,0.00223434724198386,0.00265061655843677,-0.00296086121255221,0.00742955569651994,0.399266880976701
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEX101,Testis-expressed protein 101,37572,-0.00323082828930758,0.00384557925300387,-0.0107681636251952,0.00430650704658,0.400844717977708
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,-0.00414393393865358,0.00494669723164592,-0.0138394605126796,0.00555159263537242,0.402204849928962
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37900,-0.00348693352650558,0.00416470602895445,-0.0116497573432563,0.00467589029024513,0.402462428814292
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAG3,Lymphocyte activation gene 3 protein,40305,0.00333359544000316,0.0039925176234967,-0.00449173910205037,0.0111589299820567,0.403752400300741
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLGAP5,Disks large-associated protein 5,37959,-0.0043616739946548,0.00524774451057702,-0.0146472532353858,0.00592390524607616,0.405902389166523
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RL2,Interleukin-1 receptor-like 2,40044,0.00322803213955324,0.00392491493435982,-0.00446480113179201,0.0109208654108985,0.410835460339595
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,0.00306169610415476,0.00373034034903878,-0.00424977097996124,0.0103731631882708,0.411800663294075
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40403,-0.0026337047386416,0.00323134708565181,-0.00896714502651914,0.00369973554923594,0.415056692323355
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF7,Fibroblast growth factor 7,37482,0.00644143535350735,0.00792496195629673,-0.00909149008083424,0.0219743607878489,0.416345684565919
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,0.00393599191835103,0.00484256101672818,-0.00555542767443621,0.0134274115111383,0.416352520651191
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37598,0.00232792281073121,0.00287497976385072,-0.0033070375264162,0.00796288314787862,0.418116936824503
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRX,Cone-rod homeobox protein,40042,0.00845632647450103,0.0104495001786595,-0.0120246938756715,0.0289373468246736,0.418379942869977
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB5,Serpin B5,40042,0.00383757433210056,0.00474519025028461,-0.00546299855845727,0.0131381472226584,0.418683218908422
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.00356430778025308,0.00441345199884979,-0.00508605813749252,0.0122146736979987,0.419334655963482
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLK,STE20-like serine/threonine-protein kinase,37714,0.00612274488875978,0.00760584603843619,-0.00878471334657516,0.0210302031240947,0.420831165342647
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSC1,Hamartin,37598,0.00597144950646041,0.00744906613138142,-0.00862872011104718,0.020571619123968,0.422777265008632
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP152,Centrosomal protein of 152 kDa,37482,0.00324161227158781,0.00406093524998607,-0.00471782081838489,0.0112010453615605,0.424744159984964
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GKN1,Gastrokine-1,39602,0.00216532047414334,0.00271658257073322,-0.00315918136449378,0.00748982231278046,0.425419875798052
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBLN1,Cerebellin-1,37541,-0.00765367159962253,0.00962564235700638,-0.026519930619355,0.01121258742011,0.426550212933843
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTR,Methionine synthase,37562,0.00506618306242875,0.00637993879637582,-0.00743849697846785,0.0175708631033253,0.42716311775923
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,0.00568963993316765,0.00721076639811802,-0.00844346220714367,0.019822742073479,0.430095802403603
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF5,Fibroblast growth factor 5,40044,-0.00245833105270514,0.00313015513841915,-0.00859343512400667,0.00367677301859639,0.432248390121235
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,0.00419974940666309,0.00537916183003796,-0.00634340778021132,0.0147429065935375,0.434967077425862
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.00253741713509781,0.00325465528916502,-0.00384170723166563,0.00891654150186125,0.435624088160309
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMBN,Ameloblastin,40044,-0.00224461027244236,0.0028813678805681,-0.00789209131835584,0.00340287077347112,0.43598648905457
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSP90B1,Endoplasmin,39878,0.00530290687143888,0.00681792544000189,-0.00806022699096482,0.0186660407338426,0.436705388750952
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRD3,Bromodomain-containing protein 3,37562,0.00366560089897014,0.00471773465933631,-0.00558115903332903,0.0129123608312693,0.437182660214536
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK3,Prostate-specific antigen,37998,-0.00429092989346261,0.00557934646134801,-0.0152264489577047,0.00664458917077948,0.441862834166925
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL9,Interleukin-9,37714,-0.00432665133324973,0.00562774881088435,-0.0153570390025831,0.00670373633608358,0.442021725392436
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA4,Carbonic anhydrase 4,40536,-0.00173437927012596,0.00226844713034456,-0.00618053564560129,0.00271177710534938,0.444540786378164
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOX2,Transcription factor SOX-2,37937,-0.00173505376311188,0.00227667168438431,-0.00619733026450513,0.00272722273828136,0.446013056033438
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,0.0105324521796705,0.0138396880141776,-0.0165933363281175,0.0376582406874586,0.44665143566978
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERVV_1,,37562,-0.0035805074001198,0.00471286674837312,-0.0128177262269311,0.00565671142669151,0.447429508118456
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRN1,Neuritin,37959,0.0027112113417197,0.00357640487141237,-0.00429854220624856,0.00972096488968795,0.448414587958978
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDAC9,Histone deacetylase 9,37541,-0.00471337446876721,0.00621960941019361,-0.0169038089127467,0.00747705997521227,0.448569496506377
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPM3,Tropomyosin alpha-3 chain,37562,0.00312733763107535,0.0041359814647244,-0.00497918603978448,0.0112338613019352,0.449585137663813
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37482,0.00363769810436998,0.00482335110017302,-0.00581607005196914,0.0130914662607091,0.450751889830554
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBQLN3,Ubiquilin-3,37562,-0.00327912377651815,0.00439951547587257,-0.0119021741092284,0.00534392655619209,0.456081090887994
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PITHD1,PITH domain-containing protein 1,37457,-0.00596454047112601,0.00802727594884771,-0.0216980013308675,0.00976892038861551,0.457474403503767
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB6,Integrin beta-6,40044,-0.0021730036878044,0.00292677626436607,-0.00790948516596191,0.0035634777903531,0.457822060216031
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HIP1,Huntingtin-interacting protein 1,37562,-0.00244759922422721,0.00331837220243455,-0.00895160874099894,0.00405641029254451,0.460776638764287
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAG,Myelin-associated glycoprotein,37572,0.00334107370406234,0.0045632793416903,-0.00560295380565065,0.0122851012137753,0.464080904421452
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP15,Matrix metalloproteinase-15,37990,0.00355013406893152,0.00486558621096843,-0.0059864149045666,0.0130866830424296,0.465621915688667
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KHDC3L,KH domain-containing protein 3,37482,-0.00486425022976038,0.00667122579123361,-0.0179398527805783,0.00821135232105748,0.465929807474343
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,0.00289028498679271,0.00401268996707415,-0.00497458734867262,0.010755157322258,0.471361675282099
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.00412102929343125,0.0057234463148594,-0.00709692548369317,0.0153389840705557,0.471521881378838
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,0.00400532320166176,0.00556677237261003,-0.00690555064865389,0.0149161970519774,0.471840313760636
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37541,0.00283283491032761,0.00394065044505423,-0.00489083996197869,0.0105565097826339,0.472230802175085
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,-0.00295260492529143,0.004111051681969,-0.0110102662219507,0.00510505637136782,0.472639602282185
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC25A,M-phase inducer phosphatase 1,37482,0.00287270594300159,0.00400579771909452,-0.00497865758642368,0.0107240694724268,0.473302393937298
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37541,-0.00269821938134891,0.00376484208465109,-0.010077309867265,0.00468087110456722,0.473579052600093
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,0.0065681764378066,0.00916501743366413,-0.0113952577321751,0.0245316106077883,0.473598324766901
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PYDC1,Pyrin domain-containing protein 1,37628,0.00297666441312382,0.00416814970283216,-0.00519290900442721,0.0111462378306748,0.475150003228719
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,-0.0035346830107707,0.00495204070745031,-0.0132406827973733,0.00617131677583191,0.475374033153178
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,METAP1,Methionine aminopeptidase 1,39961,0.00211714266572584,0.00298578113744752,-0.0037349883636713,0.00796927369512298,0.478288614264145
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ODAM,Odontogenic ameloblast-associated protein,39934,-0.00368580613885675,0.00520597284347738,-0.0138895129120724,0.00651790063435892,0.478958615716933
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,0.00296193344627508,0.00418920415232124,-0.00524890669227455,0.0111727735848247,0.479552459710955
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,0.00597538952265168,0.00848191635730466,-0.0106491665376654,0.0225999455829688,0.481142802393679
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESR1,Estrogen receptor,37598,0.00399278909299135,0.00568880904558585,-0.00715727663635691,0.0151428548223396,0.482774343614195
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACRV1,Acrosomal protein SP-10,37598,-0.00241329790675404,0.00344238887491602,-0.00916038010158943,0.00433378428808135,0.483282193050985
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,0.00231770655508347,0.00332261374902365,-0.00419461639300289,0.00883002950316982,0.485467786349229
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC123,Cell division cycle protein 123 homolog,37482,0.0043724626175099,0.00626938723253195,-0.00791553635825273,0.0166604615932725,0.485545788871016
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNMA2,Paraneoplastic antigen Ma2,37541,0.00297015387926011,0.0042604445507512,-0.00538031744021223,0.0113206251987325,0.485723516554327
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSL3,Insulin-like 3,37942,-0.00405153912920432,0.00582254036027487,-0.0154637182353431,0.00736063997693443,0.486542890044131
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYBB2,Beta-crystallin B2,37942,0.0046330566965762,0.00670708632277952,-0.00851283249607167,0.0177789458892241,0.489721725641038
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,-0.00536231760784209,0.0077673777413794,-0.0205863779809457,0.00986174276526153,0.4899775509824
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NME1,Nucleoside diphosphate kinase A,37598,-0.00148011515812376,0.00214495905269805,-0.00568423490141193,0.00272400458516441,0.49017898240804
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UNG,Uracil-DNA glycosylase,37900,0.00228110145200075,0.00330591710911934,-0.00419849608187316,0.00876069898587466,0.490202547289806
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,-0.00213107495478795,0.0031174070057768,-0.00824119268611049,0.00397904277653459,0.494234798666449
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37598,0.00245374087173946,0.00360705924755336,-0.00461609525346513,0.00952357699694405,0.496351344421684
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM171A2,Protein FAM171A2,37959,0.0106646526089979,0.0157037066629555,-0.0201146124503948,0.0414439176683907,0.497075430749959
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EXOSC10,Exosome component 10,37562,0.00415760436561168,0.00612479743477067,-0.00784699860653882,0.0161622073377622,0.497267071437531
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37562,0.00415400269791704,0.00613584653880398,-0.00787225651813876,0.0161802619139729,0.498414322720192
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37714,0.00494535810394916,0.00731128799615102,-0.00938476636850683,0.0192754825764052,0.498798261180083
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,0.003951822713601,0.00584714332513304,-0.00750857820365975,0.0154122236308618,0.499144451891847
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPHA2,Glycoprotein hormone alpha-2,37901,0.00322339280720684,0.0047855414410389,-0.00615626841722941,0.0126030540316431,0.500596883304727
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,-0.00421640188662765,0.00627514991523841,-0.0165156957204949,0.00808289194723963,0.501646220069407
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VIM,Vimentin,40042,0.00773021266880534,0.0115093912071824,-0.0148281940972723,0.0302886194348829,0.501820360564421
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXK,Tyrosine-protein kinase TXK,37714,0.00492287849565542,0.0074277414523603,-0.00963549475097077,0.0194812517422816,0.507489880330097
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37572,-0.00250914149843037,0.00379790926521837,-0.00995304365825837,0.00493476066139763,0.50883948745683
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,0.00231295823269753,0.00350540512654612,-0.00455763581533286,0.00918355228072792,0.509375097797549
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGR,Progesterone receptor,37598,0.00661693295385643,0.0101186582696977,-0.013215637254751,0.0264495031624638,0.513165876114405
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESPL1,Separin,37482,-0.0036462395700596,0.00560575339822851,-0.0146335162305875,0.00734103709046828,0.515415675456065
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNF830,Zinc finger protein 830,37900,-0.00512574496881602,0.00788177944269785,-0.0205740326765038,0.0103225427388718,0.515491229219722
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,-0.00297908387151222,0.00459911648724211,-0.0119933521865067,0.00603518444348231,0.517155075093086
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,0.00417374105918475,0.00644509141363999,-0.00845863811154963,0.0168061202299191,0.517264990314687
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,-0.00383288524786301,0.00592756579655801,-0.0154509142091167,0.00778514371339069,0.517888940854359
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.00311490901215812,0.00482948830015704,-0.00635088805614968,0.0125807060804659,0.518953358506542
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37541,-0.00447214049397628,0.00695942850563312,-0.0181126203650172,0.00916833937706464,0.520493844037707
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRND,Prion-like protein doppel,37942,0.00331027463607739,0.00523764113839402,-0.00695550199517489,0.0135760512673297,0.527386928786983
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDHR1,Cadherin-related family member 1,39961,0.00265900881874637,0.00427190680789367,-0.00571392852472523,0.011031946162218,0.533661252345717
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,0.00432624041341199,0.00700084622406935,-0.00939541818576393,0.0180478990125879,0.53661072856912
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMY2B,Alpha-amylase 2B,39311,-0.00289432774870429,0.00468551453042692,-0.0120779362283411,0.00628928073093247,0.536770558591306
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORF4L2,Mortality factor 4-like protein 2,37482,-0.00218566411061461,0.00356044200334243,-0.00916413043716579,0.00479280221593656,0.539309061179346
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,-0.00149147194907361,0.00243619225182953,-0.00626640876265949,0.00328346486451227,0.540406199159063
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,-0.00346682741258513,0.00567973948988851,-0.0145991168127666,0.00766546198759636,0.541617443555356
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCUN1D2,DCN1-like protein 2,37482,-0.00481975625125514,0.00791023414955878,-0.0203238151843904,0.0106843026818801,0.542331992707922
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37901,0.00326492295749991,0.0053674864407829,-0.00725535046643458,0.0137851963814344,0.543013500431982
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTF3,Neurotrophin-3,40341,-0.00205274391963656,0.00338907270024823,-0.00869532641212308,0.00458983857284997,0.544726048429539
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP2,Metalloproteinase inhibitor 2,37990,-0.00146490798013059,0.00243420772553204,-0.00623595512217338,0.0033061391619122,0.547316868459938
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOE,Apolipoprotein E,38013,-0.00439117359155103,0.00732219601082225,-0.0187426777727626,0.00996033058966058,0.548711415521113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNM1,Dynamin-1,37901,0.00661864006907154,0.0110660078396628,-0.0150707352966676,0.0283080154348107,0.549779617161454
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EVI2B,Protein EVI2B,37482,0.00246319442399226,0.0041207412184537,-0.005613458364177,0.0105398472121615,0.550013686530056
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FRMD7,FERM domain-containing protein 7,37572,-0.00193988737274972,0.00325795397441811,-0.00832547716260921,0.00444570241710977,0.55156556012411
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERCC1,DNA excision repair protein ERCC-1,37482,0.00194362152528546,0.00328491601983092,-0.00449481387358315,0.00838205692415407,0.554074664370483
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCARE,Photoreceptor cilium actin regulator,37541,0.00494206500556602,0.00844847834946431,-0.011616952559384,0.0215010825705161,0.558581265255821
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB118,Beta-defensin 118,37541,-0.00333126710662063,0.00571474140740284,-0.0145321602651302,0.00786962605188892,0.559953659121713
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,-0.00285288485353981,0.00497427536579869,-0.0126024645705053,0.00689669486342563,0.566297267654909
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAGEA3,Melanoma-associated antigen 3,37714,0.0047000826176832,0.00827604451430364,-0.0115209646303519,0.0209211298657183,0.570102891374532
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,-0.00434671491575686,0.00767725204330296,-0.0193941289206307,0.0107006990891169,0.571280368474151
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL6B,Myosin light chain 6B,37572,0.00511883831651063,0.00905758043633302,-0.0126340193387021,0.0228716959717234,0.57198540500142
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,0.00357446861360492,0.0063768889898375,-0.00892423380647658,0.0160731710336864,0.575122762020247
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YY1,Transcriptional repressor protein YY1,37598,-0.00153706819250209,0.00274394289508154,-0.0069151962668619,0.00384105988185773,0.575374598546242
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4C,C-type lectin domain family 4 member C,40341,-0.00247589898458897,0.00442734550167555,-0.0111534961678731,0.00620169819869511,0.576013481923581
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37572,-0.00197302439570953,0.00352943441228219,-0.00889071584378262,0.00494466705236355,0.57615761782565
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC10A,C-type lectin domain family 10 member A,40228,-0.00194715823043108,0.00349979583001917,-0.00880675805726865,0.0049124415964065,0.577970360085918
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMMR,Hyaluronan mediated motility receptor,37460,-0.00263964708727023,0.00476258849311888,-0.0119743205337832,0.00669502635924277,0.579419818401246
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,-0.00376185831432994,0.0068623564715454,-0.0172120769985589,0.00968836036989905,0.583572463313525
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.00277624715448483,0.00507394653909318,-0.0071686880621378,0.0127211823711075,0.584279946427725
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFRC,Transferrin receptor protein 1,40391,0.00210306614870702,0.0038467822779531,-0.00543662711608104,0.00964275941349509,0.584587099073475
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMY2A,Pancreatic alpha-amylase,39695,-0.00249709616949628,0.00457799778176493,-0.0114699718217555,0.00647577948276298,0.585447944042979
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOM1,Myomesin-1,37541,0.00247127739338094,0.00458913755407615,-0.00652343221260832,0.0114659869993702,0.590237028833056
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCUN1D1,DCN1-like protein 1,37541,0.00394571850454991,0.00733355578533466,-0.010428050834706,0.0183194878438058,0.590561203640446
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPHS2,Podocin,37598,-0.00545217498653534,0.0102513111194452,-0.025544744780648,0.0146403948075773,0.594837852037056
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37572,0.0015329357998149,0.00288648277122709,-0.0041245704317902,0.00719044203141999,0.595376526780268
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSAP,Gamma-secretase-activating protein,39980,0.00458019635468704,0.00870210921029199,-0.0124759376974853,0.0216363304068593,0.598665245256706
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL34,Interleukin-34,39934,0.00181140110434314,0.0034866305133631,-0.00502239470184855,0.00864519691053482,0.603400234048205
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37598,0.00112100369876537,0.00218592481508818,-0.00316340893880746,0.0054054163363382,0.608080179165615
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYT1,Synaptotagmin-1,37942,-0.00194038534806679,0.00381651439936317,-0.00942075357081861,0.00553998287468502,0.611168411796486
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,-0.0017518521034538,0.00347169028139088,-0.00855636505497993,0.00505266084807234,0.613839445337192
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLKB1,Plasma kallikrein,37721,0.00122582619101839,0.00246299679676871,-0.00360164753064828,0.00605329991268507,0.618705849211649
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHD,SH2 domain-containing adapter protein D,37531,0.00425181567585987,0.00855869932961499,-0.0125232350101855,0.0210268663619053,0.619350488136496
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,-0.00243068550420732,0.00495112468415872,-0.0121348898851584,0.00727351887674378,0.623479831588754
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,-0.00252340192794486,0.00514609374982996,-0.0126097456776116,0.00756294182172186,0.623892415013567
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMOD2,Leiomodin-2,37541,0.00312072296181422,0.00637610752434529,-0.00937644778590255,0.015617893709531,0.624538325581618
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,0.00276813651746427,0.00574763167018262,-0.00849722155609367,0.0140334945910222,0.630087304306849
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFP,Properdin,38013,0.00102690649811465,0.00213289262834646,-0.00315356305344442,0.00520737604967372,0.630196033853279
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZPR1,Zinc finger protein ZPR1,37541,0.00455702166681385,0.00953317683598293,-0.0141280049317127,0.0232420482653404,0.632646008175791
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40422,0.00129107578754545,0.00270282628985318,-0.00400646374056678,0.00658861531565768,0.632887225012505
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAP25,Synaptosomal-associated protein 25,37541,-0.00217755129404958,0.00457758085615691,-0.0111496097721171,0.00679450718401796,0.634296669803507
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HK2,Hexokinase-2,40042,0.00127394526504415,0.00269011103732563,-0.00399867236811408,0.00654656289820239,0.635816019366743
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,-0.00186467572605876,0.00398049004627059,-0.00966643621674912,0.00593708476463159,0.639467883815453
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMP4,Bone morphogenetic protein 4,40203,0.00205155978079832,0.00440752396752798,-0.00658718719555651,0.0106903067571532,0.641603040658854
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTP1,Glutathione S-transferase P,39871,-0.00314902874005141,0.00678605732055777,-0.0164497010883447,0.0101516436082418,0.642622819830466
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40424,0.000945114958347169,0.00204180496817887,-0.00305682277928342,0.00494705269597776,0.643455189533778
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37482,-0.00287258837877902,0.00620947911442503,-0.0150431674430521,0.00929799068549405,0.643649211563367
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KDM3A,Lysine-specific demethylase 3A,37598,-0.00414102835552085,0.00905107410000884,-0.0218811335915382,0.0135990768804965,0.647306405024973
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHPK,Sedoheptulokinase,37714,0.00190943414772378,0.00419539347918912,-0.00631353707148689,0.0101324053669345,0.649025787932245
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRC1,Protein regulator of cytokinesis 1,37900,-0.00205629888956434,0.00455207413726335,-0.0109783641986005,0.00686576641947182,0.65147230157849
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37942,-0.00201792427909797,0.00446949696926617,-0.0107781383388597,0.00674228978066372,0.651645124770357
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,-0.00218727060998362,0.00485075254675163,-0.0116947456016168,0.00732020438164957,0.652059243711368
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37900,0.00252848747531546,0.00561140009094813,-0.00846985670294287,0.0135268316535738,0.652286339292607
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ID4,DNA-binding protein inhibitor ID-4,37714,-0.00198623972025628,0.00445737733025733,-0.0107226992875606,0.00675021984704808,0.655888235769335
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,-0.00274452477338182,0.00617631018338842,-0.0148500927328231,0.00936104318605948,0.65678728732549
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36973,0.00216208889703706,0.00492343645691578,-0.00748784655851788,0.011812024352592,0.66056605456343
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMEM25,Transmembrane protein 25,37959,0.00186376154602036,0.00427674495743066,-0.00651865857054374,0.0102461816625845,0.662996257317945
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40536,-0.000955283729011316,0.00219302753201934,-0.00525361769176921,0.00334305023374658,0.663132506554651
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCNIP4,Kv channel-interacting protein 4,39961,0.00216755713232092,0.00498971002455092,-0.00761227451579888,0.0119473887804407,0.664000098274098
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLR3,Folate receptor gamma,40355,0.00772601277724349,0.017896035403095,-0.0273502166128227,0.0428022421673096,0.66595336653009
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,-0.00295820739732177,0.00688047877375131,-0.0164439457938743,0.0105275309992308,0.667244836395565
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,-0.00242885915370427,0.00565004272270942,-0.0135029428902147,0.0086452245828062,0.667287592450612
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,-0.00382289487818737,0.00890193939955724,-0.0212706961013196,0.0136249063449448,0.667605110805177
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,0.00248492290586919,0.00592902613996325,-0.00913596832845878,0.0141058141401972,0.675141571632919
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,-0.0016806582173182,0.00404498754285611,-0.00960883380131617,0.00624751736667977,0.677788881276831
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40332,-0.00130816352806457,0.00315466883291209,-0.00749131444057226,0.00487498738444312,0.678385152136345
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37562,-0.0029076490546581,0.00701448494053416,-0.016656039538105,0.0108407414287889,0.678499608663038
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39961,-0.00225006257830585,0.00543746120118609,-0.0129074865326306,0.00840736137601889,0.679020765464122
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROBO4,Roundabout homolog 4,37628,0.000718019725766647,0.00174455548881682,-0.00270130903231432,0.00413734848384761,0.680655846170962
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,-0.00195414264536636,0.00479674396457419,-0.0113557608159318,0.00744747552519906,0.683728662722659
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRP15,RRP15-like protein,37541,-0.00364137697746341,0.00894044278615582,-0.0211646448383288,0.013881890883402,0.683799692824649
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDHB15,Protocadherin beta-15,37900,-0.00159539980145145,0.00392961869167742,-0.00929745243713919,0.00610665283423628,0.684753806981649
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,0.00303664952834189,0.0075893373813814,-0.0118384517391657,0.0179117507958494,0.689074115261307
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.00214375167952628,0.00536391329465189,-0.00836951837799142,0.012657021737044,0.689410883108716
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGM2,Phosphoglucomutase-2,37572,-0.00234135880765491,0.00587259715662743,-0.0138516492346447,0.00916893161933486,0.690126488142682
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPT1,Translationally-controlled tumor protein,40044,0.00247973961404406,0.00645696694291216,-0.0101759155940638,0.0151353948221519,0.700953345567186
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37901,0.00475285679480417,0.0125774989060857,-0.0198990410611237,0.029404754650732,0.705521480348964
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPEP,Glutamyl aminopeptidase,37562,-0.00170851272883214,0.00452166248570701,-0.0105709712008179,0.0071539457431536,0.705547724507289
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37714,0.0013847993839856,0.00368857733460195,-0.00584481219183421,0.00861441095980541,0.707347347298131
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSTN,Osteocrin,37572,0.0015815610918195,0.00421300321014805,-0.00667592520007068,0.00983904738370968,0.707369128830624
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA8,Carbonic anhydrase-related protein,37598,0.00101592167277531,0.00271818341280655,-0.00431171781632553,0.00634356116187614,0.70859617895108
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB116,Beta-defensin 116,37541,-0.00289786261972171,0.00775813992355228,-0.0181038168698842,0.0123080916304408,0.708763465088762
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGA,Fibrinogen alpha chain,37698,0.00111360764709863,0.00301338579327681,-0.00479262850772393,0.00701984380192118,0.711721017025242
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,0.00178317950527768,0.00483492477550012,-0.00769327305470256,0.0112596320652579,0.712272704492612
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPBGL,Trophoblast glycoprotein-like,37572,-0.00150530719949409,0.00408826276799807,-0.0095183022247703,0.00650768782578212,0.71272843686967
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,-0.00146931186074214,0.00400376753396001,-0.00931669622730375,0.00637807250581948,0.713637987114457
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA10,Ephrin type-A receptor 10,39961,-0.00231726082815175,0.00635253856691025,-0.0147682364192958,0.0101337147629923,0.715282746938737
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSHB,Thyrotropin subunit beta,40359,-0.00296377558236184,0.00814105693990312,-0.0189202471845719,0.0129926960198483,0.715823328088861
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNF174,Zinc finger protein 174,37598,0.00137481924369047,0.00379369948357587,-0.00606083174411824,0.00881047023149917,0.717062401668097
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,0.00303959801710085,0.00852479704472673,-0.0136690041905635,0.0197482002247652,0.721426258508676
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLIC5,Chloride intracellular channel protein 5,37572,-0.00110894082011425,0.00315758572700942,-0.00729780884505272,0.00507992720482422,0.725444730363206
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA6C,Semaphorin-6C,37598,-0.000909623526069905,0.00260042571829964,-0.0060064579339372,0.00418721088179739,0.726495958274164
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.001095801822039,0.00314731233977546,-0.00507293036392089,0.0072645340079989,0.727716589031487
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBM19,Probable RNA-binding protein 19,37562,0.00160013108210528,0.00466588765691695,-0.00754500872545195,0.0107452708896625,0.731647231959956
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRISP3,Cysteine-rich secretory protein 3,37875,-0.000906390421860203,0.00264402172902909,-0.00608867301075722,0.00427589216703681,0.731748667516911
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,-0.00151886933169396,0.00450201259303884,-0.0103428140140501,0.00730507535066216,0.735839163658859
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CORO6,Coronin-6,37541,0.00119690244023382,0.00357326482019392,-0.00580669660734626,0.0082005014878139,0.737660278269611
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDSN,Corneodesmosin,40456,-0.00138944120925343,0.00418934042378876,-0.00960054843987941,0.00682166602137255,0.740149528051498
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL36A,Interleukin-36 alpha,37598,-0.00190799808573908,0.00577748862312917,-0.0132318757870723,0.00941587961559408,0.741218624818825
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37714,0.00272401458546014,0.00831010236196047,-0.0135637860439824,0.0190118152149027,0.74307142558488
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMCN2,Hemicentin-2,37648,0.00182422018908066,0.00559795421878028,-0.00914777007972869,0.01279621045789,0.744525874672336
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,-0.000834465460687047,0.00258188582522267,-0.00589496167812348,0.00422603075674939,0.746548783880333
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,0.00095087732333272,0.00297234347698305,-0.00487491589155406,0.0067766705382195,0.749042047179289
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL4A4,Collagen alpha-4(IV) chain,37688,-0.00164292713759836,0.00514010600833998,-0.0117175349139447,0.008431680638748,0.74925460383664
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPEP2,Dipeptidase 2,40305,-0.000888635467571072,0.00278464985630752,-0.00634654918593381,0.00456927825079167,0.749640265832588
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL5,Interleukin-5,40044,-0.00448461164631073,0.01416136705601,-0.0322408910760902,0.0232716677834688,0.751491205357419
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,0.00192698414171449,0.00624559994386689,-0.0103143917482646,0.0141683600316936,0.757680366399699
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRXN3,Neurexin-3,37572,0.00104503216024082,0.00341074492344653,-0.00564002788971438,0.00773009221019601,0.759309453183636
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORF4L1,Mortality factor 4-like protein 1,37714,-0.00122038817396061,0.00400088360290659,-0.00906212003565753,0.0066213436877363,0.760348347764955
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM171B,Protein FAM171B,37900,0.000815975900374831,0.00270104754463991,-0.00447807728711939,0.00611002908786905,0.762583485211162
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,0.00078109385701895,0.00260323614063079,-0.00432124897861739,0.00588343669265529,0.764145844602016
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37562,0.000959330316669009,0.00319786350852438,-0.00530848216003878,0.00722714279337679,0.764188766142806
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37562,-0.00278261849552671,0.0094752647687394,-0.0213541374422559,0.0157889004512025,0.76901331855611
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37541,-0.00232618564354531,0.00793499164364405,-0.0178787692650876,0.013226397977997,0.769408020754646
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTNAP2,Contactin-associated protein-like 2,40341,-0.00113955853155902,0.00389309134631155,-0.00877001757032966,0.00649090050721161,0.769745338045338
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHC1,SHC-transforming protein 1,37482,-0.00333232442186107,0.0114215845499973,-0.0257186301398559,0.0190539812961337,0.770477257963819
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAND5,DAN domain family member 5,37598,-0.0015310763095458,0.0053205446346385,-0.0119593437934373,0.00889719117434567,0.77352975920487
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOA4,Apolipoprotein A-IV,38013,-0.0010324304600268,0.00359551538111979,-0.0080796406070216,0.00601477968696799,0.774006494549356
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DIPK1C,Divergent protein kinase domain 1C,37572,-0.00119971672937269,0.00420184694032018,-0.00943533673240025,0.00703590327365486,0.775249308508061
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37942,0.00110282411236158,0.00389115729108079,-0.00652384417815676,0.00872949240287992,0.7768607621975
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,-0.00053798154825685,0.00191201536629954,-0.00428553166620395,0.00320956856969025,0.778431807111086
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,-0.00188297987425647,0.00673593687655077,-0.015085416152296,0.011319456403783,0.779832341458823
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH12,Protocadherin-12,37959,-0.000697697428823246,0.0024994798543925,-0.00559667794343254,0.00420128308578605,0.780143925871985
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRR5,Proline-rich protein 5,37598,0.0013157184055818,0.00471413608546706,-0.00792398832193362,0.0105554251330972,0.780171981247946
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKD1,Polycystin-1,37990,-0.000702516138242168,0.00252193542620594,-0.0056455095736058,0.00424047729712147,0.780585000935603
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPLX2,Complexin-2,37482,-0.000840881601299579,0.00303057200789841,-0.00678080273678046,0.0050990395341813,0.781426481025688
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTM4,Glutathione S-transferase Mu 4,37562,-0.00190110760704375,0.00698413889276695,-0.015590019836867,0.0117878046227795,0.785469776271057
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,-0.000658152455906457,0.00245512624211949,-0.00547019989046066,0.00415389497864775,0.788646764584975
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,H2AP,Huntingtin-interacting protein M,37482,-0.00135368677666192,0.00509610285360599,-0.0113420483697297,0.00863467481640582,0.790527024563761
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA2,Protein disulfide-isomerase A2,37482,-0.00107913062698652,0.00406692015090458,-0.0090502941227595,0.00689203286878645,0.7907490924103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,0.00141532080065368,0.00536595543307909,-0.00910195184818134,0.0119325934494887,0.791969510544099
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEBP1,Heme-binding protein 1,40042,0.00136224810575249,0.00529791992120311,-0.00902167493980561,0.0117461711513106,0.797082693214143
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPM1A,Protein phosphatase 1A,39980,-0.000771886495323385,0.00302121581703984,-0.00669346949672147,0.0051496965060747,0.798349055682864
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40305,-0.000523032686814269,0.00205238114602172,-0.00454569973301684,0.00349963435938831,0.798848526583002
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.000862178961872958,0.00354597309605256,-0.00608792830639007,0.00781228623013598,0.807898321982459
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCNA,Proliferating cell nuclear antigen,37482,-0.00145519197373372,0.00611474383317166,-0.0134400898867502,0.0105297059392827,0.811899684100052
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37714,0.00157908035476524,0.00665330588060498,-0.0114613991712205,0.014619559880751,0.812398478550034
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFDN6,Prefoldin subunit 6,37572,0.00152329384991151,0.00647434971820532,-0.0111664315977709,0.0142130192975939,0.813994028531869
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRPX,Sushi repeat-containing protein SRPX,37990,-0.000747521953383385,0.00318640168265691,-0.00699286925139092,0.00549782534462415,0.814524677318746
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,0.000938671028997836,0.00403158145109102,-0.00696322861514056,0.00884057067313624,0.815897410106855
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,-0.00112201140500238,0.00493135192174424,-0.0107874611716211,0.00854343836161632,0.82001822507123
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RYR1,Ryanodine receptor 1,37562,-0.000750381445919806,0.00336901185345498,-0.00735364467869157,0.00585288178685195,0.823748789289144
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SKIV2L,Helicase SKI2W,37562,0.000879954825069418,0.00395684753490532,-0.00687546634334501,0.00863537599348385,0.824015431801075
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP9,Fatty acid-binding protein 9,40341,-0.0011852789310277,0.00541920220715515,-0.0118069152570518,0.0094363573949964,0.826872267840405
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,0.000929725344430066,0.00429506687799894,-0.00748860573644785,0.00934805642530799,0.828629732255283
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD70,CD70 antigen,40341,0.00087222950377111,0.00403220127738513,-0.00703088499990374,0.00877534400744596,0.828744243615488
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,-0.000726479618245148,0.0033840903407112,-0.0073592966860391,0.00590633744954881,0.830023434635221
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA4C,Semaphorin-4C,40305,-0.00058222876250699,0.00274992767014574,-0.00597208699599264,0.00480762947097866,0.832324212151944
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,0.000598351603788438,0.00283552593166397,-0.00495927922227295,0.00615598242984983,0.832875232558688
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTNL10,Butyrophilin-like protein 10,37482,-0.000857171204034488,0.00409323642574399,-0.00887991459849271,0.00716557219042374,0.834130208950323
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,0.000547492855776455,0.0026236671262442,-0.00459489471166218,0.00568988042321509,0.834705366588383
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIRREL2,Kin of IRRE-like protein 2,39961,-0.000807925907538968,0.00390040803079949,-0.00845272564790598,0.00683687383282804,0.835904166866686
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,-0.00115944707765274,0.0056111143367212,-0.0121572311776263,0.00983833702232081,0.836298908368707
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37572,0.0007401695748593,0.00360670404220565,-0.00632897034786378,0.00780930949758237,0.837403044256458
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF2RB,Cytokine receptor common subunit beta,37598,0.000885038783219587,0.00432670043454884,-0.00759529406849613,0.0093653716349353,0.837924685270878
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR101,Probable G-protein coupled receptor 101,37541,-0.00123340105354291,0.00633270141943361,-0.0136454958356328,0.011178693728547,0.845578405746915
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFDN4,Prefoldin subunit 4,37482,-0.00102346967096909,0.00531493934899748,-0.0114407507950042,0.00939381145306598,0.847302898250539
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37541,-0.00141120850469743,0.00741119440376538,-0.0159371495360776,0.0131147325266827,0.848986271291158
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.00105087892151816,0.00560437737896893,-0.00993370074126094,0.0120354585842973,0.85126339391005
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOC2B,Double C2-like domain-containing protein beta,37572,0.000640956510541521,0.00352618634492064,-0.00627036872550293,0.00755228174658598,0.855765676625334
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTF,Ciliary neurotrophic factor,37541,-0.00060261539242766,0.00332168052723644,-0.00711310922581108,0.00590787844095576,0.856041649595479
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTO1,Protein LTO1 homolog,40044,-0.000716066558636688,0.00399572038656245,-0.00854767851629909,0.00711554539902572,0.857776416207232
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAA4,Serum amyloid A-4 protein,38013,-0.000571468866410335,0.00319009955535415,-0.00682406399490446,0.00568112626208379,0.857831821191821
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,0.000599188141071936,0.00346133955258987,-0.00618503738200422,0.00738341366414809,0.862568622728555
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,-0.000957912163204805,0.00554212272462489,-0.0118204727034696,0.00990464837705998,0.862777745864806
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,0.000777128323957889,0.00462656584356013,-0.00829094072941997,0.00984519737733575,0.866608781000628
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYTH3,Cytohesin-3,37482,-0.00120337446914536,0.00721445075097636,-0.015343697941059,0.0129369490027683,0.867529561513285
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOM3,Myomesin-3,37671,-0.00144399577835542,0.00881848471737239,-0.0187282258244053,0.0158402342676945,0.869933233670098
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRR1B,Cornifin-B,37714,0.00135245360456153,0.00834268889650525,-0.0149992166325888,0.0177041238417118,0.871219784354187
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,0.000888475249381179,0.00549871467476889,-0.00988900551316585,0.0116659560119282,0.871640081636967
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37562,-0.000613236698993199,0.00379622804457946,-0.00805384366636895,0.00682737026838255,0.871671839279309
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACE,Angiotensin-converting enzyme,37987,0.000382345521404017,0.00249846360325025,-0.00451464314096647,0.0052793341837745,0.878375119600691
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,0.000603291219595746,0.00397174731361877,-0.00718133351509704,0.00838791595428853,0.879271549036577
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA11,Carbonic anhydrase-related protein 11,39980,-0.000487429467522803,0.00322260687319044,-0.00680373893897606,0.00582888000393045,0.879777983155814
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCP11,T-complex protein 11 homolog,37714,-0.000878550281841461,0.00594994388694103,-0.0125404403002459,0.010783339736563,0.88261579054631
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAM,Basal cell adhesion molecule,40332,0.000338705968225175,0.00229969453451658,-0.00416869531942732,0.00484610725587767,0.882910500008596
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37541,-0.000714726039757471,0.00491847990009975,-0.010354946643953,0.00892549456443804,0.884464869861474
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VIT,Vitrin,37990,-0.000467525986291565,0.00359331954510374,-0.0075104322946949,0.00657538032211177,0.896481512065469
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASQ2,Calsequestrin-2,37562,-0.000628401700191646,0.00488903097390661,-0.0102109024090486,0.00895409900866532,0.897729175265043
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMOD4,Tropomodulin-4,37482,0.000505083073355009,0.0040941516062791,-0.00751945407495203,0.00852962022166204,0.90181841510106
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMIGO1,Amphoterin-induced protein 1,37572,0.000597494702744426,0.0048898738720976,-0.00898665808656687,0.0101816474920557,0.902750253105111
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.000767593441762991,0.00631190082019051,-0.0116037321658104,0.0131389190493364,0.903209336499915
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HRAS,GTPase Hras,37697,-0.0011335649424917,0.00963631638514072,-0.0200207450573675,0.0177536151723841,0.906358913014073
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RELB,Transcription factor RelB,37598,-0.000586047887733011,0.00503805040017557,-0.0104606266720771,0.0092885308966111,0.907397272871972
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAGLN3,Transgelin-3,37482,0.000675113650560776,0.00596582235564971,-0.0110178981665127,0.0123681254676342,0.909902634346839
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBR1,T-box brain protein 1,37572,-0.000536799937455358,0.0047759200522685,-0.00989760323990162,0.00882400336499091,0.910510212093294
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37572,0.00069687438247399,0.00657377909049077,-0.0121877326348879,0.0135814813998359,0.915577479666186
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL24,C-C motif chemokine 24,40396,-0.000842627071731207,0.00804932761571554,-0.0166193091985337,0.0149340550550712,0.916628736764888
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACHE,Acetylcholinesterase,37671,0.000326993963875749,0.00312618749638746,-0.00580033352904367,0.00645432145679517,0.916696133797335
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37562,-0.00058648789884173,0.00565398479195574,-0.011668298091075,0.0104953222933915,0.917385197280694
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.000702894660878154,0.00716214722283329,-0.0133349138958751,0.0147407032176314,0.921822458266081
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37482,-0.00086063477228056,0.00885988231746054,-0.0182260041145032,0.0165047345699421,0.922617982068364
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,-0.000313943725114868,0.00333387533287866,-0.00684833937755705,0.00622045192732731,0.92497729017206
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUOX2,Dual oxidase 2,40042,-0.000658623559721254,0.00704984259073463,-0.0144763150375611,0.0131590679181186,0.925568030468682
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMCH,Pro-MCH,37562,0.000735305436070106,0.00828392911979131,-0.0155011956387209,0.0169718065108611,0.929271711644894
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.000709416488989733,0.00807125731372998,-0.0165290808239005,0.015110247845921,0.929962114787802
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRD2,Bromodomain-containing protein 2,37541,0.000296432893681859,0.00338770136217889,-0.00634346177618877,0.00693632756355248,0.93027330663945
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.000454213659129123,0.00532459015462035,-0.010890410362185,0.00998198304392676,0.932020279536008
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GH2,Growth hormone variant,39980,-0.00139685172636521,0.0164382264783361,-0.033615775623904,0.0308220721711736,0.932281711831673
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANK2,Ankyrin-2,37562,0.000613143255195696,0.00723871625183308,-0.0135747405983971,0.0148010271087885,0.932498554659113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37541,-0.000449418770563739,0.00532111748313353,-0.0108788090375055,0.00997997149637797,0.93269241638104
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,-0.000508426019973304,0.00622853784826882,-0.0127163602025802,0.0116995081626336,0.934943414150085
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,-0.000380036931297762,0.00474160368788157,-0.00967358015954564,0.00891350629695012,0.936119616578188
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,0.000242502973820646,0.00316691752893364,-0.0059646553828893,0.00644966133053059,0.938963754623078
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37598,-0.000366019637825741,0.00478129529530452,-0.0097373584166226,0.00900531914097112,0.938980790708501
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAP1,Antigen peptide transporter 1,37714,-0.000460620011603698,0.00603575911844194,-0.0122907078837499,0.0113694678605425,0.939169504540355
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUP50,Nuclear pore complex protein Nup50,37562,-0.00024876413461379,0.0034633732059614,-0.00703697561829813,0.00653944734907055,0.942740582880506
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROS1,Vitamin K-dependent protein S,38013,0.00016280666406485,0.00244897524877865,-0.00463718482354131,0.00496279815167101,0.946997053677021
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ISM2,Isthmin-2,37998,0.000272422962973323,0.00434889206290249,-0.00825140548031556,0.0087962514062622,0.950052569226515
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCC,Netrin receptor DCC,37572,0.00013777743868248,0.0022858084392553,-0.00434240710225791,0.00461796197962287,0.951937414169919
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.000277738530458128,0.00477541591316555,-0.00908207665934634,0.0096375537202626,0.953622037983726
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NGF,Beta-nerve growth factor,40228,-6.68301324553916e-05,0.00118363504629968,-0.00238675482320276,0.00225309455829198,0.954974663246349
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37714,-0.000368776628401441,0.00657920523318005,-0.0132640188854343,0.0125264656286315,0.95530134567421
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,-0.000249122869630661,0.00502452037251645,-0.0100971827997629,0.00959893706050158,0.96045671218031
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUCL3,Mucin-like protein 3,37482,-0.000214659660772745,0.00440787173430659,-0.00885408826001367,0.00842476893846818,0.961159789903365
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXDC1,Plexin domain-containing protein 1,39980,-0.000146730564395457,0.00330531734210159,-0.00662515255491457,0.00633169142612366,0.964592288127388
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,-0.000118036240140972,0.00275310547916218,-0.00551412297929884,0.00527805049901689,0.965802742846287
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,-0.000485018156401234,0.0116595777917737,-0.0233377906282778,0.0223677543154753,0.966819492448848
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A13,Protein S100-A13,37598,0.000137640686555867,0.00339931852034096,-0.00652502361331241,0.00680030498642414,0.967702559589795
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37482,0.00011444414618409,0.00285278858393625,-0.00547702147833097,0.00570590977069915,0.968000791217986
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAGE2A,G antigen 2A,37482,0.000222216639356988,0.0060906784987238,-0.0117155132181417,0.0121599464968556,0.970896429059124
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FH,"Fumarate hydratase, mitochondrial",37541,-0.000295244956569648,0.00839218116984366,-0.0167439200494632,0.0161534301363239,0.971935984202127
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NLGN2,Neuroligin-2,37541,8.84301205228629e-05,0.0047369810720197,-0.00919605278063575,0.00937291302168148,0.98510621405892
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR158,Probable G-protein coupled receptor 158,37959,-5.67077702071593e-05,0.00360117858680717,-0.00711501780034922,0.0070016022599349,0.987436461199748
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2,Interleukin-2,40044,-4.77733050825411e-05,0.00304153195993335,-0.0060091759465519,0.00591362933638682,0.987468353272843
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF3,Fibroblast growth factor 3,37598,4.61782199035425e-05,0.0029777293058791,-0.0057901712196195,0.00588252765942658,0.987627246340035
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40465,5.49218819036641e-05,0.00393147659001308,-0.00765077223452198,0.00776061599832931,0.988854260957233
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUC2,Mucin-2,37998,8.57015438059684e-05,0.00884263282625592,-0.0172458587956556,0.0174172618832676,0.992267279729505
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFAP2A,Transcription factor AP-2-alpha,37541,-5.64750140732077e-05,0.00594819944535401,-0.0117149459269671,0.0116019958988207,0.992424765756615
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAX,Integrin alpha-X,37714,-4.94802739041922e-05,0.00540723193438425,-0.0106476548652973,0.0105486943174889,0.992698990560765
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37541,4.83521742596068e-05,0.00556073489866603,-0.0108506882271258,0.010947392575645,0.99306238635892
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPESP1,Sperm equatorial segment protein 1,37990,-2.08683232199165e-05,0.00269118178397776,-0.00529558461981634,0.0052538479733765,0.993813112641128
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,-2.58979076480134e-05,0.00337252044403165,-0.00663603797795004,0.00658424216265401,0.993873145616376
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37482,-1.07395635691858e-05,0.00545845986512041,-0.0107093208992052,0.0106878417720668,0.998430186858867
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,-2.54766947587215e-06,0.00283702188385995,-0.00556311056184136,0.00555801522288962,0.999283504548676
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF16,Fibroblast growth factor 16,37598,-1.79452484715863e-06,0.00479826956643427,-0.00940640287505832,0.00940281382536401,0.999701601507103
